rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TATCTCTGTGCCAGCAGCCGAGAATAGGATCTCTGTGCCAGCAGCTTGTGATACCGGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	57	3.198258351943082E-4		68	TCRBV04	TCRBV04-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	5	31	0	6	23	-1	54	60														X+TCRBV04-02+TCRBJ02-07	TCRBV04-02*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGACAGTCGCACAGATACGCAGTATTTTGGCCCA	CASSLDSRTDTQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	5	1	0	2	18	-1	38	34	40														CASSLDSRTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATACAGGGCTGGAAACACCATATATTTTGGAGAG	CASSLYRAGNTIYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	3	2	1	0	18	33	-1	34	40														CASSLYRAGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTCGGACTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGLSSYNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	0	3	3	18	30	38	33	41						01,02								CASSLGLSSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTACGGCGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGGTNTGELFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	7	3	0	3	0	18	31	-1	34	40														CASSYGGTNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATCGACGGGGGGGCTACCAGATACGCAGTATTTTGGCCCA	CASSLSTGGLPDTQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	0	4	4	4	18	33	45	37	49														CASSLSTGGLPDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGATGCAGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLDAGSSYEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	1	4	3	0	3	2	18	34	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDAGSSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGTCTCGACAACGCGACGAATGAAAAACTGTTTTTTGGCAGT	CASSLDNATNEKLFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	6	5	4	8	18	29	37	33	45														CASSLDNATNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGTTCGAGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLFELAKNIQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	6	7	0	5	1	18	32	40	37	41						01,02								CASSLFELAKNIQYF+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGCACCGTCAGCTAACTATAGCTACACCTTCGGTTCG	CASSLAPSANYSYTF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	3	9	9	11	2	18	35	50	46	52						01,02								CASSLAPSANYSYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTCGTCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	24	1.346635095554982E-4		44	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	4	1	5	0	18	31	-1	36	40						01,02								X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTCAGGGGCCCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	1.4027448912031063E-4		44	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	0	2	4	18	30	38	32	42														X+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTTCAACCCTCCGGTGTGGATGAGCAGTTCTTCGGGCCA	CASSFQPSGVDEQFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	5	8	9	5	18	32	44	41	49						01,02								CASSFQPSGVDEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGGTCGACTAGCGGGGGGGCCCAAGGAGAGACCCAGTACTTCGGGCCA	CASRSTSGGAQGETQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	4	3	7	18	29	46	32	53														CASRSTSGGAQGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCAGGACAGGGCAGGGGGAGACCCAGTACTTCGGGCCA	CASSRTGQGETQYF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	5	1	6	18	30	39	31	45														CASSRTGQGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGGTCGCAGGTCCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGSQVRTGELFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	4	4	5	4	19	35	44	40	48														CASSLGSQVRTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGGGCTAGCGCACACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGLAHTSTDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	51	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	6	0	4	6	19	33	43	37	49						01,02								CASSLGLAHTSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGACAGGGCCGGGGGAGAGCAGTACTTCGGGCCG	CASSLDRAGGEQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	7	0	8	19	-1	41	33	49														CASSLDRAGGEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGGGTACAGGGGGCGTCTGGGGACTGAAGCTTTCTTTGGACAA	CASSGYRGRLGTEAFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	5	4	8	19	31	44	35	52														CASSGYRGRLGTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCACCCGACAGGGAGAGTCCTACGAGCAGTACTTCGGGCCG	CASTRQGESYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	3	1	5	4	19	27	39	32	43														CASTRQGESYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCTCAATAGCGGGAGTGAAGCAGAGACCCAGTACTTCGGGCCA	CASSLNSGSEAETQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	2	4	5	6	19	31	45	36	51														CASSLNSGSEAETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTGGAGGAAAATACAATGAGCAGTTCTTCGGGCCA	CASSFGGKYNEQFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	1	4	1	4	19	33	39	34	43														CASSFGGKYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGGTGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGWSTDTQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	0	0	10	0	0	3	19	-1	37	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCCATCCATTTCTGCGTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	24	1.346635095554982E-4		52	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-06	01	8	3	6	5	16	5	19	27	46	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-05+TCRBJ02-06	TCRBV07-05*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCATCTCTAGTGAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSISSEISQSRANVLTF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	57	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	4	8	5	4	17	19	31	39	35	56						01,02								CASSISSEISQSRANVLTF+TCRBV07-05+TCRBJ02-06	TCRBV07-05*01	TCRBD02-01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAAAAATACTGCGCCGCACATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	27	1.5149644824993548E-4		49	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	3	10	6	8	9	19	31	42	39	51						01,02								X+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01	TCRBD02-01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGGACAGGGGGCAGGCAATGAGCAGTTCTTCGGGCCA	CASSLGQGAGNEQFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	0	6	0	3	19	-1	45	33	48														CASSLGQGAGNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTATNEKLFF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	5	0	0	0	19	-1	-1	33	38														CASSLTATNEKLFF+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGAGGGGCATGGGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASRRGMGQGAYEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	2	9	0	23	34	-1	43	54			01,02										Vb 1	CASRRGMGQGAYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGACGGACGGATGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	7.294273434256153E-5		46	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	3	1	7	0	3	6	23	36	43	39	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGACAGGCAGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASRQAGTNEKLFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	4	1	0	4	23	-1	39	34	43			01,02										Vb 1	CASRQAGTNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTAAACTCCGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	7.855371390737395E-5		38	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	10	6	5	3	23	35	43	40	46			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCGACAGCCCTACGAGCAGTACTTCGGGCCG	CASSRQPYEQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	2	1	1	23	35	41	36	42			01,02										Vb 1	CASSRQPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGGGGACTAGCGGAACCCAAGAGACCCAGTACTTCGGGCCA	CASSGGTSGTQETQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	5	1	2	3	23	36	49	38	52			01,02			01,02							Vb 1	CASSGGTSGTQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGAGGGACAGGGTGCGCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	8.97756730369988E-5		46	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	8	4	5	23	37	50	41	55			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCGCGTGCACAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CAACTGAYNEQFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	3	2	2	6	0	23	29	-1	35	42			01,02										Vb 1	CAACTGAYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGCCCACTAGCGGGAGACTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	1.1783057086106093E-4		50	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	3	2	3	4	3	23	37	52	41	55			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCGTACCATGACGGCCCTACGAGCAGTACTTCGGGCCG	CASTVP*RPYEQYF	Stop	VDJ	1	22	1.2344155042587335E-4		42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	1	2	7	2	4	3	23	38	45	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASTVP*RPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGCGACTAGCGGTGGCACAGATACGCAGTATTTTGGCCCA	CASSPATSGGTDTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	5	1	5	2	23	35	49	40	51			01,02			01,02							Vb 1	CASSPATSGGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSEGGETQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	0	5	1	0	23	36	-1	37	44			01,02										Vb 1	CASSEGGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGAAGGTGGAAACACCATATATTTTGGAGAG	CASSAEGGNTIYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	3	5	4	3	4	0	23	36	-1	40	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAEGGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCTGGGACAGGGAGGGCCAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTWDREGQSSYNEQFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	0	3	10	23	33	45	36	55			01,02										Vb 1	CASTWDREGQSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGCCGGGACTAGCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSAAGTSLYNEQFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	7	3	5	2	23	36	50	41	52			01,02			01,02							Vb 1	CASSAAGTSLYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGACAGGGGAAAATTCACCCCTCCACTTTGGGAAC	CASSVTGENSPLHF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	2	2	7	0	2	23	-1	45	37	47			01,02										Vb 1	CASSVTGENSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAATGCGGAGGTTAACTATGGCTACACCTTCGGTTCG	CASSVNAEVNYGYTF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	1	1	5	1	23	38	48	43	49			01,02										Vb 1	CASSVNAEVNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCGGGCGGGCGCGACACAGATACGCAGTATTTTGGCCCA	CASSVAGGRDTDTQYF	In	VDJ	16	552	0.0030972607197764586	0.003790818253613982	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	4	2	3	5	23	39	47	42	52			01,02			01,02							Vb 1	CASSVAGGRDTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCCTCCAGTACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVASSTSTDTQYF	In	VDJ	16	575	0.0032263132497671442	0.003948769014181231	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	4	5	0	4	4	23	39	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVASSTSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTCCGACAGGGGGGATGAAAAACTGTTTTTTGGCAGT	CASSSDRGDEKLFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	1	6	2	1	19	32	43	34	44														CASSSDRGDEKLFF+TCRBV11-01+TCRBJ01-04	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGGGCTAGCGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLGLAGGQETQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	2	2	0	19	35	-1	37	49														CASSLGLAGGQETQYF+TCRBV11-01+TCRBJ02-05	TCRBV11-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTCTCCCTCCAGGGGGCTAGTCTACGAGCAGTACTTCGGGCCG	CASSSPSRGLVYEQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	48	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	0	3	7	4	19	32	47	39	51														CASSSPSRGLVYEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGTGGCAGAACGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGTCCAGGGGGTACGCAGTATTTTGGCCCA	CASSQSPGGTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	8	4	0	34	49	-1	53	60													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCGGGTATAATTCACCCCTCCACTTTGGGAAC	CASSQAGYNSPLHF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	8	4	4	1	0	29	45	-1	46	50						01,02							Vb 16	CASSQAGYNSPLHF+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAAGACAGGGATGTGGCTACACCTTCGGTTCG		Out	VDJ	1	19	1.0660861173143608E-4		40	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	7	3	3	29	43	53	46	56													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGAGGACAGGGCTTCAATATTTTGGCCCA	CASSQVRTGLQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	15	3	6	29	45	56	48	62													Vb 16	CASSQVRTGLQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGAAAGGGGAGACCCAGTACTTCGGGCCA	CASSQKGETQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	3	5	3	5	3	0	29	43	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQKGETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACCGGTATAGCGGGAGCTGGGAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	43	2.4127212128693428E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	5	2	6	6	5	28	45	60	51	65													Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAACAGGGCCCAGAGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	56	3.142148556294958E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	8	2	8	29	42	50	44	58													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGGGGGATACGCAGTATTTTGGCCCA	CASSQVGDTQYF	In	VDJ	2	59	3.310477943239331E-4	4.0517803797685676E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	1	6	2	6	1	0	29	45	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVGDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCTTGGACGGATTTTTTGGCGAGCAGTACTTCGGGCCG	CASSPLDGFFGEQYF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	4	1	7	6	4	11	29	42	50	46	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPLDGFFGEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTACAGACAGGGGAAGGTGAAAAACTGTTTTTTGGCAGT	CASSLQTGEGEKLFF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	7	5	4	29	41	54	46	58													Vb 16	CASSLQTGEGEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGGTCCCGCCTATGGCTACACCTTCGGTTCG	CASSQGGPAYGYTF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	1	6	2	4	0	6	29	-1	49	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGGPAYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGGGAGCGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASRERGAYNEQFF	In	VDJ	3	96	5.386540382219928E-4	6.592727397589534E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	1	2	2	0	29	40	-1	42	51													Vb 16	CASRERGAYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGCCCCGGGGGGACCCAGTACTTCGGGCCA	CASSQSPGGTQYF	In	VDJ	3	113	6.34040690823804E-4	7.760189540912681E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	2	7	5	0	29	44	-1	49	55													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGTAACAGGGGCTTTTACCGGGGAGCTGTTTTTTGGAGAA	CASSQDVTGAFTGELFF	In	VDJ	3	120	6.73317547777491E-4	8.240909246986917E-4	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	2	5	4	5	29	46	57	50	62													Vb 16	CASSQDVTGAFTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGGTCACTGAAGCTTTCTTTGGACAA	CASSQDRVTEAFF	In	VDJ	4	151	8.472579142866761E-4	0.0010369810802458538	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	1	1	29	46	51	47	52						01,02							Vb 16	CASSQDRVTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATCCCCAGGGGGAAGGCAGTACTTCGGGCCG	CASSQSPGGRQYF	In	VDJ	7	243	0.0013634680342494193	0.0016687841225148509	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	9	4	3	29	44	55	48	58													Vb 16	CASSQSPGGRQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCAAGGGGAGCGGGAGCATCTTACAATAGGGTGAGCAGTTCTTCGGGCCA	CASSPKGSGSILQ*GEQFF	Stop	VDJ	8	269	0.0015093535029345423		57	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	2	9	8	15	18	31	47	39	62													Vb 16	CASSPKGSGSILQ*GEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTACTCAGTCGGCGGACTCTTACTGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	27	944	0.005296764709182929		58	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	10	5	12	10	16	32	49	44	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGTCCAGGGGGTACGCAGTATTTTGGCCCA	CASSQSPGGTQYF	In	VDJ	103	3650	0.02048007541156535	0.02506609895958521	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	8	4	0	29	44	-1	48	55													Vb 16	CASSQSPGGTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCATACACTAGTGTGTTGGCTGATACGCAGTATTTTGGCCCA	CASSPYTSVLADTQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	8	6	6	10	24	36	47	42	57						01,02								CASSPYTSVLADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCCTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSVALAGGTDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	1	6	0	24	36	-1	42	52														CASSVALAGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAAGTTCCCGGGACAAGCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	7.294273434256153E-5		46	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	6	5	5	4	24	40	51	45	55														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAAGGAGTCAGGGAAACCTCTGGAAACACCATATATTTTGGAGAG	CASSQGVRETSGNTIYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	3	0	4	4	24	40	49	44	53														CASSQGVRETSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAATTGGGGACGCAGTATTTTGGCCCA	CASSVELGTQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	6	2	9	8	0	24	36	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVELGTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAGCGACAGGGGGCAAACACTAAAGCTTTCTTTGGACAA	CASSQRQGANTKAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	0	9	5	8	24	35	50	40	58														CASSQRQGANTKAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGCGCGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	9.538665260181123E-5		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	0	6	2	24	35	49	41	51														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGAGGGGGGGAACACCATATATTTTGGAGAG	CASSAEGGNTIYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	9	0	7	5	0	24	36	-1	41	48														CASSAEGGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCCCGGACAGGGAGCAGTACTTCGGGCCG	CASSVAPDREQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	7	8	0	24	36	-1	44	51														CASSVAPDREQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGGGTGGGTTCCTATGGCTACACCTTCGGTTCG	CASSRVGSYGYTF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	4	4	1	7	24	35	40	36	47						01,02								CASSRVGSYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCACCGGGACAGGGGCCGAGCAGTACTTCGGGCCG	CASSATGTGAEQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	6	6	1	24	36	52	42	53														CASSATGTGAEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTAGGACAGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSFRTGPTDTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	2	4	2	24	36	48	40	50														CASSFRTGPTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTCTTACAGCTCACTTAATCAGCCCCAGCATTTTGGTGAT	CASSYSSLNQPQHF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	3	5	4	6	7	24	31	41	37	48														CASSYSSLNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCGGGACGGAAGACGAAACACCATATATTTTGGAGAG	CASSGRDGRRNTIYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	5	0	7	5	4	7	24	36	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRDGRRNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGCTAGCGGGGGGTCCGCTACCGGGGAGCTGTTTTTTGGAGAA	CASSLASGGSATGELFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	5	4	6	24	36	51	40	57														CASSLASGGSATGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGTCTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSVGSSGGADTQYF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	4	7	0	24	36	-1	43	55														CASSVGSSGGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGAACAGGGGCAGGCTATACAAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	39	2.1882820302768458E-4		59	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	2	0	5	13	22	34	46	39	59														X+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCCCTGGGACTAGCGGGAGTTGGGATACGCAGTATTTTGGCCCA	CASSSPGTSGSWDTQYF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	2	6	6	4	24	36	56	42	60														CASSSPGTSGSWDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGGACCACAATGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSRTTMPE*KTYGYTF	Stop	VDJ	1	44	2.468831008517467E-4		54	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	1	7	4	1	21	24	36	41	37	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTTMPE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCTCAAGGCGGGCTAACTATGGCTACACCTTCGGTTCG	CASSPSRRANYGYTF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	0	8	0	24	36	-1	44	49						01,02								CASSPSRRANYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGACAGGACCGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	67	3.759356308424325E-4		44	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	2	4	5	24	36	46	40	51														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAACGACAGGGACTCTGGAAACACCATATATTTTGGAGAG	CASRNDRDSGNTIYF	In	VDJ	3	100	5.610979564812425E-4	6.867424372489098E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	0	4	1	24	35	46	39	47														CASRNDRDSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGACCGGGGGGCAGTAAAAACATTCAGTACTTCGGCGCC	CASRPGGSKNIQYF	In	VDJ	6	202	0.0011334178720921097	0.0013872197232427978	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	8	1	4	2	4	24	35	44	37	48														CASRPGGSKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGTGGAGATACGCAGTATTTTGGCCCA	CASSLGGDTQYF	In	VDJ	6	215	0.0012063606064346714	0.001476496240085156	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	5	4	5	2	3	24	36	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAGTCAGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSEAVRGTGELFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	5	3	1	23	40	49	43	50														CASSEAVRGTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCCGTAGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	6.172077521293668E-5		38	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	5	4	6	5	0	23	39	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGTCCAGGTCCGAAGCTTTCTTTGGACAA	CASSEASRSEAFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	8	3	3	23	40	47	43	50														CASSEASRSEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCAGGCAGATACGCAGTATTTTGGCCCA	CASSEAQADTQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	4	1	0	23	40	-1	41	45														CASSEAQADTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGATAAGTACCGATCTAACTATGGCTACACCTTCGGTTCG	CASSEDKYRSNYGYTF	In	VDJ	6	216	0.0012119715859994838	0.001483363664457645	48	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-02	01	1	2	8	0	9	1	23	39	50	48	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDKYRSNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAAGTGTGGGAGATACGCAGTATTTTGGCCCA	CASSLSVGDTQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	39	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-03	01	2	0	9	5	5	0	22	37	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSVGDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCAGCTGTGTATCTCTGTGTTTATTAACAGAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	1.346635095554982E-4		37	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	13	3	5	1	7	3	22	26	37	33	40														X+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTATTAGGCAGCTATAATTCACCCCTCCACTTTGGGAAC	CASSLLGSYNSPLHF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	45	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-06	01	2	4	5	3	5	0	22	37	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGSYNSPLHF+TCRBV07-04+TCRBJ01-06	TCRBV07-04*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGAACACACAGATACGCAGTATTTTGGCCCA	CASSLEHTDTQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	39	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	6	2	1	0	22	38	-1	39	42														CASSLEHTDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCCGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CACPSNTGELFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	6	0	2	1	26	34	38	36	39			unresolved			01,02							Vb 20	CACPSNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGATGGGGCAGCAACACTGAAGCTTTCTTTGGACAA	CAWRWGSNTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	2	2	3	26	37	44	39	47													Vb 20	CAWRWGSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGCAGGGGATCAGCCCCAGCATTTTGGTGAT	CAWSAAGDQPQHF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	5	3	0	26	39	-1	42	48			unresolved										Vb 20	CAWSAAGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGAAGGGGAGCAATGGCTACACCTTCGGTTCG	CAWSVKGSNGYTF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	0	5	2	6	2	4	26	40	47	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVKGSNGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGACGGACGGCTAACTATGGCTACACCTTCGGTTCG	CAGRTANYGYTF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	8	1	7	0	0	6	26	-1	36	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAGRTANYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWSRVNTGELFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	2	1	1	1	26	38	42	39	43			unresolved										Vb 20	CAWSRVNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTATCTCTGTGCCTGGAGTCCGATGCGGACTAGCGGGGGCGTCTTTTTCAGGGTCAATGAGCAGTTCTTCGGGCCA	CAWSPMRTSGGVFFRVNEQFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	63	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	6	7	15	9	21	41	28	56			01,02										Vb 20	CAWSPMRTSGGVFFRVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTAGTGCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSVVVRSYNEQFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	8	0	2	4	26	40	45	42	49						01,02							Vb 20	CAWSVVVRSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCGGGACACAGCAAGCAGATACGCAGTATTTTGGCCCA	CAWSSGTQQADTQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	6	4	3	7	26	38	47	41	54													Vb 20	CAWSSGTQQADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAGCCTAGCGCACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	1.571074278147479E-4		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	6	3	4	1	26	38	48	42	49			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAAGGGTTCAAATGGCTACACCTTCGGTTCG	CAWSVKGSNGYTF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	0	5	3	6	2	5	26	40	46	42	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVKGSNGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCTCAAGAGGGACACTTAACTATGGCTACACCTTCGGTTCG	CAWSVRSRGTLNYGYTF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	6	1	10	2	26	40	56	50	58													Vb 20	CAWSVRSRGTLNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCCTGTCCCCGAACACTGAAGCTTTCTTTGGACAA	CAWSTLSPNTEAFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	3	7	1	0	9	26	-1	40	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSTLSPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGATTATCTATTTAGGGAAGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	1.8516232563881003E-4		44	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	8	0	8	4	14	4	26	32	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGGGTACAGGGGCCTCCCCACAGATACGCAGTATTTTGGCCCA	CAWSLGYRGLPTDTQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	2	2	7	6	26	38	52	45	58													Vb 20	CAWSLGYRGLPTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTCCCCCCCCCAGGGAGACCCAGTACTTCGGGCCA	CAWSPPPPRETQYF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	5	11	0	26	38	-1	49	53													Vb 20	CAWSPPPPRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTTTTGCCTAGCGGGGCCGGGGCCGGGGAGCTGTTTTTTGGAGAA	CAWSVLLPSGAGAGELFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	54	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	6	8	6	26	40	57	48	63													Vb 20	CAWSVLLPSGAGAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCGAACTAGCGGCGTATCCTACAATGAGCAGTTCTTCGGGCCA	CAWSRTSGVSYNEQFF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	5	1	4	4	26	37	49	41	53			unresolved			01,02							Vb 20	CAWSRTSGVSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTAGACGGCCTATGGGCAGTACTTCGGGCCG	CAWS*TAYGQYF	Stop	VDJ	1	42	2.3566114172212185E-4		36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	2	2	7	9	2	9	26	38	43	40	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWS*TAYGQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTCGGGGACAATCTGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSARGQSGNQPQHF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	6	2	4	5	26	39	49	43	54													Vb 20	CAWSARGQSGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGAACTAGCGGGAGACACAGATACGCAGTATTTTGGCCCA	CAWKELAGDTDTQYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	2	2	4	1	26	36	51	40	52													Vb 20	CAWKELAGDTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTGGCAGCGACTTTCACAGATACGCAGTATTTTGGCCCA	CAWSLAATFTDTQYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	10	2	8	2	26	38	50	46	52						01,02							Vb 20	CAWSLAATFTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGGGTCTGGAAACACCATATATTTTGGAGAG	CAWKGSGNTIYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	5	3	1	1	0	26	36	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAATCCCAGGAGTCGGCCGGCTACACCTTCGGTTCG	CAWKSQESAGYTF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	4	4	4	8	5	8	26	36	45	41	53			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKSQESAGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCTGGACGGAACTATGGCTACACCTTCGGTTCG	CAWSPGRNYGYTF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	3	1	7	2	4	2	26	37	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGRNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCAGCCGTTCTGGGGGGCACTGAAGCTTTCTTTGGACAA	CAWTPAVLGGTEAFF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	1	4	13	0	26	36	-1	49	55			unresolved										Vb 20	CAWTPAVLGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACTAGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWRLAANTGELFF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	3	5	0	0	0	26	-1	-1	37	45			unresolved			01,02							Vb 20	CAWRLAANTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTAAGGGGGCCACTGAAGCTTTCTTTGGACAA	CAWSVKGATEAFF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	4	2	0	26	40	-1	42	49			unresolved										Vb 20	CAWSVKGATEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTCAGGGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSFRGGSYNEQFF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-01	01	3	4	1	1	3	3	26	37	47	40	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFRGGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCCCCCCGTTAGCGGGAGGGTCTACGAGCAGTACTTCGGGCCG	CAWRPPVSGRVYEQYF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	0	3	9	1	26	37	57	46	58													Vb 20	CAWRPPVSGRVYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTCGGGGTTTCCTACGAGCAGTACTTCGGGCCG	CAWSVLGVSYEQYF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	1	3	2	26	40	48	43	50			unresolved										Vb 20	CAWSVLGVSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTTAGACAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	62	3.4788073301837035E-4		38	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	1	3	0	26	35	-1	38	45			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCCTCTAGTCGGGGGCTACGAGCAGTACTTCGGGCCG	CAWSPPLVGGYEQYF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	2	3	11	0	26	38	-1	49	55			unresolved										Vb 20	CAWSPPLVGGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAGACGGGGGTGAGCAGTTCTTCGGGCCA	CAWSVLDGGEQFF	In	VDJ	2	76	4.264344469257443E-4	5.219242523091715E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	9	6	0	26	40	-1	46	52													Vb 20	CAWSVLDGGEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTCCCGGGGGGCCTGGAAACACCATATATTTTGGAGAG	CACPGGPGNTIYF	In	VDJ	2	78	4.3765640605536915E-4	5.356591010541496E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	8	1	2	3	1	26	34	44	37	45													Vb 20	CACPGGPGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAGGAAACATTCAGTACTTCGGCGCC	CAWSAGNIQYF	In	VDJ	2	81	4.544893447498064E-4	5.562613741716169E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	4	6	0	0	26	-1	-1	39	43			unresolved										Vb 20	CAWSAGNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAGGGGGCTTTGGAAACACCATATATTTTGGAGAG	CAWSEGGFGNTIYF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	5	0	3	1	2	26	39	47	40	49													Vb 20	CAWSEGGFGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTAAGGGGTCCTATGGCTACACCTTCGGTTCG	CAWSVKGSYGYTF	In	VDJ	3	103	5.779308951756797E-4	7.073447103663771E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	4	2	2	26	40	47	42	49			unresolved										Vb 20	CAWSVKGSYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACAGCGGGAGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSVTAGVSYNEQFF	In	VDJ	3	115	6.452626499534288E-4	7.897538028362463E-4	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	2	0	3	1	26	40	51	43	52			unresolved										Vb 20	CAWSVTAGVSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCACACAGGGGGGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSHTGGVSYNEQFF	In	VDJ	5	181	0.0010155873012310489	0.0012430038114205268	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	1	0	4	3	26	37	49	41	52			unresolved										Vb 20	CAWSHTGGVSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCGGCAGTTGGTTCACCCCTCCACTTTGGGAAC	CAWSVPAVGSPLHF	In	VDJ	5	188	0.001054864158184736	0.0012910757820279505	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	0	4	5	9	5	4	26	40	48	45	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPAVGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGGCACGCTTTGGAACAGATACGCAGTATTTTGGCCCA	CAWSWARFGTDTQYF	In	VDJ	6	215	0.0012063606064346714	0.001476496240085156	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	8	0	3	1	10	26	38	43	39	53			unresolved										Vb 20	CAWSWARFGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCGAGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CAWSSRGAKNIQYF	In	VDJ	9	320	0.001795513460739976	0.0021975757991965113	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	11	0	1	4	0	26	38	-1	42	47			unresolved										Vb 20	CAWSSRGAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATATAGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CAWNIGSYNEQFF	In	VDJ	11	396	0.00222194790766572	0.0027195000515056827	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	4	5	4	1	4	1	26	36	43	40	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNIGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAGTAGCTCGCGGGGGACTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	7.294273434256153E-5		53	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	2	1	7	3	23	40	54	47	57														X+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCACTCCTACAGGGGGCGTAAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	8.416469347218638E-5		47	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	0	4	5	5	23	33	47	38	52														X+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGACAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQGTSSYEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	6	0	0	2	23	-1	44	39	46														CASSQGTSSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTGGGTTTCTAATTCACCCCTCCACTTTGGGAAC	CASSQDWVSNSPLHF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-06	01	0	0	9	6	2	4	23	40	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWVSNSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGTAGGCCTAATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDVGLMNTGELFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	0	5	4	1	3	6	23	40	46	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVGLMNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGGGAGTTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPGVSSYEQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	0	0	4	23	-1	42	36	46														CASSPGVSSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGGGAGGACAGCTTGTCGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	33	1.8516232563881003E-4		59	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	1	5	1	3	10	22	38	47	41	57														X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCTAGCAGCCAAGATGAGAACGGAATGAGTGGCTACGAGCAGTACTTCGGGCCG	CASSQDENGMSGYEQYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	0	1	8	3	7	8	23	40	50	47	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDENGMSGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACACGCCCGGGACAGGAAAAGGCTCACCCCTCCACTTTGGGAAC	CASSHTPGTGKGSPLHF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	4	10	7	7	23	37	52	44	59														CASSHTPGTGKGSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGATCTGGCGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDLAVNTGELFF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	7	5	1	7	1	23	37	48	44	49						01,02								CASSQDLAVNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAACCCCCGGCAGGGGAATAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	66	3.7032465127762005E-4		40	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	2	6	8	6	23	30	44	38	50														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGTCCCAACGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDVPTYTGELFF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	0	3	7	3	7	2	23	40	49	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVPTYTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACTCAGGGGGCCGGGAGCAGTACTTCGGGCCG	CASSQDSGGREQYF	In	VDJ	3	102	5.723199156108674E-4	7.00477285993888E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	7	2	3	23	40	50	42	53														CASSQDSGGREQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCCGGGAGGACAGATACGCAGTATTTTGGCCCA	CASSQAGRTDTQYF	In	VDJ	9	306	0.001716959746832602	0.002101431857981664	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	1	3	1	0	23	39	-1	40	47														CASSQAGRTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTGGGGAGGGACAGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSGEGQGNEKLFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	45	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	4	5	0	23	35	-1	40	49													Vb 14	CASSGEGQGNEKLFF+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTAAGCACTTTAGAGCGGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	6.73317547777491E-5		52	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	0	14	0	23	35	-1	49	54						01,02							Vb 14	X+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTACGGTCCAGGAGTTAGTATCAGCCCCAGCATTTTGGTGAT	CASSLRSRS*YQPQHF	Stop	VDJ	1	20	1.122195912962485E-4		48	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-05	01	2	4	4	5	5	7	23	38	47	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSLRSRS*YQPQHF+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTGCGGATACGGGACAGGCCTACGAGCAGTACTTCGGGCCG	CASSADTGQAYEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	45	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	2	8	0	23	35	-1	43	51													Vb 14	CASSADTGQAYEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTATAGCGGGAGAGATGAGCAGTTCTTCGGGCCA	CASSYSGRDEQFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	8	1	2	23	36	46	37	48													Vb 14	CASSYSGRDEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTTTGGACGGGAACTAACTATGGCTACACCTTCGGTTCG	CASSFWTGTNYGYTF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	3	0	5	1	23	37	47	42	48													Vb 14	CASSFWTGTNYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATCTCCGGGACTAGCGGGAGGATACGAGCAGTACTTCGGGCCG	CSVESPGLAGGYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	1	4	5	1	25	37	57	42	58													Vb 4	CSVESPGLAGGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCTTGGACTAGCGGGGGATTAAAGCAGTTCTTCGGGCCA	CSVSWTSGGLKQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	11	4	5	25	34	51	38	56													Vb 4	CSVSWTSGGLKQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGGTCTTGGACCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	6.172077521293668E-5		37	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	1	7	4	7	0	25	35	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGGATTCCAACTATGGCTACACCTTCGGTTCG	CSVWDSNYGYTF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	2	1	4	25	34	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVWDSNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGATATATCTCTGCAGCGTTGTAAAGAGTCTAAACACTGAAGCTTTCTTTGGACAA	CSVVKSLNTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	4	9	2	8	0	42	52	-1	60	63						01,02							Vb 4	CSVVKSLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGTAGACTCTAATGATCAGCCCCAGCATTTTGGTGAT	CSVAVDSNDQPQHF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	2	10	5	5	6	25	35	44	40	50						01,02							Vb 4	CSVAVDSNDQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTCCCTTTGGGGGGCAATCGGACAATGAGCAGTTCTTCGGGCCA	CSAPFGGQSDNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	7	6	0	5	9	6	25	32	47	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAPFGGQSDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGACCGATATACAATGAGCAGTTCTTCGGGCCA	CSVEGPIYNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	3	0	7	4	0	5	25	-1	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGPIYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCACTCTCGGACAGGGAGGGCTATGGCTACACCTTCGGTTCG	CSVSLSDREGYGYTF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	8	4	25	34	50	42	54													Vb 4	CSVSLSDREGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTTTGGACGGGGAGGGTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	1.0099763216662365E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	5	9	2	25	33	49	42	51													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAAGTGGACGGGGGTTGCGGGAGCAGTTCTTCGGGCCA	CSVGSGRGLREQFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	10	8	6	25	35	49	43	55													Vb 4	CSVGSGRGLREQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACGGGGGGCAAGCAACACTGAAGCTTTCTTTGGACAA	CSVRGASNTEAFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	2	1	5	25	33	41	34	46													Vb 4	CSVRGASNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAACGGCCCCTGAAGCTTTCTTTGGACAA	CSVGTAPEAFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	33	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	9	0	6	4	2	25	35	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGTAPEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCATCGACTAGCGGGTACGAGCAGTACTTCGGGCCG	CSASTSGYEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	2	4	4	4	0	25	32	-1	36	46						01,02							Vb 4	CSASTSGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAGGGGGGACAAGGCTCTGAAGCTTTCTTTGGACAA	CSAQGGQGSEAFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	1	6	2	9	25	32	41	34	50													Vb 4	CSAQGGQGSEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAACGTAGCGGGGCGCGGGGTTACGCAGTATTTTGGCCCA	CSVDNVAGRGVTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	3	8	5	8	25	36	49	41	57													Vb 4	CSVDNVAGRGVTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTATTGGGGGTTCCGGACACCGGGGAGCTGTTTTTTGGAGAA	CSVVLGVPDTGELFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	4	6	1	3	4	6	25	35	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVLGVPDTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGACAGGGTTGGAGTTTGCCGCTTTCTTTGGACAA	CSATGLEFAAFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	11	1	12	25	32	40	33	52													Vb 4	CSATGLEFAAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTTGGGGCCAAGCGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	1.4027448912031063E-4		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	1	3	6	25	36	44	39	50													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTCAGGCGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	1.6271840737956033E-4		37	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	7	4	4	5	0	25	36	-1	41	46						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGCGGGAGGTCTCCTACGAGCAGTACTTCGGGCCG	CSVGGREVSYEQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	1	0	4	1	25	35	47	39	48													Vb 4	CSVGGREVSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCAAGAGACAAGGGAGCCACTGAAGCTTTCTTTGGACAA	CSARDKGATEAFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	2	4	10	1	25	32	47	42	48													Vb 4	CSARDKGATEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCGTAGGGGGAGAGACCCAGTACTTCGGGCCA	CSVVVGGETQYF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	4	4	0	25	35	-1	39	45													Vb 4	CSVVVGGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGAGGGACTAGCGAGCAACAATGAGCAGTTCTTCGGGCCA	CSAEGLASNNEQFF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	6	5	4	4	25	32	46	36	50						01,02							Vb 4	CSAEGLASNNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCAGAGACTCTGGAAACACCATATATTTTGGAGAG	CSVARDSGNTIYF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	4	4	5	0	1	3	25	35	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVARDSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTATCGCCGGAAGGCACTGAAGCTTTCTTTGGACAA	CSVEVSPEGTEAFF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	1	8	4	7	3	25	38	48	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEVSPEGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGCCCCCGAGCCGGAACACTGAAGCTTTCTTTGGACAA	CSVEPPSRNTEAFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	7	1	7	2	25	36	46	43	48						01,02							Vb 4	CSVEPPSRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGAGCGGGAGGCTTCAGATACGCAGTATTTTGGCCCA	CSVDEREASDTQYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	1	4	2	3	25	36	47	38	50													Vb 4	CSVDEREASDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGAGGCGGGGAGGGAGCAGTACTTCGGGCCG	CSVEEEAGREQYF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	3	7	4	3	25	39	49	43	52						01,02							Vb 4	CSVEEEAGREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCCTCAGGAGGGGCTTTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	57	3.198258351943082E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	10	0	1	5	5	25	31	42	36	47													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGACACTAATCAGCCCCAGCATTTTGGTGAT	CSVGDTNQPQHF	In	VDJ	2	59	3.310477943239331E-4	4.0517803797685676E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	6	4	0	2	25	-1	41	35	43													Vb 4	CSVGDTNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCATCAGGGGCACTCTACGAGCAGTACTTCGGGCCG	CSASGALYEQYF	In	VDJ	2	60	3.366587738887455E-4	4.1204546234934586E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	2	3	3	4	25	32	41	35	45													Vb 4	CSASGALYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGACTAGCGGGAGTGCAGATACGCAGTATTTTGGCCCA	CSVETSGSADTQYF	In	VDJ	2	62	3.4788073301837035E-4	4.257803110943241E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	2	2	4	0	2	25	-1	48	36	50													Vb 4	CSVETSGSADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCACCCCACTAGCGAGGGAGACCCAGTACTTCGGGCCA	CSVTPLARETQYF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	6	5	6	3	25	33	46	39	49						01,02							Vb 4	CSVTPLARETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGAGGGTACACTGAAGCTTTCTTTGGACAA	CSVEGGYTEAFF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	0	3	0	1	25	-1	43	36	44													Vb 4	CSVEGGYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAGACCGCAACATCGGTCCAACACACCATATATTTTGGAGAG	CSVEDQTATSVQHTIYF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	51	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	0	2	7	8	3	17	25	39	45	42	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDQTATSVQHTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGACTAGCCAGTCAAGATACGCAGTATTTTGGCCCA	CSVGLASQDTQYF	In	VDJ	2	83	4.657113038794313E-4	5.699962229165951E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	7	5	0	6	25	-1	42	33	48						01,02							Vb 4	CSVGLASQDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGATAGACCAGACAGTCTAGGAGCAGTACTTCGGGCCG		Out	VDJ	2	88	4.937662017034934E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	7	10	5	25	33	48	43	53													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTTTGAGTTACGGCTACACCTTCGGTTCG	CSVEGLSYGYTF	In	VDJ	3	99	5.5548697691643E-4	6.798750128764207E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	2	8	4	4	25	38	45	42	49													Vb 4	CSVEGLSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACCAACTACAATGAGCAGTTCTTCGGGCCA	CSVETNYNEQFF	In	VDJ	3	103	5.779308951756797E-4	7.073447103663771E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	2	3	7	3	0	3	25	-1	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVETNYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCGGGCAGGGGTGGTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	116	6.508736295182413E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	2	3	5	6	25	31	42	36	48													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGACACGCCGCCTCCTACCGGGGAGCTGTTTTTTGGAGAA	CSVRDTPPPTGELFF	In	VDJ	4	157	8.809237916755507E-4	0.0010781856264807884	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	5	1	11	25	34	41	35	52													Vb 4	CSVRDTPPPTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACGGGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	5	172	9.650884851477371E-4	0.001181196992068125	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	0	2	3	0	25	35	-1	38	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	7	248	0.0013915229320734814	0.0017031212443772963	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	0	2	2	0	25	35	-1	37	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAAAGAGTCTAAACACTGAAGCTTTCTTTGGACAA	CSVVKSLNTEAFF	In	VDJ	11	396	0.00222194790766572	0.0027195000515056827	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	4	9	2	8	0	25	35	-1	43	46						01,02							Vb 4	CSVVKSLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGACAGGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	15	517	0.0029008764350080237	0.0035504584005768636	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	1	1	1	0	25	33	-1	34	45													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCAGGGGTTTCCCACGAGCAGTACTTCGGGCCG	CASSSGVSHEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	0	6	23	-1	42	36	48		TCRBV06-07,TCRBV06-08												CASSSGVSHEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTGGCCCTTTCTACGGGTGAGCAGTTCTTCGGGCCA	CASSLALSTGEQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	4	9	9	0	19	35	-1	44	48		TCRBV05-05,TCRBV05-06,TCRBV05-07				01,02								CASSLALSTGEQFF+TCRBV05-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCAGCYRTGTATCKCTGTGCCAGCAGCCCCCCTACTAGCAGGGACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	5.610979564812425E-5		47	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	7	5	6	6	22	34	46	40	52		TCRBV07-04,TCRBV07-07				01,02								X+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAAAAAGATCTCATGTTTGACAGAACCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	6.172077521293668E-5		55	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	3	17	6	26	37	59	54	65		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCACAGGGGGCGGGCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	11	6.172077521293668E-5		41	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	18	2	13	19	31	42	33	55		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCGCTACGAGATGAAGCTTTCTTTGGACAA	CASSEALRDEAFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	9	7	1	5	23	40	44	41	49		TCRBV06-01,TCRBV06-07				01,02								CASSEALRDEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTCCGGGACCGATGGCTACACCTTCGGTTCG	CASSSGTDGYTF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	36	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	4	0	7	6	2	2	26	39	46	41	48		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTDGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCCCGACCCGAGGGGGGGATATGGCTACACCTTCGGTTCG	CASSPDPRGGYGYTF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	0	5	10	1	18	30	47	40	48		TCRBV07-06,TCRBV07-07												CASSPDPRGGYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGCCCCCGGGACAGGGAGTACGAGCAGTACTTCGGGCCG	CASSPRDREYEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	4	4	2	19	31	44	35	46		TCRBV07-04,TCRBV07-05												CASSPRDREYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGAGACAGGGATGTATTCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGDRDVFDSNQPQHF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	57	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	3	0	3	10	24	39	49	42	59		TCRBV06-07,TCRBV06-08												CASSYGDRDVFDSNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGGAAGGTCCCAGGGCGGCTACACCTTCGGTTCG	CASSLGRSQGGYTF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	8	8	1	19	35	48	43	49		TCRBV07-05,TCRBV07-07												CASSLGRSQGGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAATTACGGTGGACTAACGGGAGTCTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	1.0660861173143608E-4		50	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	9	5	3	10	23	38	47	41	57		TCRBV06-05,TCRBV06-06,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCACTCCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	1.0660861173143608E-4		37	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	10	3	2	4	23	35	40	37	44		TCRBV06-04,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCTCACAAGCAGGGGGGAGATACGCAGTATTTTGGCCCA	CAHKQGGDTQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	4	1	5	7	1	23	28	42	35	43		TCRBV06-04,TCRBV06-08												CAHKQGGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTATCGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	1.0660861173143608E-4		38	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	9	3	0	3	22	-1	37	35	40		TCRBV07-01,TCRBV07-04				01,02								X+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACAGGTGGACTACCTACGAGCAGTACTTCGGGCCG	CASSYRWTTYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	9	2	4	0	24	39	-1	43	49		TCRBV06-05,TCRBV06-06,TCRBV06-08				01,02								CASSYRWTTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACCGGGGAGGTCTTTGGGGCTACACCTTCGGTTCG	CASSDRGGLWGYTF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	1	8	5	7	23	35	46	40	53		TCRBV06-07,TCRBV06-08												CASSDRGGLWGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCCCCAGGGTTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.122195912962485E-4		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	3	2	2	26	43	50	45	52		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCAGAGGACAGGCGACACCCTACGAGCAGTACTTCGGGCCG	CASSRGQATPYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	2	3	6	18	30	40	33	46		TCRBV11-01,TCRBV11-03												CASSRGQATPYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCCCTCCCCTCATGACAGCTACTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	1.1783057086106093E-4		43	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	2	5	6	15	5	26	31	51	46	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGTACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSESYSSYEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	5	0	2	0	23	40	-1	42	46		TCRBV10-01,TCRBV10-02												CASSESYSSYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCGGACAGGGTTAAGAGACCCAGTACTTCGGGCCA	CASSGQG*ETQYF	Stop	VDJ	1	22	1.2344155042587335E-4		39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	3	1	2	23	34	43	35	45		TCRBV10-01,TCRBV10-02												CASSGQG*ETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGACCGCAATCAGCCCCAGCATTTTGGTGAT	CASSLDRNQPQHF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-05	01	4	2	7	2	2	1	22	35	40	37	41		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDRNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACGGATACGAGCAGTACTTCGGGCCG	CASSYGYEQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	33	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	2	1	8	4	0	0	26	-1	-1	41	44		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTGGGCCGCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGRYNSPLHF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	8	0	3	0	2	18	-1	36	32	38		TCRBV07-04,TCRBV07-06												CASSLGRYNSPLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGTCGGACAGTACTCACACTATGGCTACACCTTCGGTTCG	CASSLVGQYSHYGYTF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	3	2	7	19	35	43	37	50		TCRBV07-05,TCRBV07-07												CASSLVGQYSHYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTACGTAGGGACAGGGGTCGGAAACACCATATATTTTGGAGAG	CASSYVGTGVGNTIYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	2	4	3	2	23	38	51	41	53		TCRBV06-08,TCRBV06-09												CASSYVGTGVGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCGCCAAGGGCTAATCCAAACTATGGCTACACCTTCGGTTCG	CASSSPRANPNYGYTF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	48	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	4	5	3	2	5	8	23	36	45	41	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPRANPNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCCGCGTCCTACGAGCAGTACTTCGGGCCG	CASSYSASYEQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	6	1	1	0	28	45	-1	46	49		TCRBV06-04,TCRBV06-08				01,02								CASSYSASYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGTGGCGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASRVAGGTDTQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	7	0	3	4	0	23	34	-1	38	47		TCRBV06-07,TCRBV06-08												CASRVAGGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSYSGKETQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	0	0	8	3	0	1	23	-1	44	40	45		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGKETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAAGACTCCCGGGACAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASRRLPGQSSYEQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	0	9	2	26	37	53	46	55		TCRBV06-07,TCRBV06-08												CASRRLPGQSSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTTGGACCAGCAAGAGACCCAGTACTTCGGGCCA	CASSLDQQETQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	4	1	7	2	1	3	23	36	41	37	44		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDQQETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAAAGACAGGCTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASKDRLNTGELFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	4	2	2	3	23	33	41	35	44		TCRBV06-04,TCRBV06-08												CASKDRLNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCATGTATCGCTGTGCCAGCACTACCTCGGGGGTAGCGTCCGGGGAGCTGTTTTTTGGAGAA	CASTTSGVASGELFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	2	6	6	6	18	28	40	34	46		TCRBV07-06,TCRBV07-07												CASTTSGVASGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAAGAGGGAAGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	38	2.1321722346287215E-4		43	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	2	2	4	28	42	49	44	53		TCRBV06-01,TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGGTGAAATTTGGCAGGGGTATTCACCCCTCCACTTTGGGAAC	CASSLGEIWQGYSPLHF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	2	8	11	1	19	35	52	46	53		TCRBV07-05,TCRBV07-07												CASSLGEIWQGYSPLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGCCTGGACTAGCAGTGAGCAGTTCTTCGGGCCA	CASSAWTSSEQFF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	9	4	2	23	35	47	39	49		TCRBV06-07,TCRBV06-08				01,02								CASSAWTSSEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCTCTCGCGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSRGNYNEQFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	7	3	3	4	1	23	32	42	36	43		TCRBV06-07,TCRBV06-08												CASSRGNYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAATGGGCAGGCTACGAGCAGTACTTCGGGCCG	CASSEWAGYEQYF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	3	5	0	23	37	-1	42	46		TCRBV10-01,TCRBV10-02												CASSEWAGYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTAGCTAAGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSE*LSSGELFF	Stop	VDJ	1	46	2.5810505998137155E-4		42	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	9	6	2	4	26	42	47	44	51		TCRBV10-01,TCRBV10-02				01,02								CASSE*LSSGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTACTGGCTGGGGGGGCGGAAGGCTACACCTTCGGTTCG	CASSLLAGGAEGYTF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	9	0	8	6	5	18	33	46	39	51		TCRBV07-02,TCRBV07-06												CASSLLAGGAEGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTTGGAACAGGGATTTTCAACTGCGGGGAGCTGTTTTTTGGAGAA	CASSVGTGIFNCGELFF	In	VDJ	2	54	3.0299289649987095E-4	3.7084091611441127E-4	51	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	7	5	11	23	36	47	41	58		TCRBV10-01,TCRBV10-02												CASSVGTGIFNCGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTCCGGGACTAGCGGGGGCGTGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	59	3.310477943239331E-4		49	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	3	5	26	39	56	42	61		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCAGGGGACAGACTATGGCTACACCTTCGGTTCG	CASSQGTDYGYTF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	3	3	0	20	32	-1	35	42		TCRBV07-02,TCRBV07-08												CASSQGTDYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGGGGAGGACAGGGGGCAAGAAACATTCAGTACTTCGGCGCC	CARGGQGARNIQYF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	9	1	0	6	4	3	23	31	46	35	49		TCRBV10-01,TCRBV10-02												CARGGQGARNIQYF+TCRBV10-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATGGTGGGGGTTTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYGGGLSSYNEQFF	In	VDJ	2	65	3.647136717128076E-4	4.4638258421179135E-4	51	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	3	6	1	0	4	6	23	37	46	41	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGGLSSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGGAGGCACGCTACCCACTGAAGCTTTCTTTGGACAA	CASSLGGTLPTEAFF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	1	4	0	9	18	-1	38	34	47		TCRBV11-01,TCRBV11-03												CASSLGGTLPTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGGCGCTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSLGASGGETQYF	In	VDJ	2	73	4.09601508231307E-4	5.013219791917042E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	4	3	0	18	34	-1	37	47		TCRBV11-01,TCRBV11-03												CASSLGASGGETQYF+TCRBV11-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCTGTGCAGCATGGCTACACCTTCGGTTCG	CASSEAVQHGYTF	In	VDJ	2	85	4.769332630090561E-4	5.837310716615734E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	0	4	5	6	4	1	23	40	47	44	48		TCRBV06-01,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAVQHGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCGGACAGACATCTTCCGCGGGGAGCTGTTTTTTGGAGAA	CASRTDIFRGELFF	In	VDJ	3	105	5.891528543053046E-4	7.210795591113553E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	5	7	1	10	26	35	42	36	52		TCRBV06-07,TCRBV06-08												CASRTDIFRGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCGAGATGGACAGGGAATTGGTAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	114	6.396516703886165E-4		58	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	1	6	11	18	32	46	38	57		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTTCACAGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSSQGATGELFF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	4	2	0	26	38	-1	40	49		TCRBV10-01,TCRBV10-02												CASSSQGATGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTGGGTGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	169	9.482555464532998E-4		38	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	1	0	9	4	0	4	26	-1	45	42	49		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCCGGGACTCATGAAAAACTGTTTTTTGGCAGT	CASSPGTHEKLFF	In	VDJ	6	204	0.0011446398312217347	0.001400954571987776	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	6	3	1	23	35	44	38	45		TCRBV06-07,TCRBV06-08				01,02								CASSPGTHEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTCAGCAGGGGTCACTGAAGCTTTCTTTGGACAA	CASSSAGVTEAFF	In	VDJ	6	208	0.0011670837494809844	0.0014284242694777324	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	4	0	1	18	-1	40	35	41		TCRBV07-02,TCRBV07-08												CASSSAGVTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTCATTAACCAAGAGACCCAGTACTTCGGGCCA	CASSFINQETQYF	In	VDJ	7	249	0.0013971339116382938	0.0017099886687497853	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-05	01	3	4	6	0	0	3	22	-1	38	36	41		TCRBV07-02,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFINQETQYF+TCRBV07-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAAAAAGACCTCATGTTTGACAGGACCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	53	1879	0.010543030602282547		55	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	3	17	5	23	34	57	51	62		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAAGGGCCCCAAAAACATTCAGTACTTCGGCGCC	CASSKGPKNIQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-04	01	5	5	3	2	1	2	22	34	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGPKNIQYF+TCRBV07-01+TCRBJ02-04	TCRBV07-01*01		TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGCTTTCGGACTAGCGGACTACGAGCAGTACTTCGGGCCG	CASSLAFGLADYEQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	48	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	5	3	4	1	22	39	53	43	54						01,02								CASSLAFGLADYEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGGACAGGATATGAGCAGTTCTTCGGGCCA	CASSLGTGYEQFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	4	8	2	2	22	35	45	37	47														CASSLGTGYEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCATCTTGACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	59	3.310477943239331E-4		43	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-01	01	2	2	8	0	4	0	22	37	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCGCAGGGACTAGCGGGAGAGAGACCCAGTACTTCGGGCCA	CAAGTSGRETQYF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	0	2	4	3	0	22	28	-1	31	45														CAAGTSGRETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCTATGGGCGGGAGGGCAACGAGCAGTACTTCGGGCCG	CASSPYGREGNEQYF	In	VDJ	4	129	7.238163638608028E-4	8.858977440510936E-4	45	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	5	8	2	22	34	51	42	53														CASSPYGREGNEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCTCTACGACGGGAGGAAAGAATGAGCAGTTCTTCGGGCCA	YASSSTTGGKNEQFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	45	TCRBV07	TCRBV07-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	7	6	4	22	35	48	41	52														YASSSTTGGKNEQFF+TCRBV07-03+TCRBJ02-01	TCRBV07-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTGGGGGGGGACAGGCGACGCTGAAAAACTGTTTTTTGGCAGT	CASSWGGTGDAEKLFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	48	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	4	7	5	6	20	33	46	38	52			01,02											CASSWGGTGDAEKLFF+TCRBV07-08+TCRBJ01-04	TCRBV07-08	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGCAGGGTCGAACATTCAGTACTTCGGCGCC	CASSESAGSNIQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	3	7	2	3	23	40	47	42	50													Vb 12	CASSESAGSNIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGAACGTCGGTAGCGGGTGGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	6.73317547777491E-5		49	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	4	5	10	5	23	36	53	46	58						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGGTTCAATCAGCCCCAGCATTTTGGTGAT	CASSESGFNQPQHF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	0	9	3	1	2	23	40	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGFNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCCCCTGGAGGGGTTACTGAAGCTTTCTTTGGACAA	CASSPPGGVTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	5	6	3	23	35	47	41	50													Vb 12	CASSPPGGVTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAAGGACAGGGGGATCACCCCTCCACTTTGGGAAC	CASSERTGGSPLHF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	1	10	2	1	23	37	49	39	50													Vb 12	CASSERTGGSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGAGGACGGGAGGCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	1.122195912962485E-4		46	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	0	5	1	23	34	46	39	47													Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATTCCCGCGGGGAGGGCTTCCAGAGTACTTCGGGCCA		Out	VDJ	1	20	1.122195912962485E-4		40	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	9	0	12	8	7	23	33	48	41	55													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGACGGACAGGGGGGTTCTACGAGCAGTACTTCGGGCCG	CASGRTGGFYEQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	1	3	4	3	23	32	46	36	49													Vb 12	CASGRTGGFYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCCAGACATCTGTGTATTTCTGCGCCAGCGATTAGCCGTTAGGACTAGCGGGTCCTAGGCTCCGAGATACGCAGTATTTTGGCCCA	CASD*PLGLAGPRLRDTQYF	Stop	VDJ	1	31	1.7394036650918518E-4		60	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	1	4	5	12	12	21	30	53	42	65						01,02							Vb 12	CASD*PLGLAGPRLRDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGACCAGATACAATGAGCAGTTCTTCGGGCCA	CASSETRYNEQFF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	5	4	2	1	23	38	43	40	44													Vb 12	CASSETRYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCATCCAAGAGGGAACAGGAGACAATGAGCAGTTCTTCGGGCCA	CAIQEGTGDNEQFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	10	3	4	5	11	2	23	30	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAIQEGTGDNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGCCTTAATCAGCCCCAGCATTTTGGTGAT	CASSESGLNQPQHF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	8	0	4	0	3	23	-1	44	40	47													Vb 12	CASSESGLNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGCCGGGACACCCTACGAGCAGTACTTCGGGCCG	CASAGTPYEQYF	In	VDJ	2	88	4.937662017034934E-4	6.043333447790406E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	2	3	1	23	32	41	35	42													Vb 12	CASAGTPYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGACGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSGDGMNTEAFF	In	VDJ	3	103	5.779308951756797E-4	7.073447103663771E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	4	0	7	0	0	4	23	-1	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGDGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCAGACAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSRQSSGNTIYF	In	VDJ	3	109	6.115967725645543E-4	7.485492566013116E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	6	0	2	3	23	34	40	36	43													Vb 12	CASSRQSSGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGGGACAGGGCCGAGCAGTACTTCGGGCCG	CASSRDRAEQYF	In	VDJ	4	129	7.238163638608028E-4	8.858977440510936E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	1	1	23	35	45	36	46													Vb 12	CASSRDRAEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATTAACGGGGGCGGGATGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	19	673	0.003776189247118762		44	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	7	6	0	4	5	8	23	33	44	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGACGGGACTAGTCCTCCTCGAGCAGTACTTCGGGCCG	CAISESTGLVLLEQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	8	6	3	7	23	40	51	43	58						01,02							Vb 12	CAISESTGLVLLEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGACCAAACCGGGGAGCTGTTTTTTGGAGAA	CAISESDQTGELFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-02	01	0	1	7	5	0	3	23	-1	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESDQTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCGGCCAATTTAGTGGGGAAGCTTTCTTTGGACAA	CASGQFSGEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	36	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	7	5	8	0	13	24	-1	35	31	48						01,02							Vb 12	CASGQFSGEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGTCGAGGGGGGATCTACGAGCAGTACTTCGGGCCG	CASRGGIYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	10	5	1	3	4	3	24	31	41	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRGGIYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGGCCCGAGAACAGCGGGAGGGGAGAGACCCAGTACTTCGGGCCA	CAIRPENSGRGETQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	6	0	4	10	1	24	35	55	45	56													Vb 12	CAIRPENSGRGETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTGCCTCGGACATCTCTGGAAACACCATATATTTTGGAGAG	CAISESASDISGNTIYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	51	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	6	0	6	1	23	40	51	46	52													Vb 12	CAISESASDISGNTIYF+TCRBV10-03+TCRBJ01-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCTTAGGGTTCCTCGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAISESLGFLGSGANVLTF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	57	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-06	01	0	5	3	0	3	8	23	40	47	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESLGFLGSGANVLTF+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTCCAGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CAISESPGSSYEQYF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	0	4	3	0	2	2	23	40	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESPGSSYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGAGGACGGGATGTACTCCTATAATTCACCCCTCCACTTTGGGAAC	CAISESEDGMYSYNSPLHF	In	VDJ	3	106	5.94763833870117E-4	7.279469834838444E-4	57	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	8	3	0	6	4	23	40	51	46	55													Vb 12	CAISESEDGMYSYNSPLHF+TCRBV10-03+TCRBJ01-06	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCGGGACAGGGGTATGATCAGCCCCAGCATTTTGGTGAT	CASSGQGYDQPQHF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	2	5	3	4	27	35	48	38	52			01,02										Vb 17	CASSGQGYDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGCGGGACACGAGAGAGACCCAGTACTTCGGGCCA	CASSIARDTRETQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	1	0	6	4	3	4	27	43	52	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIARDTRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGCCCACCCTGATTATACGCAGTATTTTGGCCCA	CASSIGAHPDYTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	7	1	11	27	41	47	42	58			01,02										Vb 17	CASSIGAHPDYTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCAAGGGAACAGGTGGACGGGGGATACGCAGTATTTTGGCCCA	CASSAQGNRWTGDTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	3	4	6	10	9	27	39	54	49	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAQGNRWTGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCGCGAGGCAGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSGREAGGADTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	4	10	2	27	39	56	49	58			01,02										Vb 17	CASSGREAGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGTCAGCCCCTAGGCGAGCAGTACTTCGGGCCG	CASSQPLGEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	8	6	6	1	45	57	67	63	68			01,02			01,02							Vb 17	CASSQPLGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTCAGCCCCTAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	5.610979564812425E-5		35	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	24	4	8	6	24	1	46	39	67	63	68			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACACAGGGGCATCAGCCCCAGCATTTTGGTGAT	CASSTQGHQPQHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	5	1	1	27	40	48	41	49			01,02										Vb 17	CASSTQGHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCACCTTAAGGGGCCATGAAAAACTGTTTTTTGGCAGT	CASSTTLRGHEKLFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	6	8	2	27	40	53	48	55			01,02										Vb 17	CASSTTLRGHEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCCGCCCAGCGGAAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNPPSGRNTGELFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	6	5	1	8	3	27	37	50	45	53			01,02			01,02							Vb 17	CASNPPSGRNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTTGGGGCGAAGTGGAATGAGCAGTTCTTCGGGCCA	CASSMVGAKWNEQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	7	0	7	4	7	27	41	50	45	57			01,02										Vb 17	CASSMVGAKWNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCCCGGACTAGCGGGTGTCGGGGAGACCCAGTACTTCGGGCCA	CASSSPGLAGVGETQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	4	5	6	7	27	39	56	45	63			01,02			01,02							Vb 17	CASSSPGLAGVGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGMAGCTTTCTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSMGYGEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	6	2	6	0	5	45	-1	63	59	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVYSNQPQHF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	5	9	0	4	0	27	38	-1	42	44			01,02			01,02							Vb 17	CASSVYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCTGGCGGGAGGGCCGATGAGCAGTTCTTCGGGCCA	CASSIAGGRADEQFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	0	8	3	3	27	43	55	46	58			01,02										Vb 17	CASSIAGGRADEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCAGAGGGCAACTGATACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	7.294273434256153E-5		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	0	0	3	9	27	41	49	44	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGTTAAAGGCCCCTTATCAGCCCAGCATTTTGGTGAT	CASSAVKGPLSAQHF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	4	5	11	19	0	27	39	-1	58	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAVKGPLSAQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCGGGAAGGGTAGCACTGAAGCTTTCTTTGGACAA	CASIGKGSTEAFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	8	3	4	1	7	27	37	43	38	50			01,02										Vb 17	CASIGKGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	7.294273434256153E-5		35	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	24	6	2	6	20	5	46	39	63	59	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCGTTGTCCGGGACAGGGGTGTAGACGGCTACACCTTCGGTTCG	CASSMGVVRDRGVDGYTF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	8	11	7	27	41	62	52	69			01,02										Vb 17	CASSMGVVRDRGVDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGTTCATAAATCAGCCCCAGCATTTTGGTGAT	CASSRFINQPQHF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	10	4	0	6	27	-1	42	40	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRFINQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTTCAGGGGGAACTGAAGCTTTCTTTGGACAA	CASSASGGTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	5	4	1	27	39	50	43	51			01,02										Vb 17	CASSASGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGTCGGACAGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSGRTEMNTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	0	4	3	27	39	49	43	52			01,02										Vb 17	CASSGRTEMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATTCTGGACATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	9.538665260181123E-5		37	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	6	3	5	1	27	37	47	42	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACTGGGATAATCAGCCCCAGCATTTTGGTGAT	CASSYWDNQPQHF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	0	8	4	4	1	27	39	47	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYWDNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCCCAAGGGTCAGGCGAATAATGGCTACACCTTCGGTTCG	CASSRPKGQANNGYTF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	4	4	6	11	6	27	40	55	51	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRPKGQANNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCCCAAGTTAGCGGGCCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	1.0660861173143608E-4		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	4	1	9	3	27	41	57	50	60			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGGCGATCGGGGAACAGTGGTTCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	1.0660861173143608E-4		53	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	7	0	6	2	20	27	39	46	41	66			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGTTCAGACGGGGAGCTGTTTTTTGGAGAA	CASSIRSDGELFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	5	7	5	1	27	41	49	46	50			01,02										Vb 17	CASSIRSDGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCGACTAGCGGGGGGGCCTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSMRLAGGPFQETQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	2	0	1	2	5	27	41	57	43	62			01,02										Vb 17	CASSMRLAGGPFQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTCTTAACACAGATACGCAGTATTTTGGCCCA	CASSIGLNTDTQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	5	2	0	6	27	-1	44	41	50			01,02			01,02							Vb 17	CASSIGLNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGYTTCTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSMGYGEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	6	2	6	0	5	45	-1	63	59	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAAGTAACATCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVTSSYNEQFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	6	0	6	2	27	39	48	45	50			01,02										Vb 17	CASSQVTSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTCTTCTAGCGGGAGAATCCTACGAGCAGTACTTCGGGCCG	CASTPLLAGESYEQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	2	1	8	2	27	37	55	45	57			01,02										Vb 17	CASTPLLAGESYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGCAGATGAACACTGAAGCTTTCTTTGGACAA	CASRGQMNTEAFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	7	0	0	0	3	27	-1	43	38	46			01,02										Vb 17	CASRGQMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGTTCAGGGTTGGCCCCAGCATTTTGGTGAT	CASNVQGWPQHF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	3	9	5	3	27	37	47	42	50			01,02										Vb 17	CASNVQGWPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCACTGGCGGACAGGCCTGAGCAGTACTTCGGGCCG	CASSPLADRPEQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	7	9	3	27	38	54	47	57			01,02										Vb 17	CASSPLADRPEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTAACGGGAGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	1.5149644824993548E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	1	2	5	0	27	41	-1	46	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCATCCTAGCGGGAGCGGTTGAGCAGTTCTTCGGGCCA	CASSIILAGAVEQFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	9	4	4	27	41	55	45	59			01,02										Vb 17	CASSIILAGAVEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACAAGAGGAGGGAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	1.6271840737956033E-4		52	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	0	0	10	0	27	39	-1	49	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCCGGGGGGGCCTCCCAGCATTTTGGTGAT	CASSAGGASQHF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	0	11	3	3	27	38	49	41	52			01,02										Vb 17	CASSAGGASQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTGGACAGGGGCCCAGAACGGAGCAGTTCTTCGGGCCA	CASSPGQGPRTEQFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	10	3	9	27	39	51	42	60			01,02										Vb 17	CASSPGQGPRTEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCCCTAATAGGGGGGATCCCATACGGGGTTGGCTACACCTTCGGTTCG	CASTSLIGGIPYGVGYTF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	5	1	7	10	15	27	37	53	47	68			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTSLIGGIPYGVGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAAGCGACAGGCCGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	1.9077330520362245E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	4	3	5	4	27	43	54	48	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGAGACTGGCTACGAGCAGTACTTCGGGCCG	CASSRETGYEQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	10	3	0	2	27	-1	48	44	50			01,02			01,02							Vb 17	CASSRETGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGGGACAGGCGAAAGAATCTCGACACTGAAGCTTTCTTTGGACAA	CASTRDRRKNLDTEAFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	3	3	13	27	37	48	40	61			01,02										Vb 17	CASTRDRRKNLDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCGTACTAACTATGGCTACACCTTCGGTTCG	CASSRRTNYGYTF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	9	0	0	0	3	27	-1	43	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRRTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCGGATGAACACTGAAGCTTTCTTTGGACAA	CASSIGRMNTEAFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	0	1	1	27	43	48	44	49			01,02			01,02							Vb 17	CASSIGRMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGAAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	38	2.1321722346287215E-4		41	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	1	0	4	27	-1	45	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAACCCCTCGGGCGCTTTCTTTGGACAA	CASSINPSGAFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	8	0	11	9	0	27	41	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSINPSGAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCGGGTGTGTACAATGAGCAGTTCTTCGGGCCA	CASSFSGVYNEQFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	4	4	4	27	39	47	43	51			01,02			01,02							Vb 17	CASSFSGVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGATTAGCGGCTCAAGAGACCCAGTACTTCGGGCCA	CASGLAAQETQYF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	5	5	2	4	2	27	36	46	40	48			01,02			01,02							Vb 17	CASGLAAQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGGGATTCCTACGAGCAGTACTTCGGGCCG	CASSIDRDSYEQYF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	1	1	1	27	44	50	45	51			01,02										Vb 17	CASSIDRDSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGTGGACAATGAGCAGTTCTTCGGGCCA	CASSMGVDNEQFF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	6	1	5	0	3	27	-1	46	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGVDNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAAACAGGGGGCGGATGAAGCTTTCTTTGGACAA	CASRKQGADEAFF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	7	3	3	27	38	50	41	53			01,02										Vb 17	CASRKQGADEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCCCCCACTGAAGCTTTCTTTGGACAA	CASSIDPPTEAFF	In	VJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	0	0	4	0	6	27	-1	44	-1	50			01,02										Vb 17	CASSIDPPTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACTTGGGGTTAGGAGAGCAGTACTTCGGGCCG	CASSIDLGLGEQYF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	0	6	2	7	3	6	27	44	51	47	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDLGLGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTCCTTAGCGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPSLAGGTGELFF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	5	1	4	7	0	27	39	-1	46	56			01,02										Vb 17	CASSPSLAGGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGGCAGGGTATCAGCCCCAGCATTTTGGTGAT	CASSQAGYQPQHF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	5	4	1	27	39	48	43	49			01,02										Vb 17	CASSQAGYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGAGACCCAGTACTTCGGGCCA	CASSIEETQYF	In	VJ	1	45	2.524940804165591E-4	3.090340967620094E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	0	0	5	0	1	27	-1	44	-1	45			01,02										Vb 17	CASSIEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATGCGGGGGCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYAGANTGELFF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	2	2	3	2	27	39	49	42	51			01,02										Vb 17	CASSYAGANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCATTTCYAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	2.749379986758088E-4		41	TCRBV19	TCRBV19-01		unresolved			TCRBJ02	TCRBJ02-07	01	7	4	8	0	8	0	27	37	-1	45	49			01,02	TCRBD01,TCRBD02									Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	unresolved	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTGGCAGGGCTCAGCCCCAGCATTTTGGTGAT	CASSIVGRAQPQHF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	6	4	1	27	43	52	47	53			01,02										Vb 17	CASSIVGRAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGATAGATGAACACTGAAGCTTTCTTTGGACAA	CASSMG*MNTEAFF	Stop	VDJ	1	50	2.8054897824062125E-4		42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	0	0	4	27	-1	45	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMG*MNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGCGGGAGGGCCTTAGCAGATACGCAGTATTTTGGCCCA	CASRSGRALADTQYF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	0	4	1	6	27	38	49	39	55			01,02										Vb 17	CASRSGRALADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAACCCATCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	53	2.973819169350585E-4		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	3	7	3	2	5	27	43	47	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTCAGGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	55	3.086038760646834E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	5	2	0	27	40	-1	42	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACAGGGGCCAACACTGAAGCTTTCTTTGGACAA	CASSRTGANTEAFF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	2	0	2	27	-1	49	40	51			01,02										Vb 17	CASSRTGANTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGATCAAGGACCTGGCGGCTACACCTTCGGTTCG	CASSIDQGPGGYTF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	1	7	8	7	5	27	41	52	48	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDQGPGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAACCCCGGGGGAGAGGGGCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	57	3.198258351943082E-4		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	2	6	5	8	27	42	53	47	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTTGGACCGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASLGPGGTGELFF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	8	1	4	7	0	27	36	-1	43	50			01,02										Vb 17	CASLGPGGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSMGRGNTEAFF	In	VDJ	2	60	3.366587738887455E-4	4.1204546234934586E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	3	0	27	41	-1	44	50			01,02										Vb 17	CASSMGRGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGAGAGGGCAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASMRGQSSYNEQFF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	11	0	0	3	5	27	37	45	40	50			01,02										Vb 17	CASMRGQSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAAGTCTTTCTAACTATGGCTACACCTTCGGTTCG	CASSSSLSNYGYTF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	4	6	0	1	7	27	39	42	40	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSSLSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCGAAACAGGGTTTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	65	3.647136717128076E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	3	3	3	5	2	27	36	47	41	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCARTAGTATGACAGGGGGATTTCTGGAGACCCAGTACTTCGGGCCA	CAXSMTGGFLETQYF	In	VDJ	2	66	3.7032465127762005E-4	4.5325000858428046E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	1	5	0	7	27	-1	50	41	57			01,02										Vb 17	CAXSMTGGFLETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCGTCTCCCGCGGTCAGCCCCAGCATTTTGGTGAT	CASSVVSRGQPQHF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	5	6	10	0	27	39	-1	49	53			01,02			01,02							Vb 17	CASSVVSRGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCGGAGGGGCGACAGGCCTTAATGAAAAACTGTTTTTTGGCAGT	CASSPGGATGLNEKLFF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	2	4	4	12	3	27	38	56	50	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPGGATGLNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGCGGGGGGGCCAGAGATACGCAGTATTTTGGCCCA	CASSISGGARDTQYF	In	VDJ	2	70	3.9276856953686975E-4	4.8071970607423684E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	0	5	0	4	27	-1	52	41	56			01,02										Vb 17	CASSISGGARDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGACCAGGGCTTTAACTATGGCTACACCTTCGGTTCG	CASIDQGFNYGYTF	In	VDJ	2	73	4.09601508231307E-4	5.013219791917042E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	1	5	3	27	37	47	42	50			01,02										Vb 17	CASIDQGFNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGTAGCCAGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAVASANTGELFF	In	VDJ	2	76	4.264344469257443E-4	5.219242523091715E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	11	5	7	0	1	5	27	33	38	34	43			01,02			01,02							Vb 17	CAVASANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGACTGTTGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGLLGSNQPQHF	In	VDJ	2	78	4.3765640605536915E-4	5.356591010541496E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	0	10	1	0	7	27	-1	44	38	51			01,02			01,02							Vb 17	CASRGLLGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCAGCCTACGGCCTCGCTGGGTAGCCAGTACTTCGGGCCA	CATQPTASLGSQYF	In	VDJ	2	86	4.8254424257386855E-4	5.905984960340625E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	10	0	9	10	19	3	27	34	56	53	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATQPTASLGSQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAGGGACTAGCGGGGGAACCTACAATGAGCAGTTCTTCGGGCCA	CASSSGTSGGTYNEQFF	In	VDJ	2	86	4.8254424257386855E-4	5.905984960340625E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	2	3	2	27	39	56	42	58			01,02										Vb 17	CASSSGTSGGTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCAGAGGGGGGATTCCGCGAAAAACTGTTTTTTGGCAGT	CASSPEGGFREKLFF	In	VDJ	2	87	4.88155222138681E-4	5.974659204065515E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	5	1	8	5	8	27	38	49	43	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPEGGFREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATACGGGCCCCCGGGAGACCCAGTACTTCGGGCCA	CASSIDTGPRETQYF	In	VDJ	2	87	4.88155222138681E-4	5.974659204065515E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	8	0	5	3	6	27	44	51	47	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDTGPRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGATTGGGGGAAAGACCCAGTACTTCGGGCCA		Out	VDJ	3	92	5.162101199627431E-4		38	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	6	1	6	6	2	27	38	49	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAAGGGGGACTGGCAATGGAGACCCAGTACTTCGGGCCA	CASSIKGGLAMETQYF	In	VDJ	3	95	5.330430586571803E-4	6.524053153864643E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	5	1	5	3	10	27	41	50	44	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIKGGLAMETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCCCTCGGGACAGCCTCAGGGGAGCAGTTCTTCGGGCCA	CASRSLGTASGEQFF	In	VDJ	3	99	5.5548697691643E-4	6.798750128764207E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	10	7	8	27	38	52	45	60			01,02										Vb 17	CASRSLGTASGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGAGACAGGACTATGGCTACACCTTCGGTTCG	CASSMRRQDYGYTF	In	VDJ	3	105	5.891528543053046E-4	7.210795591113553E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	3	5	0	27	41	-1	46	52			01,02										Vb 17	CASSMRRQDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGCCGGGACACCGAACACTGAAGCTTTCTTTGGACAA	CASSAAGTPNTEAFF	In	VDJ	3	107	6.003748134349294E-4	7.348144078563335E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	1	6	2	27	39	51	45	53			01,02										Vb 17	CASSAAGTPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACGAGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSNERNTGELFF	In	VDJ	3	111	6.228187316941791E-4	7.622841053462899E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	11	2	1	2	2	27	40	45	42	47			01,02										Vb 17	CASSNERNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCCGGGGTTTCGGCCAAAAACATTCAGTACTTCGGCGCC	CASSIAGVSAKNIQYF	In	VDJ	3	114	6.396516703886165E-4	7.828863784637572E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	8	3	1	3	5	27	41	49	44	54			01,02										Vb 17	CASSIAGVSAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTATCGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASLSTSGANVLTF	In	VDJ	3	120	6.73317547777491E-4	8.240909246986917E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	8	2	7	0	5	0	27	36	-1	41	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLSTSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGCTAGCGGGTTCCAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	121	6.789285273423034E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	4	7	4	5	27	39	51	43	56			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCAGGGGAGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGRAYEQYF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	9	0	2	6	0	27	36	-1	42	49			01,02										Vb 17	CASSQGRAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTTGSYNEQFF	In	VDJ	4	128	7.182053842959904E-4	8.790303196786045E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	1	2	0	27	40	-1	42	48			01,02										Vb 17	CASSTTGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGCGTAGGACAGTTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	131	7.350383229904276E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	1	5	4	5	2	27	35	46	40	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCCAGGGACTAGGGGTGTTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	134	7.51871261684865E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	8	6	4	7	27	36	48	40	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCAAATAGGGAGGATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASTQIGRISNQPQHF	In	VDJ	4	140	7.855371390737395E-4	9.614394121484737E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	9	1	0	8	2	27	37	51	45	53			01,02										Vb 17	CASTQIGRISNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTGTGCAGGGAATTGGCACCTTCGGTTCG	CASSFVQGIGTF	In	VDJ	4	141	7.911481186385519E-4	9.683068365209628E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	13	6	6	27	39	50	45	56			01,02										Vb 17	CASSFVQGIGTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCACAGGGGGAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	5	188	0.001054864158184736		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	1	3	3	2	27	41	52	44	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCACAGTCTTACGGCTACACCTTCGGTTCG	CASSIAQSYGYTF	In	VDJ	5	190	0.0010660861173143606	0.0013048106307729287	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	5	8	3	6	27	41	48	44	54			01,02										Vb 17	CASSIAQSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGATCGACAGGTTGGGGAGAGACCCAGTACTTCGGGCCA	CASSRSTGWGETQYF	In	VDJ	5	193	0.001082919056008798	0.001325412903890396	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	4	4	5	6	27	39	50	44	56			01,02										Vb 17	CASSRSTGWGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGTAGCGGGGCTCCAAATGAGCAGTTCTTCGGGCCA	CASSMSSGAPNEQFF	In	VDJ	7	238	0.001335413136425357	0.0016344470006524052	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	3	7	3	5	27	41	52	44	57			01,02										Vb 17	CASSMSSGAPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTGCCCGGGACAGCCAAGAGACCCAGTACTTCGGGCCA	CASSPARDSQETQYF	In	VDJ	8	270	0.0015149644824993546	0.0018542045805720565	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	1	8	0	27	38	-1	46	53			01,02										Vb 17	CASSPARDSQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTGGACTAGCGGGGGTTGTACGAGCAGTACTTCGGGCCG		Out	VDJ	8	275	0.001543019380323417		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	4	2	3	27	40	55	42	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCTGACAGCTGATCAGCCCCAGCATTTTGGTGAT	CASSILTADQPQHF	In	VDJ	9	326	0.0018291793381288504	0.002238780345431446	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	5	3	3	27	41	49	44	52			01,02										Vb 17	CASSILTADQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCCGGGCATACTACACCGGGGAGCTGTTTTTTGGAGAA	CASSIGRAYYTGELFF	In	VDJ	10	350	0.001963842847684349	0.0024035985303711843	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	1	8	0	3	3	5	27	43	50	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGRAYYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACCGGGCAGAGTAAGAGCTTCGGGCCG		Out	VDJ	10	355	0.001991897745508411		34	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	8	0	15	4	10	27	39	47	43	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGCGAGGACCGTTCAGCCCCAGCATTTTGGTGAT	CASSIDARTVQPQHF	In	VDJ	11	386	0.002165838112017596	0.002650825807780792	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	1	7	6	5	3	27	44	53	49	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDARTVQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTCATCGGAGTCAATGAGCAGTTCTTCGGGCCA	CASSIFIGVNEQFF	In	VDJ	11	395	0.002216336928100908	0.002712632627133194	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	6	6	1	27	42	52	48	53			01,02										Vb 17	CASSIFIGVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCAACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	12	439	0.0024632200289526544		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	2	4	0	27	40	-1	44	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAGGCGCGCGTTTCGGGCTATGGCTACACCTTCGGTTCG	CASSIKARVSGYGYTF	In	VDJ	13	446	0.0025024968859063417	0.003062871270130138	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	4	14	0	27	41	-1	55	59			01,02			01,02							Vb 17	CASSIKARVSGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCAGGGGAAACTACGAGCAGTACTTCGGGCCG	CASSMGRGNYEQYF	In	VDJ	13	479	0.0026876592115451514	0.003289496274422278	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	3	3	3	27	41	50	44	53			01,02										Vb 17	CASSMGRGNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASKQGNTEAFF	In	VDJ	16	575	0.0032263132497671442	0.003948769014181231	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	2	1	1	27	37	44	38	45			01,02										Vb 17	CASKQGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGCCCCTAGGCGAGCAGTACTTCGGGCCG	CASSQPLGEQYF	In	VDJ	38	1355	0.007602877310320836	0.009305360024722728	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	8	6	6	1	27	39	49	45	50			01,02			01,02							Vb 17	CASSQPLGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGCGGACAGAGACACACCGGGGAGCTGTTTTTTGGAGAA	CASGGQRHTGELFF	In	VDJ	49	1722	0.009662106810606997	0.011825704769426227	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	5	3	3	4	27	36	45	39	49			01,02										Vb 17	CASGGQRHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSMGYGEQYF	In	VDJ	73	2592	0.014543659031993806	0.01780036397349174	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	6	2	6	0	5	27	-1	45	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGAAAAGGGACAGGCGTTCACGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	7.855371390737395E-5		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	4	1	5	8	23	39	52	44	60													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACGACACTACGAGCAGTACTTCGGGCCG	CASSERHYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	6	3	1	0	23	38	-1	39	43													Vb 11	CASSERHYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCCTTTCCCCCCGGGCGTAAGACTGAAGCTTTCTTTGGACAA	CASSAFPPGRKTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	4	8	0	5	11	5	23	36	51	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSAFPPGRKTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAATTCATAACTGGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSNS*LGKTYGYTF	Stop	VDJ	1	17	9.538665260181123E-5		48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	11	5	23	35	50	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSNS*LGKTYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTCTACACCAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	22	1.2344155042587335E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	23	35	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACGGGAAAACTACAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	1.346635095554982E-4		41	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	3	6	1	9	23	33	39	34	48													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACAAGAGAGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSEQESHTGELFF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	2	3	3	4	23	38	44	41	48													Vb 11	CASSEQESHTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAGAACGGCTCGGGATGAGCAGTTCTTCGGGCCA	CASSRTARDEQFF	In	VDJ	2	65	3.647136717128076E-4	4.4638258421179135E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	8	9	0	23	35	-1	44	48						01,02							Vb 11	CASSRTARDEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAAATGTGGCAGATACGCAGTATTTTGGCCCA	CASSENVADTQYF	In	VDJ	4	134	7.51871261684865E-4	9.202348659135391E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-03	01	2	0	10	4	5	0	23	38	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSENVADTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGACCGACCGGGACTAGCGCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLEDRPGLARSGANVLTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	63	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	0	6	0	10	2	18	34	54	44	56						01,02							Vb 5.1	CASSLEDRPGLARSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD02-01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCCCAGATTTGCTTAAGAGACCCAGTACTTCGGGCCA	CASSPPRFA*ETQYF	Stop	VDJ	1	10	5.610979564812425E-5		45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	5	3	5	8	19	31	39	36	47													Vb 5.1	CASSPPRFA*ETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAACGCTGAATCGTGGTGGCGCTGAAGCTTTCTTTGGACAA	CASSLTLNRGGAEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	2	9	0	6	16	1	19	33	52	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLTLNRGGAEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGGCAGGGGGCAGATACGCAGTATTTTGGCCCA	CASSLGQGADTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	4	4	0	19	33	-1	37	44													Vb 5.1	CASSLGQGADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGGGGGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSLGGSQETQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	2	5	1	1	0	3	19	-1	39	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGGSQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGGGGGGGCTAATGAGCAGTTCTTCGGGCCA	CASSLGGGANEQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	7	0	2	19	-1	44	35	46													Vb 5.1	CASSLGGGANEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTTACTCACCTAGCGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	6.172077521293668E-5		53	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	5	0	9	2	19	31	47	40	49						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGGGGGCAGATACGCAGTATTTTGGCCCA	CASSLGQGADTQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	1	4	0	0	19	-1	-1	35	44													Vb 5.1	CASSLGQGADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAGGTGACTAGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKVTSPNTGELFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	7	0	5	1	19	31	43	36	44						01,02							Vb 5.1	CASSKVTSPNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCCTGGGGAGTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLLGSSGGTDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	3	1	11	0	19	31	-1	42	50													Vb 5.1	CASSLLGSSGGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACTCCCCGCTCTATTTTTCCCTTTTACAATGAGCAGTTCTTCGGGCCA	CASTPRSIFPFYNEQFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	9	4	9	11	19	29	41	38	52						01,02							Vb 5.1	CASTPRSIFPFYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCTCGGGGACAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSSGTGYNEQFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	3	5	0	19	32	-1	37	45													Vb 5.1	CASSSSGTGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACCGGGTTCGTTTTGTATACAATGAGCAGTTCTTCGGGCCA	CASSLDRVRFVYNEQFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	4	4	2	11	19	35	41	37	52						01,02							Vb 5.1	CASSLDRVRFVYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTGAACGGGAGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	7.855371390737395E-5		44	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	1	2	4	0	19	34	-1	38	45													Vb 5.1	X+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCCTACAGGCCTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	7.855371390737395E-5		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	4	3	4	3	19	33	42	37	45													Vb 5.1	X+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGGTCGCTAGCGGGAGGGGGCCCCCCCGACAATACGCAGTATTTTGGCCCA	CASSLRSLAGGGPPDNTQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	60	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	4	0	7	6	13	19	34	52	40	65													Vb 5.1	CASSLRSLAGGGPPDNTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACAGTAAAATGAAAAACTGTTTTTTGGCAGT	CASSLEQ*NEKLFF	Stop	VDJ	1	15	8.416469347218638E-5		42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	5	5	1	3	19	35	40	36	43													Vb 5.1	CASSLEQ*NEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAGACTCAGGGACGCGGGGAGCTGTTTTTTGGAGAA	CASSKTQGRGELFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	4	0	7	7	8	1	19	31	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSKTQGRGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGATTTTAGCGGGCACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPDFSGHSYNEQFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	4	0	8	2	19	31	46	39	48						01,02							Vb 5.1	CASSPDFSGHSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGAACAGGGGGCTTTGGCACAGATACGCAGTATTTTGGCCCA	CASSRTGGFGTDTQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	0	1	3	4	19	31	43	34	47													Vb 5.1	CASSRTGGFGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACAGGCTACACTGAAGCTTTCTTTGGACAA	CASSLGTGYTEAFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	4	3	0	2	19	-1	42	35	44													Vb 5.1	CASSLGTGYTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAAGTCAGGGCGGAACACTGAAGCTTTCTTTGGACAA	CASSLKSGRNTEAFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	1	4	2	19	34	43	38	45													Vb 5.1	CASSLKSGRNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGACAGGGAGACAATCAGCCCCAGCATTTTGGTGAT	CASSWGQGDNQPQHF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	3	1	3	19	32	42	33	45													Vb 5.1	CASSWGQGDNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCACAGGGGAATGAGCAGTTCTTCGGGCCA	CASSLAPQGNEQFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	2	7	4	0	19	35	-1	39	46													Vb 5.1	CASSLAPQGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGAGTCGACTCTGGAAACACCATATATTTTGGAGAG	CASSLAGVDSGNTIYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	10	2	0	2	4	19	35	41	37	45													Vb 5.1	CASSLAGVDSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGATTAACTATGGCTACACCTTCGGTTCG	CASSLGQINYGYTF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	1	0	2	19	-1	40	35	42													Vb 5.1	CASSLGQINYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCGCGGGCTCCAATTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFRGLQLNTGELFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	7	4	1	2	8	19	33	40	35	48						01,02							Vb 5.1	CASSFRGLQLNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGACTAGCGTAGCCCAAGAGACCCAGTACTTCGGGCCA	CASRTSVAQETQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	6	1	0	4	19	-1	38	30	42						01,02							Vb 5.1	CASRTSVAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGGGGGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSLDGGSGELFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	6	0	6	2	1	19	35	43	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLDGGSGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCTCAGGGGACTACACAGATACGCAGTATTTTGGCCCA	CASSLSGDYTDTQYF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	2	7	0	19	31	-1	38	45						01,02							Vb 5.1	CASSLSGDYTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGACCCCGGGATAGCTGGAAACACCATATATTTTGGAGAG	CASSPDPGIAGNTIYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	8	3	2	8	3	19	31	44	39	47													Vb 5.1	CASSPDPGIAGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGAAACAGGGGTGGGCTCACCCCTCCACTTTGGGAAC	CASSSETGVGSPLHF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	2	10	5	5	19	32	44	37	49													Vb 5.1	CASSSETGVGSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGGCTTTGGCAGATCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	2.1321722346287215E-4		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	4	0	12	19	-1	38	32	50													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGGGGCGAGGGGGTCTATGGCTACACCTTCGGTTCG	CASSRGEGVYGYTF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	1	4	7	1	19	31	44	38	45													Vb 5.1	CASSRGEGVYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSLEGNTDTQYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	2	0	2	19	-1	40	35	42													Vb 5.1	CASSLEGNTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTAGTAGGACGGCTTCAAGAGACCCAGTACTTCGGGCCA	CASSLVVGRLQETQYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	0	1	7	2	5	5	19	35	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVVGRLQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTATTCAGGGACAGATACGCAGTATTTTGGCCCA	CASSLYSGTDTQYF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	3	3	4	0	19	34	-1	38	43													Vb 5.1	CASSLYSGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTGTAAGTGATAGGGGTAATTTCTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	58	3.2543681475912065E-4		53	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	2	1	10	9	19	28	43	38	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTTTCGGGGAGGCTACACCGAGGGCGATACGCAGTATTTTGGCCCA	CASFRGGYTEGDTQYF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	1	6	5	13	19	28	39	33	52													Vb 5.1	CASFRGGYTEGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGTGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGAYNEQFF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	0	6	2	2	0	2	19	-1	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGGAYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCTAGCGGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLASGGSSYNEQFF	In	VDJ	44	1548	0.008685796366329634	0.010630772928613124	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	0	0	3	19	-1	45	35	48													Vb 5.1	CASSLASGGSSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGCGGCACCCATAAATTCCTACGAGCAGTACTTCGGGCCG	CASSAAPINSYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	5	1	1	11	25	36	41	37	52						01,02							Vb 3	CASSAAPINSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCGAGACAACTCCTACGAGCAGTACTTCGGGCCG	CASSPRDNSYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	0	6	1	25	37	47	43	48													Vb 3	CASSPRDNSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCATGGAACACTAGCGGGGGGGTGGTACTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	5.610979564812425E-5		53	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	0	9	4	6	25	42	59	46	65													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGCTAGCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLASTGELFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	6	4	3	2	25	40	49	43	51						01,02							Vb 3	CASSLGLASTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTGTGGGTGGTAATCAGCCCCAGCATTTTGGTGAT	CASSLFVGGNQPQHF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	1	0	9	4	4	4	25	41	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLFVGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTCGAAGCGGGGGCAACTATGGCTACACCTTCGGTTCG	CASRSGGNYGYTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	9	6	2	2	4	1	25	33	45	37	46													Vb 3	CASRSGGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACGTTTGGTGGCACCAACCAGACACTATGTACCTCTGTGCCAGCAGTCACAGGGGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRGGAKNIQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	5	3	2	1	1	4	36	48	56	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSHRGGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGTGGCACCAACCAGAATCTATGTACCTCTGTGCCAGCAGTCCCCCCGGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGTSGNTGELFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	5	1	6	0	30	42	-1	48	59						01,02							Vb 3	CASSPPGTSGNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCCCGGGACAGGGCACAGGGGAGACCCAGTACTTCGGGCCA	CASSLFPGQGTGETQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	5	4	7	25	41	54	45	61													Vb 3	CASSLFPGQGTGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCCGGACAGGTAGAAACCTACGAGCAGTACTTCGGGCCG	CASSSPGQVETYEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	2	5	6	25	38	50	43	56													Vb 3	CASSSPGQVETYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGACGTGACAGGGGGCAAAGTGGCTACACCTTCGGTTCG	CASRRDRGQSGYTF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	0	7	6	4	25	34	50	40	54													Vb 3	CASRRDRGQSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCCACAATCAGCCCCAGCATTTTGGTGAT	CASSTHNQPQHF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	3	7	3	0	3	25	-1	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTHNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTATGGCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSSLWREYNEQFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	2	4	7	0	25	38	-1	45	52													Vb 3	CASSSLWREYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGGGACTAGGGGACGGAATACGCAGTATTTTGGCCCA	CASSPGTRGRNTQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	7	4	8	25	36	48	40	56						01,02							Vb 3	CASSPGTRGRNTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCGGGTGGGGTCCAGCCCCAGCATTTTGGTGAT	CASSPPGGVQPQHF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	6	2	7	9	2	25	37	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPGGVQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAAGCCAGGTGGAAACACCATATATTTTGGAGAG	CASSLKPGGNTIYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	4	3	4	0	25	40	-1	44	48													Vb 3	CASSLKPGGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGCCGGGGGCAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLLPGAGSNQPQHF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	1	6	0	0	4	3	25	41	51	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLPGAGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGACGGCAGGTCATTTTGACAATGAGCAGTTCTTCGGGCCA	CASKTAGHFDNEQFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	4	5	6	8	25	35	45	41	53													Vb 3	CASKTAGHFDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTATGACTAGCGGGAGGAAGGAGCAGTACTTCGGGCCG	CASSPMTSGRKEQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	1	7	5	3	25	37	55	42	58													Vb 3	CASSPMTSGRKEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAAGCCCTTCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSLKPFLNQPQHF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	6	7	3	1	7	25	40	44	41	51						01,02							Vb 3	CASSLKPFLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCAGGGACAGGGTATCAGCCCCAGCATTTTGGTGAT	CASSFAGTGYQPQHF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	5	4	1	25	39	52	43	53													Vb 3	CASSFAGTGYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCGATCTTAACACTGAAGCTTTCTTTGGACAA	CASADLNTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	2	8	2	3	4	25	34	39	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASADLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACGTTTGGTGGCACCACCAGACATCTATGTACCTCTGTGCCAGCAGTCACAGGGGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRGGAKNIQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	5	3	2	1	1	4	36	48	56	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSHRGGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGGGTTGGCCGCCTCAAGAGACCCAGTACTTCGGGCCA	CASKGWPPQETQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	7	5	3	2	0	10	25	-1	39	35	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASKGWPPQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCGGGACAGCTAAATACAATGAGCAGTTCTTCGGGCCA	CASSLGTAKYNEQFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	4	4	5	25	36	47	40	52													Vb 3	CASSLGTAKYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTGCGGGGCCAGCTCCTACGAGCAGTACTTCGGGCCG	CATCGASSYEQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	7	3	0	3	4	25	32	41	35	45													Vb 3	CATCGASSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACACCGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASTPASSYEQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	7	9	0	0	4	3	25	35	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTPASSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCAGGTGGGGTTCGGGGACCAGTTATGGCTACACCTTCGGTTCG	CATRWGSGTSYGYTF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	5	10	4	25	36	51	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATRWGSGTSYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTCGGGCCCCGGCGGGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRAPAGGANVLTF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	7	3	4	12	0	25	37	-1	49	55													Vb 3	CASSPRAPAGGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCGTGGGGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSAVGGSTEAFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	4	5	2	25	37	49	42	51													Vb 3	CASSAVGGSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGCGGACAGTATGGCTACACCTTCGGTTCG	CASSRGQYGYTF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	5	3	0	25	37	-1	40	46													Vb 3	CASSRGQYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAATAGAGTCGGGGAGCTGTTTTTTGGAGAA	CASSLNRVGELFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	8	7	2	3	25	40	45	42	48						01,02							Vb 3	CASSLNRVGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGTCTGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLSLGTYEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	0	8	2	6	0	25	40	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSLGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACAAAAAACGACAGGGCGGAAAGCTCGGGCCG		Out	VDJ	1	22	1.2344155042587335E-4		35	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	17	8	8	25	35	50	43	58													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACACCGGTGGCCTACGAGCAGTACTTCGGGCCG	CASSTPVAYEQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	3	6	2	0	7	25	-1	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTPVAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACAGGACAGGGCTTGGTCTATGGCTACACCTTCGGTTCG	CASSTGQGLVYGYTF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	3	6	25	37	48	40	54													Vb 3	CASSTGQGLVYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTGGGACACCTACTCTAGAAACACCATATATTTTGGAGAG	CASSFWDTYSRNTIYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	6	5	2	9	25	39	47	41	56													Vb 3	CASSFWDTYSRNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAAGCGGGCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPSGLSYNEQFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	4	0	4	2	25	36	46	40	48						01,02							Vb 3	CASSPSGLSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCGGGGTTGACTATGGCTACACCTTCGGTTCG	CASAGVDYGYTF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	8	3	3	2	3	25	34	41	36	44													Vb 3	CASAGVDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGGACAGATCTATGGCTACACCTTCGGTTCG	CASSPGQIYGYTF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	4	4	2	25	36	46	40	48													Vb 3	CASSPGQIYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACACCAAATCAGCCCCAGCATTTTGGTGAT	CASSLGTPNQPQHF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	6	4	0	3	25	-1	46	40	49													Vb 3	CASSLGTPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATAGGGGCCCTCACTCCCAGCATTTTGGTGAT		Out	VDJ	1	25	1.4027448912031063E-4		40	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	2	11	0	8	25	-1	46	41	54													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGCGGACAGGGGTGTATGGCTACACCTTCGGTTCG	CASSRRTGVYGYTF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	5	5	2	25	36	50	41	52													Vb 3	CASSRRTGVYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTGCGGACTAGCGGAACCTACAATGAGCAGTTCTTCGGGCCA	CASSLRTSGTYNEQFF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	5	2	5	2	25	36	51	41	53						01,02							Vb 3	CASSLRTSGTYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGGACAGCCCGGGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	1.4588546868512305E-4		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	6	2	8	25	36	45	38	53													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASFTSGANVLTF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	8	3	7	0	3	0	25	34	-1	37	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASFTSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTACAGGTCCATGAGCAGTTCTTCGGGCCA	CASRLQVHEQFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	4	8	0	3	25	-1	44	40	47													Vb 3	CASRLQVHEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCAAGCGGGGGGGATGAGACCCAGTACTTCGGGCCA	CASSSPSGGDETQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	5	5	2	25	38	53	43	55													Vb 3	CASSSPSGGDETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCTCCCCGGCGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSFLPGGSTDTQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	5	0	8	1	25	39	51	47	52						01,02							Vb 3	CASSFLPGGSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTCACAGGGAATGAGCAGTTCTTCGGGCCA	CASSFTGNEQFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	7	4	0	25	36	-1	40	46													Vb 3	CASSFTGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATACCCAGCGAGTACCGGGGAGCTGTTTTTTGGAGAA	CASSLYPASTGELFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	6	6	5	4	3	25	41	49	45	52						01,02							Vb 3	CASSLYPASTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCCCCCGGGGAACCTACAATGAGCAGTTCTTCGGGCCA	CASSLPRGTYNEQFF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	2	6	2	25	37	48	43	50													Vb 3	CASSLPRGTYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTTACTCTCTAGCGCAAGCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSFLLSSASSQETQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	6	1	8	7	25	39	53	47	60						01,02							Vb 3	CASSFLLSSASSQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCCGGGACTAGCGGGAAGCGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	1.795513460739976E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	3	9	5	5	25	36	54	41	59													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGCAGGACTACGAGCAGTACTTCGGGCCG	CASSFGQDYEQYF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	4	4	3	4	1	25	39	47	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFGQDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGCTTCAGGGGGGCTAGGGGAGCTGTTTTTTGGAGAA	CASRASGGLGELFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	8	5	4	25	36	48	41	52													Vb 3	CASRASGGLGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGATGCAGATACGCAGTATTTTGGCCCA	CASSLDADTQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	2	2	8	4	0	2	25	-1	42	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLDADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTCGGACAACTCCTACGAGCAGTACCTCGGGCCG	CATSDNSYEQYL	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	6	17	4	18	25	32	41	36	59													Vb 3	CATSDNSYEQYL+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCCGGGACTAGCGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASTPGLAATGELFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	0	5	4	4	1	25	35	50	39	51						01,02							Vb 3	CASTPGLAATGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAAGGGGACTAGCGGGAGCCTATGAGCAGTTCTTCGGGCCA	CASSPRGLAGAYEQFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	8	5	3	25	37	56	42	59													Vb 3	CASSPRGLAGAYEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAGGGAGCGTATCCTACGAGCAGTACTTCGGGCCG	CASKGSVSYEQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	9	2	1	2	4	25	35	42	37	46													Vb 3	CASKGSVSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGCTACTAAGGGGAATCGCAATGAGCAGTTCTTCGGGCCA	CASTATKGNRNEQFF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	6	9	5	25	35	49	44	54													Vb 3	CASTATKGNRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCAGCCATCGAAACTACGAGCAGTACTTCGGGCCG	CASSPSHRNYEQYF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	4	5	3	3	9	25	36	42	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPSHRNYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCACGGGACTACACGAGCAGTACTTCGGGCCG	CASSPTGLHEQYF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	5	5	1	25	37	49	42	50						01,02							Vb 3	CASSPTGLHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGGTTCGCCAGCCCCAGCATTTTGGTGAT	CASSRVRQPQHF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	4	7	0	5	25	-1	41	37	46						01,02							Vb 3	CASSRVRQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAACGGGACAGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSSTGQGSYEQYF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	1	4	1	25	38	51	42	52													Vb 3	CASSSTGQGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTAACAGGGGCACTGAAGCTTTCTTTGGACAA	CASSFNRGTEAFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	4	2	0	25	39	-1	41	48													Vb 3	CASSFNRGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTTCGGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSFRGSTEAFF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	4	4	2	25	36	46	40	48													Vb 3	CASSFRGSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACAGGGTCGAAAGTCACCCCTCCACTTTGGGAAC	CASRQGRKSPLHF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	10	0	7	25	-1	42	36	49													Vb 3	CASRQGRKSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTAGCGGGGGGGCTATCTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSSSGGAISTGELFF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	0	4	0	7	25	-1	50	38	57													Vb 3	CASSSSGGAISTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGAGGGGGGACAGGTGTGTACGAGCAGTACTTCGGGCCG	CASSGGGTGVYEQYF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	4	6	4	25	37	51	43	55													Vb 3	CASSGGGTGVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAGGTCCGGTACTGGTTACGAGCAGTACTTCGGGCCG	CASSLRSGTGYEQYF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	1	4	0	12	25	-1	43	39	55													Vb 3	CASSLRSGTGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCTGTGCCAGCAGTTTAGGGCCCAGGGGCGGTTTCGAAAGAAGCCGAAAGTACAATGAGCAGTTCTTCGGGCCA	CASSLGPRGGFERSRKYNEQFF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	66	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	4	5	22	2	17	28	22	50													Vb 3	CASSLGPRGGFERSRKYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCTCCAGGGGGGACCCAGTACTTCGGGCCA	CASSSPPGGTQYF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	7	6	0	25	38	-1	44	51													Vb 3	CASSSPPGGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAACCGTGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	50	2.8054897824062125E-4		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	2	3	7	4	1	4	25	40	43	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCTCTGTGCCAGCAGCCCCTCCCACAGGGAATTTAAGGCGGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPSHREFKAGRSYNEQFF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	63	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	0	8	16	8	19	33	27	49													Vb 3	CASSPSHREFKAGRSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCCAGGGCCACCTAAGGACTAGTCAACGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	55	3.086038760646834E-4		55	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	8	4	15	6	25	35	57	50	63						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGTGGACAGGCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRGQAATNEKLFF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	4	0	3	3	25	34	44	37	47													Vb 3	CASRGQAATNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTAAGACCCAGGGGGATCAGCCCCAGCATTTTGGTGAT	CASIKTQGDQPQHF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	1	5	8	0	25	35	-1	43	50													Vb 3	CASIKTQGDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGCAGTTTTGTCTCCGGCACAGATACGCAGTATTTTGGCCCA	CVSSFVSGTDTQYF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	10	1	3	3	25	39	44	42	47						01,02							Vb 3	CVSSFVSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACGGACTAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASNGLAGGADTQYF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	1	0	4	2	1	25	35	52	37	53													Vb 3	CASNGLAGGADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGACAGGGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSRTGGPYEQYF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	2	2	1	25	36	49	38	50													Vb 3	CASSRTGGPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTATGAAGGGCCCTACAATGAGCAATTCTTCGGGCCA	CASYEGPYNEQFF	In	VDJ	2	59	3.310477943239331E-4	4.0517803797685676E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	8	5	3	16	5	15	25	34	43	39	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASYEGPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGTTCCGGGATCTAAAATTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	60	3.366587738887455E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	3	3	5	9	25	36	46	41	55													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGGACGGATGGGAGACCCAGTACTTCGGGCCA	CASSLPDGWETQYF	In	VDJ	2	60	3.366587738887455E-4	4.1204546234934586E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	2	1	7	5	2	6	25	40	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLPDGWETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTCGTCGACCCATCTCAACGTCCCTTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	63	3.534917125831828E-4		56	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	1	2	7	9	6	15	25	41	50	47	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGACAGGGGGTGAGTACTGAAGCTTTCTTTGGACAA	CASSLRQGVSTEAFF	In	VDJ	2	64	3.591026921479952E-4	4.3951515983930224E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	5	1	5	25	40	50	41	55													Vb 3	CASSLRQGVSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCTCTGTGCCAGCGACTCACTAGGCCGGTGGGGAGACACATCAGATTCTAATCAGCCCCAGCATTTTGGTGAT	CASDSLGRWGDTSDSNQPQHF	In	VDJ	2	64	3.591026921479952E-4	4.3951515983930224E-4	63	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	3	8	4	5	26	8	17	27	22	53						01,02							Vb 3	CASDSLGRWGDTSDSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGGGGGTACTGAAGCTTTCTTTGGACAA	CASSLSGGTEAFF	In	VDJ	2	65	3.647136717128076E-4	4.4638258421179135E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	5	0	1	25	-1	48	41	49													Vb 3	CASSLSGGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGGSNQPQHF	In	VDJ	2	67	3.759356308424325E-4	4.6011743295676957E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	2	1	0	1	25	-1	45	39	46													Vb 3	CASSFGGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGCCCCCAGGGGGCCCCAGCATTTTGGTGAT	CASTAPRGPQHF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	9	7	0	25	35	-1	42	48													Vb 3	CASTAPRGPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTGACAGCCGAACATATAGAGCTTTCTTTGGACAA	CASTDSRTYRAFF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	5	10	2	12	25	35	42	37	54													Vb 3	CASTDSRTYRAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCACAGGGCAATGAGCAGTTCTTCGGGCCA	CASSSQGNEQFF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	6	3	0	25	36	-1	39	45													Vb 3	CASSSQGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGGACAGCTCTGGAAACACCATATATTTTGGAGAG	CASSWDSSGNTIYF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	5	0	2	0	25	36	-1	38	45													Vb 3	CASSWDSSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGAAAAGACAGTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	75	4.208234673609319E-4		38	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	2	5	2	4	2	25	33	42	37	44													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATGGGGAGCTTCACAGATACGCAGTATTTTGGCCCA	CASSLMGSFTDTQYF	In	VDJ	2	78	4.3765640605536915E-4	5.356591010541496E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	2	2	3	3	25	40	48	43	51													Vb 3	CASSLMGSFTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTSYSNQPQHF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	4	9	0	4	0	25	35	-1	39	42						01,02							Vb 3	CASTSYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAACCCCGGACAGGGGGCATGTAGGGGAGCTGTTTTTTGGAGAA	CASSPTPDRGHVGELFF	In	VDJ	2	87	4.88155222138681E-4	5.974659204065515E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	0	8	9	5	25	36	56	45	61													Vb 3	CASSPTPDRGHVGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTAGAAGCACAGATACGCAGTATTTTGGCCCA	CASSFRSTDTQYF	In	VDJ	2	87	4.88155222138681E-4	5.974659204065515E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	8	0	0	1	25	-1	42	39	43						01,02							Vb 3	CASSFRSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTGGAGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLEGYSNQPQHF	In	VDJ	3	100	5.610979564812425E-4	6.867424372489098E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	0	0	3	3	25	36	45	39	48													Vb 3	CASSLEGYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAAGGGGGGAAGGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	103	5.779308951756797E-4		44	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	5	1	1	3	6	25	36	45	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAGGGCCAGAAGCCCCAGCATTTTGGTGAT	CASSLEGQKPQHF	In	VDJ	3	108	6.059857929997419E-4	7.416818322288225E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	0	8	0	5	25	-1	45	39	50													Vb 3	CASSLEGQKPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGTAACCCTCGGAACCCCCAATCAGCCCCAGCATTTTGGTGAT	CAVTLGTPNQPQHF	In	VDJ	3	109	6.115967725645543E-4	7.485492566013116E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	11	1	8	3	9	5	25	31	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAVTLGTPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATAAGGCGGCGGGAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSL*GGGRNTGELFF	Stop	VDJ	3	112	6.284297112589916E-4		51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	7	2	2	6	1	25	41	54	47	55													Vb 3	CASSL*GGGRNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACACTCCGAGAGGGGAAAACTGTTTTTTGGCAGT	CASRHSERGKLFF	In	VDJ	3	120	6.73317547777491E-4	8.240909246986917E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	5	2	10	10	0	25	36	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRHSERGKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCACTAGGTTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTRFNTGELFF	In	VDJ	3	121	6.789285273423034E-4	8.309583490711808E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	8	2	3	4	25	37	45	40	49						01,02							Vb 3	CASSPTRFNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGAGGTCGGGCTATGGCTACACCTTCGGTTCG	CASKRSGYGYTF	In	VDJ	3	123	6.901504864719282E-4	8.44693197816159E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	8	4	4	6	0	25	35	-1	41	45						01,02							Vb 3	CASKRSGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATCGACAGTCCTACCGGGGAGCTGTTTTTTGGAGAA	CASSLIDSPTGELFF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	5	5	3	4	25	40	48	43	52													Vb 3	CASSLIDSPTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGAGGGGCTCCCACAATGAGCAGTTCTTCGGGCCA	CASSLGRGSHNEQFF	In	VDJ	4	128	7.182053842959904E-4	8.790303196786045E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	0	5	0	6	25	-1	47	40	53													Vb 3	CASSLGRGSHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATACAGGGAATTAATCAGCCCCAGCATTTTGGTGAT	CASSIQGINQPQHF	In	VDJ	4	130	7.294273434256153E-4	8.927651684235827E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	4	2	4	25	37	45	39	49													Vb 3	CASSIQGINQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAAAAATGACAGGGTCTAGTGGGGAGCAGTACTTCGGGCCG	CASKKMTGSSGEQYF	In	VDJ	4	145	8.135920368978016E-4	9.957765340109191E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	7	7	9	25	35	49	42	58													Vb 3	CASKKMTGSSGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGTTACTAGGGTCCCACTACGAGCAGTACTTCGGGCCG	CASKLLGSHYEQYF	In	VDJ	4	150	8.416469347218638E-4	0.0010301136558733648	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	8	3	4	7	25	35	44	39	51						01,02							Vb 3	CASKLLGSHYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGATGGGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSLDGANQPQHF	In	VDJ	5	169	9.482555464532998E-4	0.0011605947189506575	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	7	0	3	3	0	25	40	-1	43	48													Vb 3	CASSLDGANQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGATCACTAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRITSGTGELFF	In	VDJ	6	202	0.0011334178720921097	0.0013872197232427978	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	5	4	4	0	25	36	-1	40	48						01,02							Vb 3	CASRITSGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCTCAGGGCCAAAAGGGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	6	202	0.0011334178720921097		46	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	10	15	0	25	37	-1	52	58													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGGACAGGGGCGAATGAGCAGTACTTCGGGCCG	CASRRTGANEQYF	In	VDJ	6	207	0.001161472769916172	0.0014215568451052432	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	7	2	5	25	36	47	38	52													Vb 3	CASRRTGANEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTATGAAGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASYEGPYNEQFF	In	VDJ	6	223	0.0012512484429531708	0.001531435635065069	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	8	5	3	2	5	1	25	34	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASYEGPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGAAACAGACCAATGAACACTGAAGCTTTCTTTGGACAA	CASSRNRPMNTEAFF	In	VDJ	6	226	0.001268081381647608	0.0015520379081825362	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	0	4	5	25	37	45	41	50													Vb 3	CASSRNRPMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTGGCCGCGGAGTGACTATGGCTACACCTTCGGTTCG	CASSFWPRSDYGYTF	In	VDJ	6	227	0.0012736923612124205	0.0015589053325550252	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	3	6	4	25	39	49	45	53						01,02							Vb 3	CASSFWPRSDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGTCCAACAATGAGCAGTTCTTCGGGCCA	CASSSSNNEQFF	In	VDJ	7	233	0.001307358238601295	0.0016001098787899598	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	4	4	6	5	4	0	25	38	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSSNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLSGSNQPQHF	In	VDJ	7	249	0.0013971339116382938	0.0017099886687497853	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	3	1	0	0	25	-1	-1	41	46													Vb 3	CASSLSGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATGAGGGAAGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	7	253	0.0014195778298975435		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	0	5	2	3	25	37	44	39	47													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTAGGAGCCGGGACTGCCGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASLGAGTAVSGANVLTF	In	VDJ	8	288	0.0016159621146659784	0.0019778182192768602	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	8	0	10	0	9	5	25	34	49	43	54						01,02							Vb 3	CASLGAGTAVSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCTACCCCCAGCGGGGGGGTGGCAGGAGATACGCAGTATTTTGGCCCA	CASSTPSGGVAGDTQYF	In	VDJ	8	299	0.0016776828898789151	0.0020533598873742403	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	6	0	5	9	7	25	34	53	43	60													Vb 3	CASSTPSGGVAGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTACAGGGGCAAGTAAACACCATATATTTTGGAGAG	CASSSLQGQVNTIYF	In	VDJ	9	326	0.0018291793381288504	0.002238780345431446	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	6	4	5	25	38	49	42	54													Vb 3	CASSSLQGQVNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGGGACAGGGTGTGTTCGGCACTGAAGCTTTCTTTGGACAA	CASSLRGQGVFGTEAFF	In	VDJ	9	326	0.0018291793381288504	0.002238780345431446	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	4	2	9	25	40	51	42	60													Vb 3	CASSLRGQGVFGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTTAAACTAGCGGATCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	13	456	0.002558606681554466		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	3	6	4	25	37	51	43	55						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGGACAGGGGAACAGCCCCAGCATTTTGGTGAT	CASSWTGEQPQHF	In	VDJ	14	500	0.0028054897824062123	0.003433712186244549	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	7	2	2	25	36	47	38	49													Vb 3	CASSWTGEQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAACGGCGGTGCCACAGATACGCAGTATTTTGGCCCA	CASSLNGGATDTQYF	In	VDJ	15	527	0.002956986230656148	0.0036191326443017545	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	5	2	5	3	25	39	48	44	51						01,02							Vb 3	CASSLNGGATDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGACGGGGGGGCCCCAGGTGAGAAGCAGTACTTCGGGCCG	CASSFDGGAPGEKQYF	In	VDJ	16	566	0.0031758144336838327	0.0038869621948288296	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	0	8	3	12	25	39	50	42	62													Vb 3	CASSFDGGAPGEKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACTTGGAGGGAGAGGAGCCCTGAAGCTTTCTTTGGACAA	CASRTWRERSPEAFF	In	VDJ	22	776	0.004354120142294441	0.0053291213130515405	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	6	5	9	25	36	47	41	56													Vb 3	CASRTWRERSPEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTCCTCTGGAGACTACGAGCAGTACTTCGGGCCG	CASSSGDYEQYF	In	VDJ	22	796	0.0044663397335906905	0.005466469800501322	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	10	2	3	7	1	25	33	44	40	45													Vb 3	CASSSGDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTCGCCTCGTCCGGGAGAGGCGCTGAAGCTTTCTTTGGACAA	CASLASSGRGAEAFF	In	VDJ	23	818	0.004589781284016564	0.005617553136696082	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	2	6	11	5	25	34	51	45	56													Vb 3	CASLASSGRGAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCGGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGTSGNTGELFF	In	VDJ	44	1567	0.00879240497806107	0.010761253991690416	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	5	1	6	0	25	37	-1	43	54						01,02							Vb 3	CASSPPGTSGNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGCCACTAGCGGGGGGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLCH*RGDSGANVLTF	Stop	VDJ	46	1640	0.009202006486292377		57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	3	1	0	2	1	24	41	55	43	56													Vb 3	CASSLCH*RGDSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACAGGGGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRGGAKNIQYF	In	VDJ	153	5429	0.030462008057366655	0.037283246918243314	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	5	3	2	1	1	4	25	37	45	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSHRGGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCACAGGGCAGGGCTCCCCTCGGATACGCAGTATTTTGGCCCA	CASRHRAGLPSDTQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	48	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	6	1	14	18	30	37	31	51														CASRHRAGLPSDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCCTCGGGACAGGGGTTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	12	6.73317547777491E-5		52	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	2	1	3	1	18	35	48	38	49														X+TCRBV12-02+TCRBJ01-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCAAGTCGCTTCCTAAGTGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	6.73317547777491E-5		43	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	9	0	1	5	18	32	36	33	41						01,02								X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCATTACTCAACAGGGGATTCGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	24	1.346635095554982E-4		44	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	11	3	2	3	7	5	18	24	38	31	43														X+TCRBV12-02+TCRBJ01-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCCAGAGGACCGGGACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CAQRTGTGAGELFF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	0	2	6	10	0	18	23	-1	33	43														CAQRTGTGAGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGTCGAGGGGATCTCAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	6	199	0.0011165849333976726		49	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-03	01	0	5	2	5	4	7	18	35	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTGGGCAACAAAAATGAGCAGTTCTTCGGGCCA	CASSLGNKNEQFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	7	2	6	23	35	41	37	47													Vb 22	CASSLGNKNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCCCGGGACAGGGGGCCCGAGCAGTACTTCGGGCCG	CASSSRDRGPEQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	6	4	1	23	35	51	39	52													Vb 22	CASSSRDRGPEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGACCGGACAGACCCTAATCAGCCCCAGCATTTTGGTGAT	CASRDRTDPNQPQHF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	5	5	23	34	45	39	50													Vb 22	CASRDRTDPNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTTGATCCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVDPYSNQPQHF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	4	2	8	0	2	6	23	36	40	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVDPYSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGGCCAGGGTTTCTCCGGAACAGACGAGCAGTACTTCGGGCCG	CASSEGQGFSGTDEQYF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	5	2	14	23	39	46	41	60													Vb 22	CASSEGQGFSGTDEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCACTTCCCAAGAGGGGGACATTCAGTACTTCGGCGCC	CATSQEGDIQYF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	5	1	8	9	0	23	30	-1	39	45													Vb 22	CATSQEGDIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGGGGGACAGGGAAACTTTACTACGAGCAGTACTTCGGGCCG	CASGGTGKLYYEQYF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	3	3	3	8	23	32	44	35	52													Vb 22	CASGGTGKLYYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGATCCCAGGGACCTACACCTTCGGTTCG	CASSEIPGTYTF	In	VDJ	3	117	6.564846090830537E-4	8.034886515812245E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	10	7	0	23	37	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEIPGTYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCTACAGGGACCTCCTCCTACGAGCAGTACTTCGGGCCG	CASSPTGTSSYEQYF	In	VDJ	5	163	9.145896690644252E-4	0.001119390172715723	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	0	3	5	23	35	44	38	49													Vb 22	CASSPTGTSSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTAGAAGTTTAGCGGGAGATCGCTACGAGCAGTACTTCGGGCCG	CASSRSLAGDRYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	2	3	7	4	28	40	56	47	60			01,02											CASSRSLAGDRYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTGACGGAAATGAGCAGTTCTTCGGGCCA	CAISDGNEQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	33	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-01	01	2	1	8	7	0	0	28	-1	-1	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDGNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTACGTTACTCTGGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	7.855371390737395E-5		49	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-02	01	5	1	8	4	10	8	28	40	53	50	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ01-02	TCRBV06-04		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCAGACATCTGTGTACTTCTGTGCCAGCAGTCCCCCACAGGCCGGGGCTAGCGGGCAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	8.97756730369988E-5		59	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	4	2	16	2	19	31	55	47	57			01,02			01,02								X+TCRBV06-04+TCRBJ02-02	TCRBV06-04	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACTCGGGACAGGGCGCCGAGCAGTACTTCGGGCCG	CASSYSGQGAEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	6	0	3	28	-1	54	45	57			01,02											CASSYSGQGAEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACAGGAGGGGACAGCTACTCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	1.5149644824993548E-4		52	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	5	4	5	7	28	43	55	48	62			01,02											X+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGCGGTTTTATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYAVLSGANVLTF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	48	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	7	5	1	3	5	28	40	47	43	52			01,02			01,02								CASSYAVLSGANVLTF+TCRBV06-04+TCRBJ02-06	TCRBV06-04	TCRBD02-01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCTACCCGAAGATACGCAGTATTTTGGCCCA		Out	VDJ	15	524	0.0029401532919617105		32	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-03	01	8	2	8	5	5	0	28	37	-1	42	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ02-03	TCRBV06-04		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGTTAGCGGGTCCCTAGCCAGTGAGCAGTTCTTCGGGCCA	CASSEVSGSLASEQFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	4	9	5	11	26	38	50	43	61						01,02								CASSEVSGSLASEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCATCAGTCTAGGGAATGAGCAGTTCTTCGGGCCA	CAISLGNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	5	5	3	7	2	0	26	38	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISLGNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAAGGACAGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASS*GQGANYGYTF	Stop	VDJ	1	16	8.97756730369988E-5		45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	0	1	2	26	40	49	41	51														CASS*GQGANYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACAGACCTTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	1.2905252999068578E-4		44	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-05	01	2	2	7	0	1	3	26	41	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCKTACGAGCAGTACTTCGGGCCG	CASSYSYEQYF	In	VJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	0	0	0	4	0	1	26	-1	43	-1	44														CASSYSYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACACAGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSYTGSNTEAFF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	4	1	0	3	26	-1	46	41	49														CASSYTGSNTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCATCAGTGAGGGCAACGAGCAGTACTTCGGGCCG	CAISEGNEQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	0	5	0	2	26	-1	43	38	45														CAISEGNEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCTAGCACGGGACTAGCCGTAGATACGCAGTATTTTGGCCCA	CASTGLAVDTQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	7	5	1	3	26	36	46	37	49						01,02								CASTGLAVDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCGTACACTGAAGCTTTCTTTGGACAA	CASSYPYTEAFF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	36	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	6	3	1	1	26	41	44	42	45						01,02								CASSYPYTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAAGGGGACTACGACACACAGATACGCAGTATTTTGGCCCA	CASSERGLRHTDTQYF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	2	5	5	26	38	50	43	55						01,02								CASSERGLRHTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	101	5.667089360460549E-4		35	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	0	2	8	3	0	0	26	-1	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCATCTGACCCGGGACAGGGTAACGAGCAGTACTTCGGGCCG	CASSYSSDPGQGNEQYF	In	VDJ	3	106	5.94763833870117E-4	7.279469834838444E-4	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	9	2	26	43	61	52	63														CASSYSSDPGQGNEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCTGCAGGGAGGCCAGGGAGCAGTACTTCGGGCCG	CACREAREQYF	In	VDJ	16	564	0.0031645924745542075	0.003873227346083851	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	1	7	0	5	26	-1	42	37	47														CACREAREQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCAAACAACAGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKQQGNTGELFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	2	5	1	19	31	42	36	43														CASSKQQGNTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAACCAGGGGATTATCGGATACGCAGTATTTTGGCCCA	CASSLTRGLSDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	6	2	7	19	34	42	36	49														CASSLTRGLSDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCAACAGGGAATCGAGAGACCCAGTACTTCGGGCCA	CASSPTGNRETQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	4	3	5	19	31	40	34	45														CASSPTGNRETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGTCTAGCGGCGGGGGCCCCTTTATACAATGAGCAGTTCTTCGGGCCA	CASSLAAGAPLYNEQFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	51	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	4	1	14	19	30	38	31	52						01,02								CASSLAAGAPLYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGACACAGGGGGTAACCACTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	22	1.2344155042587335E-4		56	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	1	0	5	9	19	31	44	36	53														X+TCRBV07-07+TCRBJ01-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTTTCAACGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSTGSYNEQFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	0	7	0	19	31	-1	38	42						01,02								CASSLSTGSYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCGAGCGTTCTAGGGTCGCCCGGGACCCAGTACTTCGGGCCA	CASSSSVLGSPGTQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-05	01	4	5	3	7	10	8	19	32	46	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSVLGSPGTQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGAGGGACACGGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSLEGHGGSDTQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	1	4	9	1	19	33	49	42	50														CASSLEGHGGSDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCACAAGAACTTAGGACAGTGGGCTGGAAACACCATATATTTTGGAGAG	CASSHKNLGQWAGNTIYF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	54	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	5	2	10	4	27	41	57	51	61			01,02											CASSHKNLGQWAGNTIYF+TCRBV16-01+TCRBJ01-03	TCRBV16-01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAACTAGCGGGTCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQTSGSNTGELFF	In	VDJ	2	79	4.432673856201816E-4	5.425265254266387E-4	48	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	4	2	0	3	29	-1	53	44	56			01,02			01,02								CASSQTSGSNTGELFF+TCRBV16-01+TCRBJ02-02	TCRBV16-01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCTAGGACAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSQSRTGYNEQFF	In	VDJ	2	81	4.544893447498064E-4	5.562613741716169E-4	45	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	4	2	0	29	46	-1	48	56			01,02											CASSQSRTGYNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGGGAACCGGGGCCGCTTTCTTTGGACAA	CASSQSGTGAAFF	In	VDJ	5	195	0.001094141015138423	0.0013391477526353741	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-01	01	0	7	0	11	7	1	29	46	58	53	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSGTGAAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCACCAGTGACCAGGGTGGAGGCTTTCTTTGGACAA		Out	VDJ	1	10	5.610979564812425E-5		34	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	13	4	3	11	12	5	25	28	45	40	50														X+TCRBV22-01+TCRBJ01-01	TCRBV22-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGAATGACGGGGGGGCAGGAGGAGAGACCCAGTACTTCGGGCCA	CASSQNDGGAGGETQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	0	4	6	7	23	37	51	43	58													Vb 7.1	CASSQNDGGAGGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCTCCAGGGGGAGATAGCGGGAGGGCCGTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	8.97756730369988E-5		55	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	0	5	12	6	23	32	55	44	61													Vb 7.1	X+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAACCCCCCCATACGCAGTATTTTGGCCCA	YASSQEPPHTQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	0	3	7	7	0	6	22	-1	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQEPPHTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGTGGGGAACACTGAAGCTTTCTTTGGACAA	YASSQVGNTEAFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	1	0	9	1	1	0	22	38	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQVGNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGCCCGGGACTAGCGCAGTTCTTCGGGCCA	CASSQGPGLAQFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	7	12	4	0	23	39	-1	43	52						01,02							Vb 7.1	CASSQGPGLAQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCACGCCGGGAGGGGACCCATAACAATGAGCAGTTCTTCGGGCCA	CASSPRREGTHNNEQFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	0	5	5	8	23	36	49	41	57													Vb 7.1	CASSPRREGTHNNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGCCAACCGGGACAGTCTACCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	1.6271840737956033E-4		50	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	4	7	7	23	37	51	44	58													Vb 7.1	X+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGGCGAAGGGAAAAGGATGGCTTTCTTTGGACAA	CASSQEGEGKRMAFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	11	7	8	23	40	51	47	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQEGEGKRMAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGCCAGCGGGGGCCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQEPAGAYTGELFF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	6	2	3	3	3	23	40	51	43	54													Vb 7.1	CASSQEPAGAYTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTTTCTGCCGGGACAGGGGGAAACTATGGCTACACCTTCGGTTCG	CASSLSAGTGGNYGYTF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	1	2	8	1	23	36	55	44	56													Vb 7.1	CASSLSAGTGGNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACTCGTACAGGGGGCTTTCGGATGGCTACACCTTCGGTTCG	CASSQDSYRGLSDGYTF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	6	5	6	23	40	54	45	60													Vb 7.1	CASSQDSYRGLSDGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTAAATAGGGGGCTTGGCTATGGCTACACCTTCGGTTCG	CASSQVNRGLGYGYTF	In	VDJ	2	54	3.0299289649987095E-4	3.7084091611441127E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	0	4	5	4	23	39	51	44	55													Vb 7.1	CASSQVNRGLGYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTGACGGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVTGANTGELFF	In	VDJ	2	67	3.759356308424325E-4	4.6011743295676957E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	8	2	0	3	0	23	39	-1	42	48													Vb 7.1	CASSQVTGANTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCAGGGACTTCTACCTACGAGCAGTACTTCGGGCCG	CASSPGTSTYEQYF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	2	2	4	23	36	44	38	48						01,02							Vb 7.1	CASSPGTSTYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCACCCACGGGGGACAGGGGAATTCACCCCTCCACTTTGGGAAC	CASSTHGGQGNSPLHF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	7	8	0	23	35	-1	43	53													Vb 7.1	CASSTHGGQGNSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCAAAGGACCACGGGACAGGCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSQRTTGQAPGELFF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	4	6	8	3	23	38	54	46	57													Vb 7.1	CASSQRTTGQAPGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCTCTACAGGCTAAACTATGGCTACACCTTCGGTTCG	CASSQDLYRLNYGYTF	In	VDJ	6	224	0.0012568594225179832	0.001538303059437558	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	2	5	3	23	40	50	45	53													Vb 7.1	CASSQDLYRLNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATATAAGGGACAGGGGGACCGGGGAGCTGTTTTTTGGAGAA	XASSQDIRDRGTGELFF	In	VDJ	7	249	0.0013971339116382938	0.0017099886687497853	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	1	5	5	0	23	40	-1	45	56													Vb 7.1	XASSQDIRDRGTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGCACAGGGGCTGAAGCTTTCTTTGGACAA	CASSTGAEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	33	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	6	1	0	26	37	-1	38	45													Vb 13.1	CASSTGAEAFF+TCRBV06-09+TCRBJ01-01	TCRBV06-09*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGAGGCTAGGGGAGACCCAGTACTTCGGGCCA	CASSERLGETQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	39	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-05	01	2	5	3	5	5	0	26	41	-1	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSERLGETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGAAGTCTAGCGGGAGACTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	1.571074278147479E-4		40	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	9	4	2	26	37	51	41	53			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGCGGTAGCGGGGATAGATGAGCAGTTCTTCGGGCCA	CASSESAVAGIDEQFF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	5	4	26	43	56	48	60			01,02										Vb 12	CASSESAVAGIDEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCGTTTACAGGGAGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	57	3.198258351943082E-4		46	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	0	1	7	0	22	34	-1	41	48														X+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGTAGCGGGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CATSRVVAGGTGELFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	5	0	5	3	0	18	34	-1	37	48														CATSRVVAGGTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCGGCGGCCAGGGGGAATCAGCCCCAGCATTTTGGTGAT	CATSRDPAARGNQPQHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	1	4	9	0	18	35	-1	44	51														CATSRDPAARGNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGGACAGGGTTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	7.855371390737395E-5		43	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	2	3	18	32	43	34	46														X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTTGGGGCCCTGTATGGCTACACCTTCGGTTCG	CATSRDLGALYGYTF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	7	0	5	4	4	18	35	44	39	48														CATSRDLGALYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGACAGGGGAGACCGGGGAGCTGTTTTTTGGAGAA	CATSRTGETGELFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	2	5	0	2	18	-1	40	32	42														CATSRTGETGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCCCGTCGAATGGGGACAGGGGCAAATCAGCCCCAGCATTTTGGTGAT	CATSRPRRMGTGANQPQHF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	57	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	2	4	12	2	18	33	55	45	57														CATSRPRRMGTGANQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAAAGGGGGCCTATTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	1.1783057086106093E-4		47	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	6	3	4	18	35	45	38	49														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAATGGGCCAGGGTGGCGGGAGCCAATGAGTAGTTCTTCGGGCCA	CATSRDQWARVAGANE*FF	Stop	VDJ	1	22	1.2344155042587335E-4		57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	14	16	9	18	35	58	51	67														CATSRDQWARVAGANE*FF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTCCTTTGGGGCACAGATACGCAGTATTTTGGCCCA	CATSRDLLWGTDTQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	0	0	9	1	8	0	18	35	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDLLWGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCCTGACAGGGGGTGGGTTCAATGAGCAGTTCTTCGGGCCA	CASSLTGGGFNEQFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	6	2	6	18	30	41	32	47														CASSLTGGGFNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGAGAGGGGATATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	1.6271840737956033E-4		47	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	5	2	6	6	2	18	35	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCTCGACCCAGTCAAGTTCGCAATCAGCCCCAGCATTTTGGTGAT	CATSPRPSQVRNQPQHF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	51	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	5	2	7	2	4	12	18	30	37	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPRPSQVRNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGGTCGGACAGCCTCAGATACGCAGTATTTTGGCCCA	CATSRVGRTASDTQYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	4	6	3	18	34	46	40	49														CATSRVGRTASDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACAGACGCCACTGACCGGGACAGGGGGCTTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	49	2.749379986758088E-4		59	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	0	4	11	3	18	35	58	46	61														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATCTAAGGTTTCCGGGGGGGAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	73	4.09601508231307E-4		56	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	0	1	11	1	18	33	52	44	53														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAACAGGGGCTCTGGAAACACCATATATTTTGGAGAG	CATSNRGSGNTIYF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	0	0	0	18	-1	-1	31	38														CATSNRGSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGAAACTTCAACCTGGAAACACCATATATTTTGGAGAG	CATSRGKLQPGNTIYF	In	VDJ	3	101	5.667089360460549E-4	6.936098616213989E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-03	01	1	1	8	2	0	9	18	-1	37	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGKLQPGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCCTTTCCCCCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	104	5.835418747404922E-4		41	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	10	4	2	8	18	31	35	33	43						01,02								X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGTGGGGGTCAGCCCCAGCATTTTGGTGAT	CATSRDGGGQPQHF	In	VDJ	3	108	6.059857929997419E-4	7.416818322288225E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	0	6	1	6	4	0	18	35	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDGGGQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCCGAGCCAAAGCGGGAACGCGCAATGAGCAGTTCTTCGGGCCA	CATRAKAGTRNEQFF	In	VDJ	4	143	8.023700777681767E-4	9.82041685265941E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	3	6	8	5	18	27	42	35	47														CATRAKAGTRNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATGGGAGCAGATACGCAGTATTTTGGCCCA	CATSRDMGADTQYF	In	VDJ	4	146	8.19203016462614E-4	0.0010026439583834083	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	2	4	3	0	18	35	-1	38	43														CATSRDMGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGGGCGGGGGTTATTCGGCGGGAGAACCCAAAGAGACCCAGTACTTCGGGCCA	CATSRDRGGGYSAGEPKETQYF	In	VDJ	6	202	0.0011334178720921097	0.0013872197232427978	66	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	7	2	3	5	20	15	32	44	37	64						01,02								CATSRDRGGGYSAGEPKETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCACACCGGACAGGGCCGGAGAGACCCAGTACTTCGGGCCA	CATTPDRAGETQYF	In	VDJ	7	249	0.0013971339116382938	0.0017099886687497853	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	1	3	4	4	4	18	28	40	32	44														CATTPDRAGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACGCGACGGCCGCCGTGAGGAACAAAAGAGACCCAGTACTTCGGGCCA	CATRRPP*GTKETQYF	Stop	VDJ	11	383	0.0021490051733231586		48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	11	1	3	14	5	18	26	44	40	49														CATRRPP*GTKETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATCCACAGGTAGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	18	637	0.0035741939827855147		41	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	5	3	3	18	31	39	34	42														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCCGGACAGGTTGCGAACACTGAAGCTTTCTTTGGACAA	CASSAGQVANTEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	1	4	4	26	37	48	41	52	TCRBV09,TCRBV12													CASSAGQVANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGGAGCTTGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	5.610979564812425E-5		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	1	1	1	41	58	62	59	63		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTATTAGGGGACACTATAGCACAGATACGCAGTATTTTGGCCCA	CIRGHYSTDTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	14	0	6	0	5	4	24	27	38	32	42	TCRBV06,TCRBV10													CIRGHYSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GARGACTCSGCCSTGTATCTCTGTGCCAGCAGCCTCGGGGGGGGATATGGCTACACCTTCGGTTCG	CASSLGGGYGYTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	5	2	2	20	32	42	34	44	TCRBV04,TCRBV07													CASSLGGGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCGTACGGGGGAATGGCTACACCTTCGGTTCG	CSALVRGNGYTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	6	6	1	26	35	47	41	48		TCRBV20-01,TCRBV20-or09_02												CSALVRGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAGCCACGTTTGGTGGGAGACACGGCACKTATCTCTGCGCCAGCAGCCAAAGACCTACTCTGAACACTGAAGCTTTCTTTGGACAA	CASSQRPTLNTEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV04						TCRBJ01	TCRBJ01-01	01	2	2	7	0	1	6	36	51	55	52	61		TCRBV04-01,TCRBV04-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRPTLNTEAFF+TCRBV04-X+TCRBJ01-01	TCRBV04		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGCGGGGACAGTAAATGAAAAACTGTTTTTTGGCAGT	CASSAGTVNEKLFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	5	3	2	22	34	44	37	46		TCRBV12-03,TCRBV12-04												CASSAGTVNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCACGTTTGGTGCCCCAACCAGACAGCTCTTTATTCTGTGCCACCAGTGATCCCCCCAGGAGGGGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	5.610979564812425E-5		44	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	22	10	0	8	25	3	37	33	64	58	67		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCGGGAGGGCCGATACGCAGTATTTTGGCCCA	CATSGGRADTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	0	6	0	2	24	-1	46	37	48		TCRBV24-01,TCRBV24-or09_02												CATSGGRADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGCGGATAACACCGGGGAGCTGTTTTTTGGAGAA	CATSVADNTGELFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	5	2	2	2	24	37	43	39	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATSVADNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACCAGGCCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLYQASSYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	4	0	6	4	24	36	46	42	50		TCRBV24-01,TCRBV24-or09_02												CASSLYQASSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAATCGGAAATCGGGCAGTTCTTCGGGCCA	CAISESEIGQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	36							TCRBJ02	TCRBJ02-01	01	2	1	8	12	2	6	23	38	43	40	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISESEIGQFF+X+TCRBJ02-01			TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTCCCWSSSASWCAKCTGTRTACTTCTGTGCCAGCACCGCGTCTCCCGGGCAGGGTGAAGCTTTCTTTGGACAA	CASTASPGQGEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	7	14	0	26	36	-1	50	55	TCRBV06,TCRBV12													CASTASPGQGEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MWCCCWSKSASWCWKCTGTKTAYTTYTGTGCCAGCAGTTTAAATCAAGACGAGTCTGGCTACACCTTCGGTTCG	CASSLNQDESGYTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	4	2	7	7	8	5	26	39	50	47	55	TCRBV06,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNQDESGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGTAGGGGTTGGGCGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSRGWAGQGTDTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	4	1	12	0	18	29	-1	41	49	TCRBV07,TCRBV11													CASSRGWAGQGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAGCCCGCAGGAGGGGGCTGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	5.610979564812425E-5		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	0	2	11	2	18	30	48	41	50	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCCCCACTAGCGGGAGATGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	5.610979564812425E-5		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	3	2	4	3	4	18	27	41	30	45	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCGATTTCTTTTAGACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	5.610979564812425E-5		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	5	8	3	9	1	18	27	39	36	40	TCRBV03,TCRBV11					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTCCTAGCTCTAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFLALGSYNEQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	7	0	4	6	20	31	40	35	46	TCRBV07,TCRBV23					01,02								CASSFLALGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTTAGCGGAACCTACGAGCAGTACTTCGGGCCG	CASSFSGTYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	5	2	3	2	20	31	40	34	42	TCRBV07,TCRBV23					01,02								CASSFSGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAGGCTGACAGGTTTCATGGCTACACCTTCGGTTCG	YASSQADRFHGYTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	6	4	4	22	36	46	40	50	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												YASSQADRFHGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGAATCGAGGGCGCATGGCTACACCTTCGGTTCG	CASSLESRAHGYTF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	0	6	4	3	19	35	44	39	47	TCRBV07,TCRBV11													CASSLESRAHGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTAGCGCTGATCGGGGGGGAGCAGTACTTCGGGCCG	CASSLALIGGEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	1	7	6	0	19	36	-1	42	49	TCRBV07,TCRBV11													CASSLALIGGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTCCGGACAGAAAACCATGGGCAGGAACACTGAAGCTTTCTTTGGACAA	CASSSGQKTMGRNTEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	1	2	14	19	32	40	34	54	TCRBV05,TCRBV11													CASSSGQKTMGRNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTAACGGGGGAGAACATGAACACTGAAGCTTTCTTTGGACAA	CASSLTGENMNTEAFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	0	2	6	19	33	41	35	47	TCRBV05,TCRBV07													CASSLTGENMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGCGACGGGGAGGGAGACCCAGTACTTCGGGCCA	CASSLATGRETQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	1	5	7	0	19	33	-1	40	46		TCRBV05-06,TCRBV05-07												CASSLATGRETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTCGAGGGACAGGTCTGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	5.610979564812425E-5		47	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	1	4	5	19	30	42	34	47		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAATGAATGGTCTAGAGGAGGAGAGACCCAGTACTTCGGGCCA	CASNEWSRGGETQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	1	4	14	0	23	33	-1	47	52	TCRBV02,TCRBV09													CASNEWSRGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTTGGTGCATCCTGAAGACAGCAGCTTCTCATCTGCAGTGCTATTCCGAGGGGCAGGGGATTTGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	5.610979564812425E-5		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	19	4	2	4	24	5	34	29	59	53	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTATTCCGAGGGGCAGGGGATTTGCAGATACGCAGTATTTTGGCCCA	CSAIPRGRGFADTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	4	10	5	33	43	59	53	64		TCRBV20-01,TCRBV20-or09_02												CSAIPRGRGFADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCACGGGACAGGGTCACTATTGGAATTCACCCCTCCACTTTGGGAAC	CASSPTGQGHYWNSPLHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	7	6	10	26	37	52	43	62		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPTGQGHYWNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGATTCGGAGACCCAGTACTTCGGGCCA	CASSPDSETQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	6	5	2	0	26	43	-1	45	47		TCRBV03-01,TCRBV03-02				01,02								CASSPDSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLPGNTEAFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	1	3	0	26	39	-1	42	46		TCRBV03-01,TCRBV03-02				01,02								CASSLPGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGATCAGCCCGGGCGGCGATGAGCAGTTCTTCGGGCCA	CASSAISPGGDEQFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	45	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	8	0	8	11	4	26	38	53	49	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAISPGGDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGTCCTCTCTATGGCTACACCTTCGGTTCG	CSARQGPLYGYTF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	4	0	6	26	-1	43	38	49		TCRBV20-01,TCRBV20-or09_02												CSARQGPLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGCGGGGGCTACAAGAGACCCAGTACTTCGGGCCA	CSARVRGLQETQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	2	2	1	3	26	39	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSARVRGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCCGCTTCAAAAGATGTCGGAAGAGACCCAGTACTTCGGGCCA	CSARSPLQKMSEETQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	5	3	19	0	26	38	-1	57	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSPLQKMSEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGCCCCCCCGAGCGGAGACCCAGTACTTCGGGCCA	CSAPPPRAETQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	6	5	11	0	26	35	-1	46	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPPPRAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATATCCCCAGCCCCAGCATTTTGGTGAT	CASSEYPQPQHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	36	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	5	9	7	0	4	23	-1	40	38	44		TCRBV06-01,TCRBV06-08				01,02								CASSEYPQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGGTCAGGGTAAGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	11	6.172077521293668E-5		47				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	5	2	7	18	34	41	36	48	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02												X+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCRGCYSTGTATYTYTGTGCCAGCAGCTTGGGGGCGGGAGGTGCCACAGATACGCAGTATTTTGGCCCA	CASSLGAGGATDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	7	1	2	7	3	26	37	52	44	55	TCRBV05,TCRBV12													CASSLGAGGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGTGTGGACAGGGTTAGGTAAGCAGTTCTTCGGGCCA	CASSQVWTGLGKQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	3	11	3	7	23	39	50	42	57	TCRBV01,TCRBV23													CASSQVWTGLGKQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCAGTGTTGGGGTAGAGAACACTGAAGCTTTCTTTGGACAA	CATSVGVENTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	unresolved						TCRBJ01	TCRBJ01-01	01	4	6	2	1	2	4	24	37	43	39	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSVGVENTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTACCAGCAGCCAAGCGTCATACTATGGCTACACCTTCGGTTCG	CTSSQASYYGYTF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	4	6	3	3	1	26	42	47	45	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSQASYYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGCCACCCGGGACAGGTAGGGAATACGCAGTATTTTGGCCCA	CASSQTGHPGQVGNTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	4	7	11	6	26	41	60	52	66		TCRBV03-01,TCRBV03-02												CASSQTGHPGQVGNTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAGGGGGGAAACGCCTACGAGCAGTACTTCGGGCCG	CASSQQGGNAYEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	2	0	6	26	-1	48	41	54		TCRBV03-01,TCRBV03-02												CASSQQGGNAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTCGGGGGGGGAGACCCAGTACTTCGGGCCA	CASSSGGETQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	5	2	0	26	37	-1	39	47		TCRBV03-01,TCRBV03-02												CASSSGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
RGGGGACTYRGCYSTGTATCTCTGTGCCACCCGGTCCCCGGGGATCCACGAGCAGTACTTCGGGCCG	CATRSPGIHEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	9	8	3	5	9	4	22	29	43	38	47	TCRBV05,TCRBV07													CATRSPGIHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACTAGCGGGAGGTTGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSARGTSGRLGGTDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	1	1	1	0	7	26	-1	53	39	60		TCRBV20-01,TCRBV20-or09_02												CSARGTSGRLGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAAGCCACGTTTGGTGGGAGACACGGCACTGTWCTCTGCGCCAGCAGCCAAAGACCTACTCTGAACACTGAAGCTTTCTTTGGACAA	CASSQRPTLNTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	unresolved						TCRBJ01	TCRBJ01-01	01	2	2	7	0	1	6	36	51	55	52	61	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRPTLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGGACGGCGAACACTGAAGCTTTCTTTGGACAA	CASRTANTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	36	unresolved						TCRBJ01	TCRBJ01-01	01	13	1	7	1	7	3	25	28	39	35	42	TCRBV22,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTANTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGATACAGGGAAAACACTGAAGCTTTCTTTGGACAA	CASSQDRYRENTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	2	5	2	23	40	51	45	53	TCRBV01,TCRBV04													CASSQDRYRENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCAAGCAGGGGCTGGGGGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPSRGWGTSNQPQHF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	0	6	9	22	33	45	39	54		TCRBV12-03,TCRBV12-04												CASSPSRGWGTSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCCCCTTTGGGGCTAGGGGTCAGCCCCAGCATTTTGGTGAT	CASSPFGARGQPQHF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	5	2	6	13	0	22	33	-1	46	51	TCRBV12,TCRBV21													CASSPFGARGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTGGTAGCGGGGGGGCTTTACGCAATGAGCAGTTCTTCGGGCCA	CATSAGSGGALRNEQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	6	4	7	24	37	52	41	59		TCRBV24-01,TCRBV24-or09_02												CATSAGSGGALRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGTTTTACAGGGTAGTTATCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	6.73317547777491E-5		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	6	5	8	24	35	46	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGCGGAGAGGGATCAGCCCCAGCATTTTGGTGAT	CASSAERDQPQHF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	5	5	0	23	35	-1	40	45	TCRBV06,TCRBV10													CASSAERDQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGGATGAAAGGACTAGCGGGCTGGAGACCCAGTACTTCGGGCCA	CASSQDWDERTSGLETQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	57	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	1	4	5	11	3	24	41	63	52	66		TCRBV03-01,TCRBV03-02				01,02								CASSQDWDERTSGLETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGTCCGGACTAGCGGACCGCCCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSVRTSGPPLAKNIQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	1	5	0	4	9	24	36	50	40	59	TCRBV03,TCRBV12					01,02								CASSVRTSGPPLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGGATTTTACAAAGGTTACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	12	6.73317547777491E-5		55	unresolved						TCRBJ02	TCRBJ02-06	01	5	1	8	5	0	20	18	-1	33	30	53	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGATCAAGAGTTCTCCTACGAGCAGTACTTCGGGCCG	CASSLDQEFSYEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	2	0	4	2	18	35	42	39	44	TCRBV07,TCRBV11													CASSLDQEFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGTCTCAGGGGATATACAATGAGCAGTTCTTCGGGCCA	CASSLSQGIYNEQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	4	4	3	18	32	42	36	45	TCRBV11,TCRBV23													CASSLSQGIYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTTGGCAGATCACAGATACGCAGTATTTTGGCCCA	CASSFWQITDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	5	2	4	2	19	33	40	37	42		TCRBV05-06,TCRBV05-07												CASSFWQITDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCCCGACAGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSPTGATDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	2	2	1	19	31	41	33	42	TCRBV05,TCRBV07													CASSPTGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTTGGTGGGGACTCGGCCMYGTATCTCTGTGCCAGCAGCTTAGTCGGACTGATAGGGGGCAAGAACTATGGCTACACCTTCGGTTCG	CASSLVGLIGGKNYGYTF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	0	2	12	3	19	33	52	45	55	TCRBV05,TCRBV11													CASSLVGLIGGKNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTACCGACAGGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSYRQGLNTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	0	3	2	22	35	45	38	47	TCRBV07,TCRBV11													CASSYRQGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCAACCTACAGGGTTTAACACTGAAGCTTTCTTTGGACAA	CASSSQPTGFNTEAFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	2	8	3	26	39	53	47	56		TCRBV12-03,TCRBV12-04												CASSSQPTGFNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTGELFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	3	6	2	5	0	0	26	-1	-1	40	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAGATCTCGACAGGAACACTGAAGCTTTCTTTGGACAA	CASRDLDRNTEAFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	7	0	24	35	-1	42	47	TCRBV06,TCRBV10													CASRDLDRNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGCGTGCGGCGGGAGGGGAGGAGACCCAGTACTTCGGGCCA	CSARRRAAGGEETQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	7	0	5	9	3	26	38	56	47	59		TCRBV20-01,TCRBV20-or09_02												CSARRRAAGGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGTTGGCGGGAGGAGTCACCTACGAGCAGTACTTCGGGCCG	CSARVLAGGVTYEQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	1	2	5	5	26	39	52	44	57		TCRBV20-01,TCRBV20-or09_02												CSARVLAGGVTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCTGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CSASPLTGMNTEAFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	0	6	1	26	37	50	43	51		TCRBV20-01,TCRBV20-or09_02												CSASPLTGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTCACTAGCGGGAGGGGAGATACGCAGTATTTTGGCCCA	CSARFTSGRGDTQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	0	5	4	1	26	37	54	41	55		TCRBV20-01,TCRBV20-or09_02												CSARFTSGRGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGAGGACAGGGGAATTGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	7.294273434256153E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	6	2	5	24	38	49	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCACGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDLHGSSYNEQFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	0	2	0	24	42	-1	44	50		TCRBV24-01,TCRBV24-or09_02												CATSDLHGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCGACAGGGGCTTCTCCTACGAGCAGTACTTCGGGCCG	CASSSDRGFSYEQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	0	2	3	19	32	42	34	45		TCRBV05-06,TCRBV05-07												CASSSDRGFSYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGAGACATTAGCGGGGGGGACCCTAAGGAGACCCAGTACTTCGGGCCA	CSARDISGGDPKETQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	3	8	30	44	58	47	66		TCRBV20-01,TCRBV20-or09_02												CSARDISGGDPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGAGTCTGGAAACACCATATATTTTGGAGAG	CASSESGNTIYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	36	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	3	5	5	1	0	0	23	-1	-1	36	38	TCRBV03,TCRBV09			TCRBD01,TCRBD02										CASSESGNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAATAGGTACCAAGAGACCCAGTACTTCGGGCCA	CASNRYQETQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	36	unresolved						TCRBJ02	TCRBJ02-05	01	12	4	5	0	0	8	26	-1	34	31	42	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNRYQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATCCTTTGCCCAGGGGGAATGAGCAGTTCTTCGGGCCA	XASSQDPLPRGNEQFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	7	9	0	23	40	-1	49	56	TCRBV01,TCRBV04													XASSQDPLPRGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGGAGCTTGGTGACTCTGCTGTGTTTTCTGTGCCAGCAGCCAAGATACTGTCCTACGAGCAGTACTTCGGGCCG	VPAAKILSYEQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	22	4	5	1	9	14	42	37	49	46	63		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									VPAAKILSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGKGACTCKGCYSTGTATYTCTGTGCCAGCAGTCGCAACCAGGGGAACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRNQGNSNQPQHF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	1	7	3	26	37	50	44	53	TCRBV03,TCRBV05													CASSRNQGNSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAATGGGTGCTCTTGCCTACAATGAGCAGTTCTTCGGGCCA	CSARVMGALAYNEQFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	0	9	2	4	8	26	39	46	43	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVMGALAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGACCGGGGAAGTCAATCAGCCCCAGCATTTTGGTGAT	CSARVTGEVNQPQHF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	8	3	3	4	4	26	39	48	43	52		TCRBV20-01,TCRBV20-or09_02												CSARVTGEVNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACTACATGGGGGGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	7.855371390737395E-5		43	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	9	0	3	6	2	22	32	45	38	47		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCCCAGGACAGATACGCAGTATTTTGGCCCA	CASSPRTDTQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	3	3	0	23	34	-1	37	41	TCRBV24,TCRBV27													CASSPRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGATTCCTGGCTGGCTACACCTTCGGTTCG	CATSDGFLAGYTF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	1	8	7	1	8	24	38	42	39	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDGFLAGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGAAGGACTAGCGGGGTCAGATACGCAGTATTTTGGCCCA	CASSLEGLAGSDTQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	4	6	1	24	36	54	42	55		TCRBV24-01,TCRBV24-or09_02												CASSLEGLAGSDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGCCCGAGTCGCACGAGCAGTACTTCGGGCCG	CASSLSPESHEQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	2	5	9	4	24	36	48	45	52	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSPESHEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTATGGGGGACCCCGGGAAAGGGGCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGGPRERGYTGELFF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	57	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	7	3	4	15	18	31	40	35	55	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGPRERGYTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGTGTGAGTTACCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	14	7.855371390737395E-5		55	unresolved						TCRBJ02	TCRBJ02-06	01	4	3	6	5	14	5	18	31	48	45	53	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTGGACAGATAGAGTGAGTCACGAGCAGTACTTCGGGCCG	CASSLAWTDRVSHEQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	5	2	12	18	35	43	37	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAWTDRVSHEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGACTCRGCYGTGTATSTCTGTGCCAGCTTTTCTGGAAGACCGGGACAGGGTCGCTTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	14	7.855371390737395E-5		61	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	0	3	0	14	7	18	27	50	41	57	TCRBV07,TCRBV11													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGRGGACTCRGCYSTGTATCTCTGTGCCAGCAGCCTGGGGACTAGCGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGGSTDTQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	0	3	1	22	34	51	37	52	TCRBV05,TCRBV07													CASSLGTSGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGRGGACTYGGCYSTGTATCTCTGTGCCAGCAGCTTAGTGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVPQETQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	39	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	4	5	8	1	0	4	22	-1	38	35	42	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLVPQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCTCAGGGGGCGCTGAAGCTTTCTTTGGACAA	CASSLSGGAEAFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	6	5	1	26	37	50	42	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLSGGAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGGCAGGGTAATAAACGAGCAGTACTTCGGGCCG	CASSQGGRVINEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	5	4	6	26	42	51	46	57		TCRBV03-01,TCRBV03-02												CASSQGGRVINEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTATTTGTCCCCCTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	8.416469347218638E-5		49	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	18	0	26	38	-1	56	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTCAAGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSAVKGSSYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	5	2	0	5	2	26	34	44	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVKGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGAAAATGGCTACACCTTCGGTTCG	CSARRENGYTF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	3	6	0	2	26	-1	43	38	45		TCRBV20-01,TCRBV20-or09_02												CSARRENGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTCGGACAGGGGAGCCGATGGCTACACCTTCGGTTCG	CSARESDRGADGYTF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	2	6	3	5	26	40	52	43	57		TCRBV20-01,TCRBV20-or09_02												CSARESDRGADGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTTCTCGGGAACAATGAGCAGTTCTTCGGGCCA	CSASLLGNNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	3	5	6	0	26	37	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSASLLGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGGGACTTTACAATGAGCAGTTCTTCGGGCCA	CSASQGLYNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	4	3	1	26	37	46	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASQGLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGCGCAGCCTAACCCCCCCTACGAGCAGTACTTCGGGCCG	CSGAQPNPPYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	8	0	2	0	14	26	-1	37	33	51		TCRBV20-01,TCRBV20-or09_02												CSGAQPNPPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAGACAGGGGCCGGGGGGAAGCTTTCTTTGGACAA	CASRDRGRGEAFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	8	1	7	23	34	43	35	50	TCRBV06,TCRBV10													CASRDRGRGEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGTGCATCCTGAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATTAGCGGGGGGGACCCTAAGGAGACCCAGTACTTCGGGCCA	CSARDISGGDPKETQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	3	8	30	44	58	47	66		TCRBV20-01,TCRBV20-or09_02												CSARDISGGDPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTCTACATCTGCAGTGCTAGAGATCTAAGGAGCGGACAGGGGTTGGTCCTTGGTTACAATGAGCAGTTCTTCGGGCCA	CSARDLRSGQGLVLGYNEQFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	63	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	2	4	10	12	9	23	42	33	54		TCRBV20-01,TCRBV20-or09_02												CSARDLRSGQGLVLGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGGACTTGGAGGGAGAGGAGCCCTGAAGCTTTCTTTGGACAA	CASRTWRERSPEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	6	5	9	36	47	58	52	67	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASRTWRERSPEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGKGACTCKGCYSTSTATYTCTGTGCCAGCAGCCACCAGGGACTAGCGGGGGGAGATACGCAGTATTTTGGCCCA	CASSHQGLAGGDTQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	0	1	5	3	0	26	40	-1	43	58	TCRBV03,TCRBV05													CASSHQGLAGGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCTTAGGCCAGATCGAGCAGTACTTCGGGCCG	CASSLGQIEQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	36	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	5	4	5	6	6	2	26	38	47	44	49	TCRBV03,TCRBV12			TCRBD01,TCRBD02										CASSLGQIEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCATCGAGCGGGGGGACTTATCAATGAGCAGTTCTTCGGGCCA	CASSHRAGGLINEQFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	1	6	6	6	26	37	52	43	58		TCRBV03-01,TCRBV03-02												CASSHRAGGLINEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCGGGGTGAACACTGAAGCTTTCTTTGGACAA	CSARSGVNTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	0	2	0	26	38	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSARSGVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTCGACGGGGGGCCCCAGGTGAGAAGCAGTACTTCGGGCCG		Out	VDJ	1	16	8.97756730369988E-5		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	1	8	3	12	25	39	49	42	61	TCRBV26,TCRBV28													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGCTATGGGGGGGGGCCTCTACTTCGGGCCA	CTSSQAMGGGLYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	9	0	14	4	6	23	39	50	43	56	TCRBV01,TCRBV04													CTSSQAMGGGLYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGTGGCACGGGGGAATGAGCAGTTCTTCGGGCCA	CASSVARGNEQFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	2	7	6	0	22	34	-1	40	46	TCRBV09,TCRBV12													CASSVARGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGCAAGCGGGGCCACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLASGATSYNEQFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	3	0	3	4	23	38	48	41	52	TCRBV24,TCRBV27													CASSLASGATSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYGGCYRTGTATCTCTGTGCCAGCAGCTCCACCTTTGGGGACCCAACGGGGGGAGATATGCAGTATTTTGGCCCA	CASSSTFGDPTGGDMQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	1	11	18	6	19	32	57	50	63	TCRBV07,TCRBV11													CASSSTFGDPTGGDMQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGCCCCTGGTCGAGGGGGGGGGCGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAPGRGGGRTNEKLFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	60				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	9	0	1	10	4	19	36	53	46	57	TCRBV07,TCRBV11	TCRBV07-09,TCRBV11-01												CASSLAPGRGGGRTNEKLFF+X+TCRBJ01-04		TCRBD02-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCCACCCAGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSPPRPQETQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	4	1	5	2	19	31	40	36	42	TCRBV05,TCRBV11													CASSPPRPQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTGGGTCTACGGCCGCGGGACACTGAAGCTTTCTTTGGACAA	CASSLGLRPRDTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	4	3	10	0	19	35	-1	45	50	TCRBV05,TCRBV11					01,02								CASSLGLRPRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCRGGRGACWYRGCWSKGTATYTCTGTGCCAGAAGCTTGCCGAGCCCGGGACATTACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	8.97756730369988E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	6	3	16	5	24	31	53	47	58	TCRBV07,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTTGGCACTGAAGCTTTCTTTGGACAA	CASSLFGTEAFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	0	10	4	3	0	26	41	-1	44	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCGACCAACAGGTGCTACTAACTATGGCTACACCTTCGGTTCG	CASSRPTGATNYGYTF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	4	0	6	5	24	36	47	42	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSRPTGATNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATCGCCTCTCCTCTGGAAACACCATATATTTTGGAGAG	CASSQDNRLSSGNTIYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	51	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	10	0	0	5	5	26	43	50	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDNRLSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCAGGTGGGGTCCCGACCCAGGATATGGCTACACCTTCGGTTCG	CSATRWGPDPGYGYTF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	48	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	4	4	5	3	18	26	34	41	37	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATRWGPDPGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCGCGCCGGCAACCTATGGCTACACCTTCGGTTCG	CSARIAPATYGYTF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	2	9	0	4	8	3	26	38	49	46	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARIAPATYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCGGGGCCTACGAGCAGTACTTCGGGCCG	CSARGGAYEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	2	2	0	26	37	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGACAGGAATCAATCAGCCCCAGCATTTTGGTGAT	CSALTGINQPQHF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	3	2	3	26	35	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSALTGINQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGTTCCAGGGGGCGGCGAGCAGTACTTCGGGCCG	CASSVPGGGEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	0	6	5	2	24	35	48	40	50		TCRBV24-01,TCRBV24-or09_02												CASSVPGGGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGCGTTACGGTGGGGGCGGCTGAAGCTTTCTTTGGACAA	CASSLGVTVGAAEAFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	6	0	6	12	2	19	33	51	45	53	TCRBV05,TCRBV11													CASSLGVTVGAAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGACATTAGCGGGGGGGACCCTAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	9.538665260181123E-5		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	21	5	0	5	23	8	31	24	58	47	66		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAATAGGGCTAGCGGGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSE*G*RGATDTQYF	Stop	VDJ	1	17	9.538665260181123E-5		51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	9	3	23	34	52	43	55	TCRBV09,TCRBV21													CASSE*G*RGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCCTCGCCTCGTCCGGGAGAGGCGCTGAAGCTTTCTTTGGACAA	CASLASSGRGAEAFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	8	2	6	11	5	36	45	62	56	67	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASLASSGRGAEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGCGGCGTCCCGCAGCGGGGGCCCCCTGGGGGGGCAGTACTTCGGGCCG	CASSAASRSGGPLGGQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	2	9	11	12	24	37	56	48	68	TCRBV06,TCRBV10													CASSAASRSGGPLGGQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTATCGGCCATGTCGCAGTATTTTGGCCCA	CASSLSAMSQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	36	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	9	0	10	5	5	26	38	46	43	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSAMSQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCATCAGCAGGGGGGCCGGCCGGGGAGCTGTTTTTTGGAGAA	CSAPSAGGPAGELFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	6	8	5	26	34	49	42	54		TCRBV20-01,TCRBV20-or09_02												CSAPSAGGPAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTTTACTGAAGCTTTCTTTGGACAA	CSARRFTEAFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	4	5	0	3	26	-1	41	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTGGGCGGCGGAAGACACCGGGGAGCTGTTTTTTGGAGAA	CSARGWAAEDTGELFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	48	TCRBV20						TCRBJ02	TCRBJ02-02	01	1	8	0	3	3	8	26	39	46	42	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGWAAEDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGAGATAATTCACCCCTCCACTTTGGGAAC	CSARTGDNSPLHF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	4	5	0	2	26	-1	43	37	45		TCRBV20-01,TCRBV20-or09_02												CSARTGDNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCAGGAGGGGGACCGGGGAGTCACCCCTCCACTTTGGGAAC	CASSRRGTGESPLHF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	5	5	1	10	3	9	18	30	39	33	48	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRGTGESPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCGGGGACAGGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRGQGGSYEQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	0	2	1	18	30	43	32	44	TCRBV05,TCRBV11													CASSRGQGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAAGGCGGTCTAGCGTCTCATCAGTTCTTCGGGCCA	CASSQGGLASHQFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	6	13	5	6	26	42	53	47	59	TCRBV03,TCRBV12					01,02								CASSQGGLASHQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGCGTATATCCCATTTCTTTCTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	1.0660861173143608E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	6	5	1	19	26	38	42	39	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTGATTATTTTCGTGTTAGACGAGCAGTACTTCGGGCCG	CASSLIIFVLDEQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	16	0	26	38	-1	54	57		TCRBV03-01,TCRBV03-02				01,02								CASSLIIFVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAGGGGGCCGTCCGGGAGCAGTTCTTCGGGCCA	CASSQGAVREQFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	10	1	7	26	37	46	38	53		TCRBV03-01,TCRBV03-02												CASSQGAVREQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGTCGAGCGGGAAGTCATGAACACTGAAGCTTTCTTTGGACAA	CSVEREVMNTEAFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	9	6	3	0	5	5	26	31	43	36	48		TCRBV20-01,TCRBV20-or09_02												CSVEREVMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTCGGGAGGGCCTTAGCAATGAGCAGTTCTTCGGGCCA	CSARTREGLSNEQFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	0	6	3	6	26	38	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSARTREGLSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGACAGGGGGTATTCACCCCTCCACTTTGGGAAC	CSAREDRGYSPLHF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	1	8	1	1	26	40	50	41	51		TCRBV20-01,TCRBV20-or09_02												CSAREDRGYSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CACCWSCCARACAKCTKTGTACTTSTGTGCCAGCAGTGGACAGGGGTACGAGCAGTACTTCGGGCCG	CASSGQGYEQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	13	1	2	4	9	0	25	28	-1	37	46	TCRBV06,TCRBV22													CASSGQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCCCGGACCCCTAACAATGAGCAGTTCTTCGGGCCA	CASSEARTPNNEQFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	5	1	7	5	7	5	22	34	45	41	50	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEARTPNNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTGGAGCGGGAGAGGCACAGATACGCAGTATTTTGGCCCA	CASWSGRGTDTQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	6	2	1	5	2	24	31	44	36	46		TCRBV24-01,TCRBV24-or09_02												CASWSGRGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCCCGGATCCGGGACAGTCTATGGCTACACCTTCGGTTCG	CASSPGSGTVYGYTF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	4	10	1	23	34	51	44	52	TCRBV06,TCRBV10													CASSPGSGTVYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTACAGGCAAGAGACCCAGTACTTCGGGCCA	CASSQDYRQETQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	4	2	2	0	18	35	-1	37	42	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDYRQETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCTTGGGACTAGCGGGGGGGCAGGAGACCCAGTACTTCGGGCCA	CASSLGLAGGQETQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	0	5	0	3	18	-1	48	32	51	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CASSLGLAGGQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCTTGACAGGGGTGGGGAAAAACTGTTTTTTGGCAGT	CASSLDRGGEKLFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	8	3	4	26	38	49	41	53		TCRBV12-03,TCRBV12-04												CASSLDRGGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGACAAAGTTTGGAGGAGAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.122195912962485E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	1	4	10	6	26	38	53	48	59	TCRBV09,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAACTTCCGGGACAGGAGAAAAACTGTTTTTTGGCAGT	XASSQTSGTGEKLFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	4	8	6	1	23	38	52	44	53	TCRBV01,TCRBV04													XASSQTSGTGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTGCAGGACACCTACGAGCAGTACTTCGGGCCG	CASSLQDTYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	2	5	0	24	36	-1	41	46	TCRBV06,TCRBV10													CASSLQDTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCACTCTGGAAACACCATATATTTTGGAGAG	CASHSGNTIYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	6	0	0	0	26	-1	-1	35	37		TCRBV03-01,TCRBV03-02												CASHSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCGGCCSTGTATSTCTGTGCCAGCAGCCTTATCCCCAGCGGGGGGGTCATTTACGAGCAGTACTTCGGGCCG	CASSLIPSGGVIYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	0	4	9	5	20	32	51	41	56	TCRBV05,TCRBV11													CASSLIPSGGVIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
RGGGGACTYRGCYSTGTATCTCTGTGCCAGCAGCTTTCGAGGGAGTAGTTCCTACGAGCAGTACTTCGGGCCG	CASSFRGSSSYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	2	1	4	4	22	36	45	40	49	TCRBV05,TCRBV07													CASSFRGSSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGGGCCCATCCCCGAGAGATCCAGTACTTCGGGCCA	CSARAHPREIQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	10	0	16	26	-1	39	34	55		TCRBV20-01,TCRBV20-or09_02												CSARAHPREIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCGGGCGACCGGGACTCAGGGCAATCAGCCCCAGCATTTTGGTGAT	CSARVRATGTQGNQPQHF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	0	10	2	11	4	26	39	56	50	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVRATGTQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTAGCGGGAGGGCCCAAGAGACCCAGTACTTCGGGCCA	CSASPSGRAQETQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	0	1	2	1	26	37	51	39	52		TCRBV20-01,TCRBV20-or09_02												CSASPSGRAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGATCGGGACAGGGTTATCAGCCCCAGCATTTTGGTGAT	CSARGSGQGYQPQHF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	5	6	2	26	37	52	43	54		TCRBV20-01,TCRBV20-or09_02												CSARGSGQGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCAAGACAGGGAGAGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.122195912962485E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	1	5	4	24	36	48	41	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTAAGGGTGGGAACACTGAAGCTTTCTTTGGACAA	CAISKGGNTEAFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	5	5	3	1	1	3	23	35	40	36	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISKGGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCGATGAAATTTCGCTACACCTTCGGTTCG	CAISESMKFRYTF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	0	2	8	9	0	9	23	-1	42	40	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISESMKFRYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGCAGAACCTCCCGGAACACAGATACGCAGTATTTTGGCCCA	CASSRTSRNTDTQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	6	1	8	2	11	1	26	37	51	48	52	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTSRNTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGTATCCCCGAGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	1.122195912962485E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	11	1	3	9	0	18	32	-1	41	45	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGCTCACGGGACAGGGGCTACGAGCAGTACTTCGGGCCG	CASSSRDRGYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	3	3	0	19	32	-1	35	45	TCRBV05,TCRBV07													CASSSRDRGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCGGGAGCGGAGAGCGACGAGCAGTACTTCGGGCCG	CASSSGAESDEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	5	0	9	19	-1	38	32	47	TCRBV05,TCRBV11													CASSSGAESDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGTGCGGGGGGGCGAGATACGCAGTATTTTGGCCCA	CASSLGAGGRDTQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	5	4	2	19	33	46	37	48		TCRBV05-06,TCRBV05-07												CASSLGAGGRDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCATACCTAGCGACTTCTACGAGCAGTACTTCGGGCCG	CASIPSDFYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	6	3	3	4	23	33	42	36	46	TCRBV02,TCRBV12					01,02								CASIPSDFYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGCCCCCATACGAGCAGTACTTCGGGCCG	CASSQTGPPYEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	4	0	6	26	-1	47	41	53		TCRBV03-01,TCRBV03-02												CASSQTGPPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTTATCACTAGCGGTTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSLAVSTGELFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	5	4	6	4	26	37	51	43	55	TCRBV03,TCRBV12					01,02								CASSLSLAVSTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAAAGGGACGGCACCTATGGCTACACCTTCGGTTCG	CSAQRDGTYGYTF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	0	7	4	5	5	26	34	44	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQRDGTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCCCACTAGCGGGAGGGTAACAGATACGCAGTATTTTGGCCCA	CSARAPTSGRVTDTQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	3	0	3	5	2	26	39	57	44	59		TCRBV20-01,TCRBV20-or09_02												CSARAPTSGRVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTGCCGGGACAGGGGGATCAGCCCCAGCATTTTGGTGAT	CSASLPGQGDQPQHF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	1	5	6	0	26	37	-1	43	54		TCRBV20-01,TCRBV20-or09_02												CSASLPGQGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCACCCCAGGGGGACCCAGTACTTCGGGCCA	CASSSHPRGTQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	7	8	0	24	36	-1	44	50		TCRBV24-01,TCRBV24-or09_02												CASSSHPRGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAAGACAGGGGCCCTCTTACGAGCAGTACTTCGGGCCG	CASSLRQGPSYEQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	2	4	1	6	18	33	42	34	48	TCRBV05,TCRBV07													CASSLRQGPSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCCCGGGGACTAGCGAGACCCAGTACTTCGGGCCA	CASSPGTSETQYF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	7	5	3	0	18	30	-1	33	42	TCRBV05,TCRBV07					01,02								CASSPGTSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTTCTACATCTGCAGTGCTAGAGGCCTGGTGGGCAATGACCTGCCATCCGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	1.1783057086106093E-4		62	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	8	0	0	7	18	11	24	35	31	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGCCGGACAGGGGATCGGGGAGCTGTTTTTTGGAGAA	CASSAGQGIGELFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	7	3	2	19	31	43	34	45	TCRBV07,TCRBV11													CASSAGQGIGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGACCCTACCACCTACGAGCAGTACTTCGGGCCG	CASSVDPTTYEQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	6	2	7	2	4	7	26	37	44	41	51	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASSVDPTTYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCCGTTGTGGGCACTGAAGCTTTCTTTGGACAA	CASSSVVGTEAFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	0	9	4	9	0	26	37	-1	46	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSVVGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGGGTACAGGGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.2344155042587335E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	1	3	3	0	24	39	-1	42	50	TCRBV06,TCRBV10													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGCCGCCCCTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSAAPGTGELFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	10	4	8	0	24	37	-1	45	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAAPGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACTAGCGGGAGTGGGCGAGCAGTACTTCGGGCCG	CASSQELAGVGEQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	2	6	0	4	26	-1	54	43	58		TCRBV03-01,TCRBV03-02												CASSQELAGVGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCCGGGCTCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSASRALSNQPQHF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	8	0	0	5	3	26	34	43	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRALSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACAGGGAACGGCTACACCTTCGGTTCG	CSARDGTGNGYTF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	8	1	3	26	40	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSARDGTGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTAAGGGGACAGGGGACTCTACGAGCAGTACTTTGGGCCG	CASS*GDRGLYEQYF	Stop	VDJ	1	22	1.2344155042587335E-4		45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	19	0	19	23	-1	49	39	68	TCRBV01,TCRBV04													CASS*GDRGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCYGTGTATSTCTGTGCCAGAAGTTCGGACAGGGACACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.2344155042587335E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	3	3	2	18	29	40	32	42	TCRBV05,TCRBV07,TCRBV11,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGGGACAGGGTTTGGTCAGCCCCAGCATTTTGGTGAT	CASSLGTGFGQPQHF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	3	6	0	5	19	-1	43	35	48	TCRBV07,TCRBV11													CASSLGTGFGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCACCTTTGACAGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASTFDRGYNEQFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	2	3	1	0	19	33	-1	34	42	TCRBV05,TCRBV07													CASTFDRGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGCCGGACTAGCGGGAGGTGAGCAGTACTTCGGGCCG	CASSAGLAGGEQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	1	1	7	3	1	19	31	48	34	49		TCRBV05-06,TCRBV05-07												CASSAGLAGGEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGGAAGGGACTCAGCCCCTACGAGCAGTACTTCGGGCCG	CASRKGLSPYEQYF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	2	3	5	19	30	39	33	44	TCRBV05,TCRBV11					01,02								CASRKGLSPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGACTAGCGGGTCAGTTCACAGATACGCAGTATTTTGGCCCA	CASSRLAGQFTDTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	4	2	1	6	26	38	49	39	55		TCRBV12-03,TCRBV12-04				01,02								CASSRLAGQFTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTATTCTTCGGCCGGGACCGGGGAGCTGTTTTTTGGAGAA	CSAYSSAGTGELFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	4	5	12	0	26	34	-1	46	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYSSAGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CSARGTASSTDTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	0	1	5	26	37	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSARGTASSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTAGGGACAGTAGGTATGGCTACACCTTCGGTTCG	CASSPRDSRYGYTF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	5	4	4	24	36	47	40	51		TCRBV24-01,TCRBV24-or09_02												CASSPRDSRYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCATGGAAGGGCCGGCGCAGATACGCAGTATTTTGGCCCA	CASHGRAGADTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	8	5	3	4	6	6	23	32	42	38	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHGRAGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCCCCCGGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGTSGNTGELFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	5	1	6	0	30	42	-1	48	59	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSPPGTSGNTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCGGTCCGGGTCGTCGAGGCTACACCTTCGGTTCG	CASSSGPGRRGYTF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	8	6	7	19	32	42	38	49		TCRBV05-06,TCRBV05-07				01,02								CASSSGPGRRGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGRGGACTCRGCYSTGTATCTCTGTGCCAGCAGCTTAGCGGGTGCCGGGGAGCTGTTTTTTGGAGAA	CASSLAGAGELFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	0	0	9	6	0	2	22	-1	42	39	44	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLAGAGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTTGCCATGGAGCGAAAACCTAAATGAAAAACTGTTTTTTGGCAGT	CASLPWSENLNEKLFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	10	6	6	5	11	8	24	31	46	42	54	TCRBV06,TCRBV10					01,02								CASLPWSENLNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATTTGGGGTCGCTCAGACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	1.346635095554982E-4		52	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	6	2	3	4	11	26	43	51	47	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGACTAGGGGAGAATGAGCAGTTCTTCGGGCCA	CSAKGLGENEQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	8	7	3	5	26	34	45	37	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKGLGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTAAGTCCGACCCCAGCTCTGAAGCTTTCTTTGGACAA	CSAIKSDPSSEAFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	2	7	6	8	7	26	36	47	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIKSDPSSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCGGAACGGGGGGGCCTATTCAAGATACGCAGTATTTTGGCCCA	CSAAGTGGPIQDTQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	5	7	8	26	35	50	42	58		TCRBV20-01,TCRBV20-or09_02												CSAAGTGGPIQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCATGAACAGGGGGCCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSHEQGARSYEQYF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	0	5	3	22	34	48	39	51		TCRBV12-03,TCRBV12-04												CASSHEQGARSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTCAGGGACTAGCGGATAACTACAATGAGCAGTTCTTCGGGCCA	CATQGLADNYNEQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	0	5	3	3	4	24	32	46	35	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATQGLADNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGGGACTAGCGGGGGCCAACAGCAGTTCTTCGGGCCA	CASSFGTSGGQQQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	11	1	5	18	32	47	33	52	TCRBV07,TCRBV11													CASSFGTSGGQQQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAACCTCGGGGAACTAGCTAGCAATGAGCAGTTCTTCGGGCCA	CASNLGELASNEQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	3	7	6	10	3	20	30	46	40	49	TCRBV01,TCRBV23					01,02								CASNLGELASNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCCTTGGTCGTAGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	1.346635095554982E-4		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	5	8	6	9	0	20	31	-1	40	43	TCRBV07,TCRBV23					01,02								X+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCTCTGCGCGGGACGGTTTCCGGGGAGCTGTTTTTTGGAGAA	CASSPLRGTVSGELFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	7	3	6	7	6	19	31	44	38	50		TCRBV05-06,TCRBV05-07												CASSPLRGTVSGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTCGGGGGGGAGAGGCAGATACGCAGTATTTTGGCCCA	CSTRGGEADTQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	0	4	3	5	26	32	43	35	48		TCRBV20-01,TCRBV20-or09_02												CSTRGGEADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCCGACAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CSASPPTGANTEAFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	1	6	1	26	37	51	43	52		TCRBV20-01,TCRBV20-or09_02												CSASPPTGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGCTAGCGGACTCCTACGAGCAGTACTTCGGGCCG	CASSLLADSYEQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	5	0	0	1	19	-1	41	34	42		TCRBV05-06,TCRBV05-07				01,02								CASSLLADSYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTACCCTCGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSTLAPYNEQFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	6	3	7	2	1	8	24	35	38	36	46	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTLAPYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGCTGTGTATTTCTGTGCCAGCAGCCATAACCTAGCGAGTCCTATCAGGCCTGCGGGAACGTACGAGCAGTACTTCGGGCCG	CASSHNLASPIRPAGTYEQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	63	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	6	4	4	24	13	27	37	31	61		TCRBV03-01,TCRBV03-02				01,02								CASSHNLASPIRPAGTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGCCCCTCAGGGAGTAACGTACAATAAGCAGTTCTTCGGGCCA	CASSAPQGVTYNKQFF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	48	unresolved						TCRBJ02	TCRBJ02-01	01	6	4	3	11	7	14	26	37	49	44	63	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPQGVTYNKQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGAGGTCAGCCCGGCGAATTCACCCCTCCACTTTGGGAAC	CASSVEVSPANSPLHF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	48	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	6	11	1	7	4	11	26	37	45	41	56	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASSVEVSPANSPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTTGGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSQDLGGQPQHF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	9	1	6	3	0	23	40	-1	43	49	TCRBV01,TCRBV04													CASSQDLGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCGCGGGAGGGACCGGGGAGCTGTTTTTTGGAGAA	CSARDIAGGTGELFF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	0	5	4	0	26	40	-1	44	53		TCRBV20-01,TCRBV20-or09_02												CSARDIAGGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCGGACTAGCGGGAGGGCCTACGGCCACAGATACGCAGTATTTTGGCCCA	CSAAGLAGGPTATDTQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	0	2	3	8	26	35	53	38	61		TCRBV20-01,TCRBV20-or09_02												CSAAGLAGGPTATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCTTTAACAGGGCCTCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	1.4588546868512305E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	1	4	4	23	36	46	40	50	TCRBV04,TCRBV23													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCTCCCGCTCCCTGTTAGCCATGACAGATACGCAGTATTTTGGCCCA	CAISSRSLLAMTDTQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	7	3	14	4	23	34	52	48	56	TCRBV06,TCRBV10					01,02								CAISSRSLLAMTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCTTAAATGGGCGGACAGATACGCAGTATTTTGGCCCA	CASSLNGRTDTQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	42							TCRBJ02	TCRBJ02-03	01	2	8	0	3	3	2	18	33	40	36	42	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGRTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCCCGAGGCGGGGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSPRGGGLSYEQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	2	0	7	3	19	31	45	38	48	TCRBV05,TCRBV11													CASSPRGGGLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCATCTTGGGGTAGGCGCGCTACGAGCAGTACTTCGGGCCG	CASILG*ARYEQYF	Stop	VDJ	1	26	1.4588546868512305E-4		42	unresolved						TCRBJ02	TCRBJ02-07	01	0	5	4	3	3	4	19	35	41	38	45	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASILG*ARYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTCRGCYSTSTATCTCTGTGCCAGCAGCTTAGGAGTGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGVGSGNTIYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	1	0	9	0	4	0	22	38	-1	42	45	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLGVGSGNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCGGTCCGGGCCGTTGAACACTGAAGCTTTCTTTGGACAA	CASSFRSGPLNTEAFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	48	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	8	0	0	7	3	26	40	51	47	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRSGPLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCTAAAGTATTTGGCTACACCTTCGGTTCG	CASSQAKVFGYTF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	9	0	7	0	9	26	-1	43	40	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAKVFGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGACGACAGAAAACTGTTTTTTGGCAGT	CSAKDDRKLFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	10	5	0	26	36	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSAKDDRKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGCGGGAGGGTTTTCGGATACGCAGTATTTTGGCCCA	CSAKAGGFSDTQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	0	6	2	6	26	36	47	38	53		TCRBV20-01,TCRBV20-or09_02												CSAKAGGFSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATTAGCGGGGGGACCCTAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	1.5149644824993548E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	5	3	8	26	40	53	43	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGCGAAACCCACAGATACGCAGTATTTTGGCCCA	CSARDLAKPTDTQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	6	2	1	5	26	40	47	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLAKPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTACTAGTCTCCAATGAGCAGTTCTTCGGGCCA	CSASLLVSNEQFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	8	6	3	4	26	37	45	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLLVSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACTAGTAGGTACGAGCAGTACTTCGGGCCG	CASSLTSRYEQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	8	4	2	4	24	36	44	38	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLTSRYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGCAGGACAAGCCGCTACGAGCAGTACTTCGGGCCG	CASGRTSRYEQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	6	3	6	5	24	31	42	37	47		TCRBV24-01,TCRBV24-or09_02												CASGRTSRYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACAGGGGTGTAGGCACTGAAGCTTTCTTTGGACAA	CAISDRGVGTEAFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	4	0	6	23	-1	43	35	49	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDRGVGTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGTGACAGCGGGACCCGTTTTAGAGACCCAGTACTTCGGGCCA	CASSLVTAGPVLETQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	6	3	4	4	8	18	34	45	38	53	TCRBV05,TCRBV11													CASSLVTAGPVLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGGACAAATTTATTTGGACACTGAAGCTTTCTTTGGACAA	CASSPGQIYLDTEAFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	6	3	3	11	19	31	39	34	50	TCRBV05,TCRBV11													CASSPGQIYLDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGGGGTAGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSRGRANEKLFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	3	3	0	5	19	-1	36	31	41		TCRBV05-06,TCRBV05-07												CASSRGRANEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD02-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTTGGGGGATTGCTCTATGGCTACACCTTCGGTTCG	CASSVGGLLYGYTF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	4	6	1	4	2	6	24	37	44	39	50	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGLLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAAGTCGGCAGGGGAATCAGACGAGCAGTACTTCGGGCCG	CSAKSAGESDEQYF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	5	8	6	26	34	48	42	54		TCRBV20-01,TCRBV20-or09_02												CSAKSAGESDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTCCCGGGACACCGAACACTGAAGCTTTCTTTGGACAA	CSARPPGTPNTEAFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	1	6	2	26	38	50	44	52		TCRBV20-01,TCRBV20-or09_02												CSARPPGTPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCATGACTAGCGGGAGATAATAACATTCAGTACTTCGGCGCC	CSARA*LAGDNNIQYF	Stop	VDJ	1	28	1.571074278147479E-4		48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	2	2	7	3	5	26	39	54	42	59		TCRBV20-01,TCRBV20-or09_02												CSARA*LAGDNNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCAGTACAGGGGGCAGGCAGATACGCAGTATTTTGGCCCA	CASSQDQYRGQADTQYF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	0	4	5	3	23	40	54	45	57	TCRBV01,TCRBV04													CASSQDQYRGQADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTCTGGTTTCGGTCACCCCTCCACTTTGGGAAC	CASSFWFRSPLHF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	8	5	10	7	0	23	37	-1	44	47	TCRBV24,TCRBV27					01,02								CASSFWFRSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCTATCGACAGGTCGAGAAGGGGCTACACCTTCGGTTCG		Out	VDJ	1	28	1.571074278147479E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	2	4	8	7	9	24	31	44	38	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTCGTACAGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFVQGGANVLTF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	3	4	4	1	22	35	45	39	46	TCRBV07,TCRBV11													CASSFVQGGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCCCCCCGGGTTCGGGAGATGGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	1.571074278147479E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	7	11	5	24	36	53	47	58	TCRBV12,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGAGGGGGAAGGGTGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGEGWSGANVLTF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	5	1	1	2	8	26	37	45	39	53	TCRBV03,TCRBV12													CASSEGEGWSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTTGGGGAATATGAACACTGAAGCTTTCTTTGGACAA	CASSFLGNMNTEAFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	0	8	0	4	3	26	40	48	44	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLGNMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCTAGTGTCCAGTCGGGATAACCGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	1.6271840737956033E-4		64				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	3	0	16	9	17	29	50	45	59	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTACAGGGGGGGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	1.6271840737956033E-4		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	1	2	3	3	26	40	51	43	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGCCGGGACTAGCGGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CSARDLPGLAGGSTDTQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	1	0	6	1	24	38	59	44	60		TCRBV20-01,TCRBV20-or09_02												CSARDLPGLAGGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTACTCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLLGSTDTQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	0	2	0	18	33	-1	35	39	TCRBV07,TCRBV11					01,02								CASSLLGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCTTGACTAGCGGGGGAATTTATGCCGGGGAGCTGTTTTTTGGAGAA	CASSSLTSGGIYAGELFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	2	2	6	4	8	18	31	47	35	55	TCRBV07,TCRBV11													CASSSLTSGGIYAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACAGCCCGGCGGAACCTATGGCTACACCTTCGGTTCG	CASSPQPGGTYGYTF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	3	5	4	1	11	26	39	44	40	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQPGGTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGAATGGGAGGATCCAACGGGGAGCTGTTTTTTGGAGAA	CASSRMGGSNGELFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	1	7	6	6	26	37	49	43	55		TCRBV03-01,TCRBV03-02												CASSRMGGSNGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAGAGTTGGGGCTCTCCCTACGAGCAGTACTTCGGGCCG	CSAREESWGSPYEQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	2	8	4	26	40	53	48	57		TCRBV20-01,TCRBV20-or09_02												CSAREESWGSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCGTTCGCCACCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSASPFATANTGELFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	48	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	3	7	0	10	2	26	37	49	47	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPFATANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAAGACAGGTTGAAGCTTTCTTTGGACAA	CSAQRQVEAFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	7	4	1	26	35	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSAQRQVEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTTCCGACGGGGGCGGGACCTACGAGCAGTACTTCGGGCCG	CSASSDGGGTYEQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	6	0	2	9	4	26	35	50	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASSDGGGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGGCTCTCAGGGTCGTCTGAGCAGTACTTCGGGCCG	CASRLSGSSEQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	7	5	6	22	33	43	38	49	TCRBV09,TCRBV12													CASRLSGSSEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGAAGCGGGGCTTCTCAATCAGCCCCAGCATTTTGGTGAT	CASSEAGLLNQPQHF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	6	3	3	2	5	22	34	43	36	48	TCRBV12,TCRBV21													CASSEAGLLNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAGTACTAGGTTTTGATACGCAGTATTTTGGCCCA	CATRVLGFDTQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	3	8	6	3	5	24	35	43	38	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATRVLGFDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACTATTCAGCGGACCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	1.6832938694437275E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	6	5	2	9	3	24	31	45	40	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGCAGAGAGATACGCAGTATTTTGGCCCA	CASSLSQRDTQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	6	4	5	5	6	2	24	36	45	42	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSQRDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGAAAGGGCAGGGGGCATCTACGAGCAGTACTTCGGGCCG	CASSERAGGIYEQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	3	8	2	24	35	51	43	53	TCRBV12,TCRBV21													CASSERAGGIYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCAGACAGTCGGGATGAAAAACTGTTTTTTGGCAGT	CASSADSRDEKLFF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	5	6	4	5	26	37	46	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSADSRDEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCCGAAAAGCGGGGGGGGCCGTTAATGAGCAGTTCTTCGGGCCA	CASRKAGGAVNEQFF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	6	0	7	5	6	36	45	60	50	66	TCRBV24,TCRBV25,TCRBV27,TCRBV28													CASRKAGGAVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTCATCCCCTTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	31	1.7394036650918518E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	12	5	26	38	53	50	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGCCGGGCGGGTGCCCCACACCTACGAGCAGTACTTCGGGCCG	CSAAGRVPHTYEQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	2	6	9	26	34	45	40	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSAAGRVPHTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAACTCTACAATGAGTAGTTCTTCGGGCCA	CSARDELYNE*FF	Stop	VDJ	1	31	1.7394036650918518E-4		39	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	3	6	14	8	6	26	40	51	48	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDELYNE*FF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAGACTAACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRLTSYNEQFF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	9	0	1	2	23	38	44	39	46	TCRBV24,TCRBV27					01,02								CASSLRLTSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTAGAGCGGATAATAATTCACCCCTCCACTTTGGGAAC	CATRADNNSPLHF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	10	6	5	5	3	3	24	32	40	35	43		TCRBV24-01,TCRBV24-or09_02				01,02								CATRADNNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTCGACAGGCCGGGAGATATTCACCCCTCCACTTTGGGAAC	CASSPRQAGRYSPLHF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	48	TCRBV24						TCRBJ01	TCRBJ01-06	01	6	2	4	8	4	9	24	36	46	40	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRQAGRYSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCAAGTCGCCCGGACCAAATAGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	1.7394036650918518E-4		43	unresolved						TCRBJ02	TCRBJ02-03	01	5	1	7	4	2	8	18	30	36	32	44	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTGGCTCCCGGGTAGGCATTCAGTACTTCGGCGCC	CASSFGSRVGIQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	8	4	9	7	4	18	32	43	39	47	TCRBV07,TCRBV11					01,02								CASSFGSRVGIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTCGACGTTTTTGGAAATTGGGAAAAACTGTTTTTTGGCAGT	CASSFDVFGNWEKLFF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	48	unresolved						TCRBJ01	TCRBJ01-04	01	3	1	8	8	10	6	19	33	46	43	52	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDVFGNWEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCTGATGAGAGGGGCCGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	1.7394036650918518E-4		41	unresolved						TCRBJ02	TCRBJ02-05	01	7	5	2	5	7	5	23	32	44	39	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATAGGCTAGCGGGCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	1.795513460739976E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	4	2	4	1	26	41	53	45	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGGTGACAATGAGCAGTTCTTCGGGCCA	CSARRGDNEQFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	5	0	2	26	-1	43	38	45		TCRBV20-01,TCRBV20-or09_02												CSARRGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCGCGGGACAGGTCGACCGGGGAGCTGTTTTTTGGAGAA	CASSPRDRSTGELFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	5	5	3	22	33	46	38	49		TCRBV12-03,TCRBV12-04												CASSPRDRSTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSLSRAYNEQFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	4	5	2	24	36	46	41	48	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRAYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGGGGACAGGGAAGCCCTATGGCTACACCTTCGGTTCG	CASSLGTGKPYGYTF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	4	2	5	22	35	46	37	51	TCRBV07,TCRBV11													CASSLGTGKPYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAGGGGAGGGACAGGGGGCAGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	32	1.795513460739976E-4		55	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	0	9	3	24	35	56	44	59	TCRBV02,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCAGCAGTTTGGGACAGCGTAACTCACCCCTCCACTTTGGGAAC	CASSSSLGQRNSPLHF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	10	9	6	26	37	53	46	59	TCRBV12,TCRBV21													CASSSSLGQRNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGCCAGGGGGGAGCAGTTCTTCGGGCCA	CASSPARGEQFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	10	5	0	26	38	-1	43	50		TCRBV12-03,TCRBV12-04												CASSPARGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTTTTTCATCCGGGGAGCTGTTTTTTGGAGAA	CASSFSSGELFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	6	6	2	1	26	40	44	42	45	TCRBV09,TCRBV12													CASSFSSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTACTCGAACAGGGCTACCTACGAGCAGTACTTCGGGCCG	CASSYSNRATYEQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	3	2	2	3	24	41	49	43	52		TCRBV06-05,TCRBV06-06												CASSYSNRATYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGAGGGGTCGAAGCTTTCTTTGGACAA	CSARRGVEAFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	2	8	2	2	26	38	45	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGVEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTCAGATTCGAGACAGATACGCAGTATTTTGGCCCA	CSARGLRFETDTQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	10	3	0	10	26	-1	43	39	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLRFETDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGCTCGTCGCTTCGGGCGGAAACACCATATATTTTGGAGAG	CASSQELVASGGNTIYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	51	unresolved						TCRBJ01	TCRBJ01-03	01	0	8	0	4	12	0	23	40	-1	52	56	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQELVASGGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACTTATGGGGGCAGGGGAGAGACCCAGTACTTCGGGCCA	CASTYGGRGETQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	2	4	10	0	22	32	-1	42	48	TCRBV02,TCRBV12													CASTYGGRGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCGGAGAGAGGGACTAGCGGCCACCGGGGAGCTGTTTTTTGGAGAA	CATSRREGLAATGELFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	0	5	4	9	1	24	35	55	44	56		TCRBV24-01,TCRBV24-or09_02				01,02								CATSRREGLAATGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAATGGAGTAACACCGGGGAGCTGTTTTTTGGAGAA	CATSEWSNTGELFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	2	2	2	1	24	38	44	40	45		TCRBV24-01,TCRBV24-or09_02												CATSEWSNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACAAAATCCCGCCGGTCCAAATTCACCCCTCCACTTTGGGAAC	CASRQNPAGPNSPLHF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	48	unresolved						TCRBJ01	TCRBJ01-06	01	6	3	6	7	0	16	23	-1	37	34	53	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRQNPAGPNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACTGAGACAGGGAATGGACGGCTACACCTTCGGTTCG	CASSLLRQGMDGYTF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	8	4	7	18	33	44	37	51	TCRBV07,TCRBV11													CASSLLRQGMDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCAAATCAAGGACCCCTCCACTTTGGGAAC	CASSPNQGPLHF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	36	unresolved						TCRBJ01	TCRBJ01-06	01	4	5	4	12	8	0	23	35	-1	43	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNQGPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGAAGGGGCTTCGAAGGCTTTCTTTGGACAA	CASSLEGASKAFF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	11	1	8	26	42	48	43	56		TCRBV12-03,TCRBV12-04												CASSLEGASKAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCCTACTAGTTTTTCGGCAGATACGCAGTATTTTGGCCCA	CASSPTSFSADTQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	8	4	3	8	36	48	56	51	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSPTSFSADTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAAACAGGGTACGACGAGCAGTACTTCGGGCCG	CASSQTGYDEQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	5	0	4	26	-1	47	41	51	TCRBV03,TCRBV12													CASSQTGYDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCCAGGGAACACTGAAGCTTTCTTTGGACAA	CSAIPGNTEAFF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	1	3	0	26	36	-1	39	43		TCRBV20-01,TCRBV20-or09_02												CSAIPGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGACTCCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGDSRSYNEQFF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	0	1	4	26	35	42	36	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGDSRSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGACAGGATCACTCCAGATACGCAGTATTTTGGCCCA	CATSDRDRITPDTQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	4	4	2	7	24	38	48	40	55		TCRBV24-01,TCRBV24-or09_02												CATSDRDRITPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCACCAGTGATTTACTAGCGGGAGGGCCCTATGAGCAGTTCTTCGGGCCA	CVTSDLLAGGPYEQFF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	0	8	0	4	24	-1	54	41	58		TCRBV24-01,TCRBV24-or09_02												CVTSDLLAGGPYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTAATAGCGGGAGAAGGGACCCAGTACTTCGGGCCA	CASSLIAGEGTQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	5	2	7	2	4	19	33	44	35	48	TCRBV05,TCRBV11													CASSLIAGEGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGAGACCGACAGGGAGATGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CSAERPTGRWTSGYEQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	5	3	19	0	26	35	-1	54	64		TCRBV20-01,TCRBV20-or09_02				01,02								CSAERPTGRWTSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGCGGGAAAAGAGACCCAGTACTTCGGGCCA	CSAGLAGKETQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	3	3	0	1	26	-1	47	35	48		TCRBV20-01,TCRBV20-or09_02												CSAGLAGKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAAGGAAACCATCGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASKETIGTNEKLFF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	45	TCRBV12						TCRBJ01	TCRBJ01-04	01	7	1	8	1	1	9	22	32	36	33	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKETIGTNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCCGTTGGGGGCAGGCGGGCTACGAGCAGTACTTCGGGCCG	CASSRWGQAGYEQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	6	0	3	4	7	18	30	40	34	47	TCRBV03,TCRBV11													CASSRWGQAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCATCATGGGGCTTAGGACGTGGGAGCAGTACTTCGGGCCG	CAIMGLRTWEQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	7	0	7	4	11	23	30	39	34	50	TCRBV02,TCRBV09													CAIMGLRTWEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCAAGCTTCGTGGGAGAGACCCAGTACTTCGGGCCA	CSATPSFVGETQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	0	9	4	13	0	26	36	-1	49	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPSFVGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTTCCCGGGACAGCCTACGAGCAGTACTTCGGGCCG	CSARLPGTAYEQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	2	6	0	26	38	-1	44	51		TCRBV20-01,TCRBV20-or09_02												CSARLPGTAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCTCCTACGAGCAGTACTTCGGGCCG		Out	VJ	1	36	2.019952643332473E-4		35	TCRBV24						TCRBJ02	TCRBJ02-07	01	4	0	0	0	0	2	24	-1	38	-1	40		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCACGGACTCAGACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSHGLRPSTDTQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	10	0	4	7	24	35	44	39	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSHGLRPSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGATTGGGGGCTCCGAGCAGTACTTCGGGCCG	CASSPIGGSEQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	6	0	6	7	2	24	35	48	42	50		TCRBV24-01,TCRBV24-or09_02												CASSPIGGSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCCCCGGACTCCTCTCGAGGAGCAGTTCTTCGGGCCA	CASSPRTPLEEQFF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	10	4	9	18	30	39	34	48	TCRBV05,TCRBV07					01,02								CASSPRTPLEEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGATAGCGGGAGCTTCACAGATACGCAGTATTTTGGCCCA	CASSLDSGSFTDTQYF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	48	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	5	2	2	1	3	19	35	45	36	48		TCRBV05-06,TCRBV05-07												CASSLDSGSFTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTGGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLLGGNTEAFF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	1	2	2	1	26	41	49	43	50		TCRBV12-03,TCRBV12-04												CASSLLGGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCTCAGTCAGGAATCAGCCCCAGCATTTTGGTGAT	CASSSSVRNQPQHF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	4	8	0	26	38	-1	46	50		TCRBV03-01,TCRBV03-02												CASSSSVRNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTTTCCGGGACGCAGTTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	37	2.0760624389805973E-4		53	TCRBV03						TCRBJ02	TCRBJ02-02	01	3	0	7	2	7	6	26	40	52	47	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCCCGGGACACTCTCCTACGAGCAGTACTTCGGGCCG	CASSPPGTLSYEQYF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	0	5	2	26	39	50	44	52		TCRBV03-01,TCRBV03-02												CASSPPGTLSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGGCACAACTATGGCTACACCTTCGGTTCG	CSARTGHNYGYTF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	2	0	3	26	-1	44	37	47		TCRBV20-01,TCRBV20-or09_02												CSARTGHNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGGAAGGTCCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSEQGRSLNQPQHF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	3	0	9	23	-1	43	38	52		TCRBV06-01,TCRBV06-08												CASSEQGRSLNQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAATCCGATATGAGGGACATTCAGTACTTCGGCGCC	CASSESDMRDIQYF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	11	0	8	11	0	24	36	-1	47	52	TCRBV09,TCRBV21													CASSESDMRDIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCGAGCCCGCCCACCCGGGCGGACCAAGAGACCCAGTACTTCGGGCCA	CSASPPTRADQETQYF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	48	TCRBV20						TCRBJ02	TCRBJ02-05	01	9	8	0	0	17	2	26	31	52	48	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPPTRADQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAAGACAAAGCTCCTACGAGCAGTACTTCGGGCCG	CSAPRQSSYEQYF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	0	5	3	26	34	43	39	46		TCRBV20-01,TCRBV20-or09_02												CSAPRQSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTTACAGGACAGGGCCCGTTTCTGGAAACACCATATATTTTGGAGAG	CSARSYRTGPVSGNTIYF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	3	1	7	6	26	38	53	45	59		TCRBV20-01,TCRBV20-or09_02												CSARSYRTGPVSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCTAACAGGGACCAGCGAGCAGTACTTCGGGCCG	XASSLTGTSEQYF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	4	3	3	6	2	5	23	36	44	38	49	TCRBV04,TCRBV07			TCRBD01,TCRBD02										XASSLTGTSEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACAGACATTCTGGGACACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	2.1321722346287215E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	6	2	10	0	24	38	-1	48	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGGCACGGGTGGCCACACTGAAGCTTTCTTTGGACAA	CASSGTGGHTEAFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	3	3	5	23	36	43	39	48	TCRBV09,TCRBV12					01,02								CASSGTGGHTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGGGGCGCCTAGGAGGCCACAATGAGCAGTTCTTCGGGCCA	CASSSGRLGGHNEQFF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	48	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	7	0	5	2	12	24	36	43	38	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRLGGHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGACAGGGAGGCGAAGACCCAGTACTTCGGGCCA	CASSLDREAKTQYF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	1	3	3	6	0	6	19	-1	41	35	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLDREAKTQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGACTAGCGGGAGGGGGCGGCATTCAGTACTTCGGCGCC	CASSPGLAGGGGIQYF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	0	0	9	1	5	26	39	56	40	61		TCRBV03-01,TCRBV03-02												CASSPGLAGGGGIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCGGGACTAGAAGGGCAGACCCAGTACTTCGGGCCA	CSATPGLEGQTQYF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	8	6	4	6	26	36	48	40	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSATPGLEGQTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGGTTGGAGGGATGGAGTTTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	40	2.24439182592497E-4		52	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	5	1	5	0	17	26	-1	46	40	63		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGTGGGGTGGAAATTCAGTACTTCGGCGCC	CSARGVEIQYF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	33	TCRBV20						TCRBJ02	TCRBJ02-04	01	6	6	2	10	4	5	26	34	42	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGVEIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTATGGAGGGGGACCACCTACGAGCAGTACTTCGGGCCG	CSARVWRGTTYEQYF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	5	1	2	5	4	26	39	50	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVWRGTTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGTTCGGCGGCAGGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	2.3005016215730943E-4		58	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	0	15	3	23	35	56	50	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGTCCACAGGGTCTCTGTATCAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	41	2.3005016215730943E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	3	3	8	4	11	24	31	41	35	52	TCRBV12,TCRBV21													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTTAGGCTCTGGAAACACCATATATTTTGGAGAG	CATSLGSGNTIYF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	39	TCRBV24						TCRBJ01	TCRBJ01-03	01	6	5	4	0	2	0	24	36	-1	38	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSLGSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCGGGACAGGGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTGGNTGELFF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	1	2	3	1	26	38	52	41	53		TCRBV12-03,TCRBV12-04												CASSLGTGGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGACAGGTCCCAACAACGCCCCAGCATTTTGGTGAT	CASSQGQVPTTPQHF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	9	0	10	26	-1	48	40	58		TCRBV03-01,TCRBV03-02												CASSQGQVPTTPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCTGGGACAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLGQGGTEAFF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	4	2	1	24	36	49	38	50	TCRBV24,TCRBV27													CASSLGQGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGAGGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEGTSYNEQFF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	5	0	7	0	3	0	24	36	-1	39	44	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGTSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATATGGGGCAGGGCAAATGAAAAACTGTTTTTTGGCAGT	CASSQIWGRANEKLFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	5	8	2	26	41	54	49	56		TCRBV03-01,TCRBV03-02												CASSQIWGRANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGGGGGGACTCACCGGGGAGCTGTTTTTTGGAGAA	CASSQDPGGLTGELFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	1	4	2	3	26	43	52	45	55		TCRBV03-01,TCRBV03-02												CASSQDPGGLTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACTAGCGGGGGGGCAGTATACAATGAGCAGTTCTTCGGGCCA	CASSRTSGGAVYNEQFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	0	4	0	5	26	-1	54	39	59		TCRBV03-01,TCRBV03-02												CASSRTSGGAVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATCGGGCGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSASGVNTGELFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	6	8	0	1	3	2	26	34	41	37	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGVNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGACGGACAAAGAGACCCAGTACTTCGGGCCA	CSARTDKETQYF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	6	3	6	0	26	34	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSARTDKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGTTCTGAGGGGGGAAAAACTGTTTTTTGGCAGT	CASSLVLRGEKLFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	5	1	8	7	0	19	33	-1	40	46	TCRBV05,TCRBV07													CASSLVLRGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTTCTGGCGGCGGATGAAGCTTTCTTTGGACAA	CASSLVLAADEAFF	In	VDJ	1	44	2.468831008517467E-4	3.021666723895203E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	7	5	7	7	4	19	33	44	40	48		TCRBV05-06,TCRBV05-07				01,02								CASSLVLAADEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCCCCAGGATCCGATACGCAGTATTTTGGCCCA	CASSAPGSDTQYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	6	5	4	26	37	46	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSAPGSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLQGNTEAFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	0	0	20	-1	-1	34	40	TCRBV05,TCRBV07													CASSLQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAAGGGGAGGGTTGAACACTGAAGCTTTCTTTGGACAA	CSAGRGGLNTEAFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	0	5	1	26	35	47	40	48		TCRBV20-01,TCRBV20-or09_02												CSAGRGGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCTTCTCTCCCGGGACAGGGGTCCCCTACGAGCAGTACTTCGGGCCG	CASSQGFSPGTGVPYEQYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	2	11	3	23	39	60	50	63	TCRBV01,TCRBV04													CASSQGFSPGTGVPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCGCGACTAGCGGGAGGGCCCGTACGCAGTATTTTGGCCCA	CASTATSGRARTQYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	0	8	4	4	23	33	51	37	55	TCRBV02,TCRBV09													CASTATSGRARTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTAGTCCCCGCGGAAACAATGAGCAGTTCTTTGGGCCA	CSAASPRGNNEQFF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02			5	4	8	22	1	28	26	35	40	36	68		TCRBV20-01,TCRBV20-or09_02				01,02		TCRBJ02-01,TCRBJ02-05						CSAASPRGNNEQFF+TCRBV20-X+TCRBJ02-X	TCRBV20	TCRBD02-01	TCRBJ02	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCGTAGCGTCTAGCACAGATACGCAGTATTTTGGCCCA	CSAVVASSTDTQYF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	6	0	4	3	26	35	44	39	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAVVASSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGATTGAACTACGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASRIELRSYNSPLHF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	3	9	0	6	2	24	35	45	41	47		TCRBV24-01,TCRBV24-or09_02				01,02								CASRIELRSYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGGGAAGGGCTTTAGAGACCCAGTACTTCGGGCCA	CASSGGRALETQYF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	6	1	4	0	9	24	-1	41	36	50	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGRALETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGCTGTGTATTTCTGTGCCAGCAGCCATAACTTAGTGAGTCCTATCAGGCCTGCGGGAACGTACGAGCAGTACTTCGGGCCG	CASSHNLVSPIRPAGTYEQYF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	63	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	3	4	25	3	13	27	58	52	61		TCRBV03-01,TCRBV03-02												CASSHNLVSPIRPAGTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACCCCTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVPLSYNEQFF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	9	1	5	0	26	42	-1	47	50		TCRBV03-01,TCRBV03-02				01,02								CASSQVPLSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGTCTAATCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	2.63716039546184E-4		49	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	0	9	5	0	20	26	-1	41	38	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTCGGACTAGCGGGGGAAGAGACCCAGTACTTCGGGCCA	CATSVGLAGEETQYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	3	2	0	24	37	-1	39	52		TCRBV24-01,TCRBV24-or09_02												CATSVGLAGEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTAGAGGGGGAGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	2.63716039546184E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	0	3	3	2	19	35	45	38	47	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCACCGAGCCCTACTCTGGAAACACCATATATTTTGGAGAG	CASSPTEPYSGNTIYF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	4	9	0	11	0	26	38	-1	49	52		TCRBV12-03,TCRBV12-04				01,02								CASSPTEPYSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTCTTTACTTCTGTGCCACCATCCCTTGGGGTATCGGACAGAACAGCGGGTTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	48	2.693270191109964E-4		62	TCRBV24						TCRBJ02	TCRBJ02-01	01	8	1	5	2	14	12	13	23	43	37	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACATCGGCAGGGGCCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	2.693270191109964E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	2	8	3	26	39	53	47	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGCGGGGGGCCGAGAGATACGCAGTATTTTGGCCCA	CSARRGGPRDTQYF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	1	5	2	5	26	37	47	39	52		TCRBV20-01,TCRBV20-or09_02												CSARRGGPRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGAGAGGGACGAGGGGGCTAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	48	2.693270191109964E-4		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	1	8	2	26	40	55	48	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGAGACAGCACCAGAGCAGTTCTTCGGGCCA	CASSLSETAPEQFF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	5	10	8	5	24	36	49	44	54	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSETAPEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTGTGTATTTCTGTGCCAGCAGCGTCCCAGCGGGACAGGGGTAAGGGGCTACCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	48	2.693270191109964E-4		62	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	2	8	13	11	23	41	31	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGGACCGGACAGGGCTTGAAAAACTGTTTTTTGGCAGT	CASRDRTGLEKLFF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	3	7	5	2	24	35	48	40	50	TCRBV02,TCRBV21													CASRDRTGLEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFINTGELFF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	9	2	0	2	26	-1	42	40	44		TCRBV12-03,TCRBV12-04				01,02								CASSFINTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTGCGCGGGACTCCTGGAAACACCATATATTTTGGAGAG	CASSLRGTPGNTIYF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	0	10	2	6	1	26	38	50	44	51		TCRBV03-01,TCRBV03-02				01,02								CASSLRGTPGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGTATCCACTAGGTCGTACTTCGGGCCG	CASRVSTRSYF	In	VDJ	1	50	2.8054897824062125E-4	3.433712186244549E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	8	12	7	3	26	37	49	44	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRVSTRSYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAATGAGACAGGGTCCCGGGGAGCTGTTTTTTGGAGAA	CSARDQMRQGPGELFF	In	VDJ	1	50	2.8054897824062125E-4	3.433712186244549E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	3	6	8	2	26	40	55	48	57		TCRBV20-01,TCRBV20-or09_02												CSARDQMRQGPGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCTCGTCGGGGGGGGAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	YASSLVGGGENTGELFF	In	VDJ	1	50	2.8054897824062125E-4	3.433712186244549E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	0	1	5	4	22	34	47	39	51	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSLVGGGENTGELFF+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCTTCGACAGGGGGCATTCAGCCCCAGCATTTTGGTGAT	CASSPSTGGIQPQHF	In	VDJ	1	50	2.8054897824062125E-4	3.433712186244549E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	0	6	5	2	23	35	50	40	52	TCRBV09,TCRBV21													CASSPSTGGIQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGAGCGGGAGCAAAGTACGAGCAGTACTTCGGGCCG	CASSQRAGAKYEQYF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	2	4	2	5	26	41	51	43	56		TCRBV03-01,TCRBV03-02												CASSQRAGAKYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGATGGGCAGTACTCCTACGAGCAGTACTTCGGGCCG	CSARGDGQYSYEQYF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	0	8	0	0	9	26	-1	43	39	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGDGQYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCCGCTTCAAAAGGTGTCGGAAGAGACCCAGTACTTCGGGCCA	CSARSPLQKVSEETQYF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	51	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	5	4	3	13	6	26	38	54	51	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSPLQKVSEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCTTTGGGTACCAAACCGGCAACCTTCGGTTCG	CATSLGTKPATF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	9	0	9	14	5	13	24	33	41	38	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSLGTKPATF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCCCCCCCGGGACAGTCCTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	52	2.917709373702461E-4		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	0	9	5	26	34	50	43	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTCCCGCGGGACACACGAACACTGAAGCTTTCTTTGGACAA	CSARTPAGHTNTEAFF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	0	6	1	8	3	26	38	52	46	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTPAGHTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAAGTCCTCACCCCTCCACTTTGGGAAC	CSARDKSSPLHF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	36	TCRBV20						TCRBJ01	TCRBJ01-06	01	0	4	6	10	0	5	26	-1	42	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDKSSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGATCCCAGGGCCAGGAACCGGGGAGCTGTTTTTTGGAGAA	CSAWIPGPGTGELFF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	5	7	6	26	35	47	42	53		TCRBV20-01,TCRBV20-or09_02												CSAWIPGPGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGGGGGACTAGCGGGGTTAAGCTCCTACGAGCAGTACTTCGGGCCG	CGGLAGLSSYEQYF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	0	3	0	2	5	26	29	44	31	49		TCRBV20-01,TCRBV20-or09_02												CGGLAGLSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTACAGGGCAGAGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	2.917709373702461E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	4	1	6	18	32	39	33	45	TCRBV05,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGACCCTATTACTAGCGACCAGGGAATACAATGAGCAGTTCTTCGGGCCA	CSAATLLLATREYNEQFF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	6	4	11	9	26	35	53	46	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSAATLLLATREYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAAAGGGACTAGCGGGAGGAAAGGGTGAGACCCAGTACTTCGGGCCA	CASSLKGLAGGKGETQYF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	0	1	5	3	7	19	33	51	36	58	TCRBV05,TCRBV07													CASSLKGLAGGKGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGGCACACAGATACGCAGTATTTTGGCCCA	CSASGGHTDTQYF	In	VDJ	2	54	3.0299289649987095E-4	3.7084091611441127E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	1	2	0	2	26	-1	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSASGGHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAGGCGCAGTCACTGAAGCTTTCTTTGGACAA	CASSLSGAVTEAFF	In	VDJ	2	54	3.0299289649987095E-4	3.7084091611441127E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	4	4	4	6	24	36	44	40	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGAVTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAGGAACAGACCAAGAGACCCAGTACTTCGGGCCA	CSALGTDQETQYF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	6	3	5	0	7	0	26	34	-1	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALGTDQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAATTAGGCTAGCGGGGGCTATTAAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	55	3.086038760646834E-4		58	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	3	9	8	23	37	56	46	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGACGTCGTCGACGCGACCCAGTACTTCGGGCCA	CASSLDVVDATQYF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	0	2	7	7	7	2	18	35	45	42	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDVVDATQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCAGTGATCCCCCCAGGAGGGGCGATGAGCAGTTCTTCGGGCCA	CATSDPPRRGDEQFF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	8	7	3	36	51	64	58	67		TCRBV24-01,TCRBV24-or09_02												CATSDPPRRGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGTATTTGCGGCAGATACGCAGTATTTTGGCCCA	CSARRVFAADTQYF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	5	3	4	0	9	26	-1	42	38	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRVFAADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSASLAGGTDTQYF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	1	3	0	26	35	-1	38	48		TCRBV20-01,TCRBV20-or09_02												CSASLAGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTGATGGTACTGAACCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	56	3.142148556294958E-4		50	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	23	35	-1	54	57	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAGCGGTAGGATACGGGAATTCACCCCTCCACTTTGGGAAC	CASSLAVGYGNSPLHF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	8	4	7	10	0	19	35	-1	45	49	TCRBV05,TCRBV07					01,02								CASSLAVGYGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCGGGGACAGGGGGCTCAGCCCCAGCATTTTGGTGAT	YASSRGQGAQPQHF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	0	6	2	0	22	34	-1	36	48	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSRGQGAQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGACCCACAGGGGAGGGTTGGAACACTGAAGCTTTCTTTGGACAA	CASSRPTGEGWNTEAFF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	51	unresolved						TCRBJ01	TCRBJ01-01	01	4	3	2	1	5	7	23	36	48	41	55	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPTGEGWNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTCGGGACAGGGTTCTACGAGCAGTACTTCGGGCCG	CSARLGTGFYEQYF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	3	3	2	26	38	50	41	52		TCRBV20-01,TCRBV20-or09_02												CSARLGTGFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCCGCAGGGCTCAATGAGCAGTTCTTCGGGCCA	CSAPPAGLNEQFF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	6	7	2	26	35	47	42	49		TCRBV20-01,TCRBV20-or09_02												CSAPPAGLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGGACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASGTGGSGNTIYF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	0	1	0	0	0	23	-1	-1	32	43	TCRBV06,TCRBV10													CASGTGGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCTATCCGGGACAACTGGCTACACCTTCGGTTCG	CASSLSGTTGYTF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	6	7	1	2	23	40	47	41	49	TCRBV24,TCRBV27													CASSLSGTTGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCAACGGGGCTCTTAGGGACCCAGTACTTCGGGCCA	CASSSTGLLGTQYF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	4	7	0	7	4	7	18	31	40	35	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGLLGTQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGATAGCACAGATACGCAGTATTTTGGCCCA	CSAPDSTDTQYF	In	VDJ	2	59	3.310477943239331E-4	4.0517803797685676E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	2	8	0	4	1	26	34	40	38	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSFSGSSYNEQFF	In	VDJ	2	60	3.366587738887455E-4	4.1204546234934586E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	2	0	2	0	26	32	-1	34	43		TCRBV20-01,TCRBV20-or09_02												CSFSGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGAGGGGATGGGGCACTGAAGCTTTCTTTGGACAA	CSVRGWGTEAFF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	7	5	2	4	2	6	26	33	40	35	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVRGWGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCTTCAGGGGGACAGGGGATTCTGGGGAGCTGTTTTTTGGAGAA	XASSFRGTGDSGELFF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	2	8	4	5	22	36	50	40	55	TCRBV04,TCRBV07													XASSFRGTGDSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCACTCAGGCCGACAGCTACGAGCAGTACTTCGGGCCG	CASTQADSYEQYF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	5	3	11	0	24	31	-1	42	47	TCRBV12,TCRBV21													CASTQADSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGCAGGCGAATGAAAAACTGTTTTTTGGCAGT	CASSQRQANEKLFF	In	VDJ	2	62	3.4788073301837035E-4	4.257803110943241E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	5	3	2	26	41	48	44	50		TCRBV03-01,TCRBV03-02												CASSQRQANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGGGACAAGAGACCCAGTACTTCGGGCCA	CSASSGQETQYF	In	VDJ	2	62	3.4788073301837035E-4	4.257803110943241E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	3	2	2	0	26	37	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSASSGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTCTTGAGGCTAGCGGGAGTACAGATACGCAGTATTTTGGCCCA	CSVLEASGSTDTQYF	In	VDJ	2	62	3.4788073301837035E-4	4.257803110943241E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	4	2	3	9	1	26	33	52	42	53		TCRBV20-01,TCRBV20-or09_02												CSVLEASGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTCTGGGGCGCGGGCACTGAAGCTTTCTTTGGACAA	CASSFWGAGTEAFF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	7	0	4	2	5	26	40	47	42	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFWGAGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCAGCGGGGGGTGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	63	3.534917125831828E-4		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	1	7	4	5	26	40	53	44	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGTCGAGAAAGCTTTCTTTGGACAA	CSARDLVEKAFF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	8	9	1	6	26	40	45	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLVEKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCAGGGGGGGTTTAGCGGAAACGGGGATGAGCAGTTCTTCGGGCCA	CASSHQGGFSGNGDEQFF	In	VDJ	2	64	3.591026921479952E-4	4.3951515983930224E-4	54	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	4	1	8	1	18	26	40	48	41	66		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHQGGFSGNGDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCCGGACTAGCGGGGGGGCTCGGGAGCAGTTCTTCGGGCCA	CSARDLRTSGGAREQFF	In	VDJ	2	64	3.591026921479952E-4	4.3951515983930224E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	1	0	10	5	5	26	40	60	45	65		TCRBV20-01,TCRBV20-or09_02												CSARDLRTSGGAREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTCGCTGGTGCTTTAGATACGCAGTATTTTGGCCCA	CSARFAGALDTQYF	In	VDJ	2	65	3.647136717128076E-4	4.4638258421179135E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	0	10	5	6	6	26	38	46	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARFAGALDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCGGGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CSANRGTVNTEAFF	In	VDJ	2	66	3.7032465127762005E-4	4.5325000858428046E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	5	0	26	36	-1	41	48		TCRBV20-01,TCRBV20-or09_02												CSANRGTVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATCGGGACAGCCTACGAGCAGTACTTCGGGCCG	CASSLIGTAYEQYF	In	VDJ	2	67	3.759356308424325E-4	4.6011743295676957E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	2	3	0	26	41	-1	44	51		TCRBV12-03,TCRBV12-04												CASSLIGTAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCATCTGGCGGGGGAGACCCAGTACTTCGGGCCA	CSAHLAGETQYF	In	VDJ	2	67	3.759356308424325E-4	4.6011743295676957E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	3	5	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAHLAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGCAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSLGRVNEQFF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	6	3	1	26	40	48	43	49		TCRBV12-03,TCRBV12-04												CASSLGRVNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCCCGGCAGCATCCCCAATCAGCCCCAGCATTTTGGTGAT	CSATPGSIPNQPQHF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	4	4	5	3	7	6	26	36	46	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPGSIPNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGCCCTGGCTCACACAGATACGCAGTATTTTGGCCCA	CASALAHTDTQYF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	8	9	0	2	5	3	23	32	40	37	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASALAHTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCCCCTGGAGGAGAGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	68	3.815466104072449E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	11	10	1	0	4	6	23	29	38	33	44	TCRBV02,TCRBV12													X+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAAAGACAGGGCTGGAGTGAAAAACTGTTTTTTGGCAGT	CASSKRQGWSEKLFF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	7	4	6	26	38	49	42	55		TCRBV03-01,TCRBV03-02												CASSKRQGWSEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGGTGGATCCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA	CASSEVDPFVMQDTQYF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	5	0	19	26	-1	42	38	61		TCRBV03-01,TCRBV03-02												CASSEVDPFVMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGATTACAGAAATCAGCCCCAGCATTTTGGTGAT	CASSDYRNQPQHF	In	VDJ	2	70	3.9276856953686975E-4	4.8071970607423684E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	5	4	2	1	24	38	44	40	45	TCRBV06,TCRBV10													CASSDYRNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGTAGGGACTTCGTCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	70	3.9276856953686975E-4		38	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	0	10	5	2	7	23	31	39	33	46	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACCTCCGCGACTAGCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSTSATSLYNEQFF	In	VDJ	2	70	3.9276856953686975E-4	4.8071970607423684E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	7	3	8	2	24	36	51	44	53		TCRBV24-01,TCRBV24-or09_02				01,02								CASSTSATSLYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCCACGAGGAACGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSTRNGNQPQHF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	1	2	4	4	23	36	44	40	48	TCRBV06,TCRBV24													CASSSTRNGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGACGGGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSEDGGPTDTQYF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	2	6	2	23	34	47	40	49	TCRBV09,TCRBV12													CASSEDGGPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCGGGGGCTCCGGGTTGAAGCTTTCTTTGGACAA	CASSFRGLRVEAFF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	6	0	7	2	7	26	40	48	42	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRGLRVEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCCACAGGGGTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	72	4.039905286664946E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	3	2	2	4	1	26	31	42	35	43		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAAACCACAGGGGTTGGTACGAGCAGTACTTCGGGCCG	CSARNHRGWYEQYF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	4	4	4	26	38	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSARNHRGWYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCAGTCCAGCCGTCCACCTACAATGAGCAGTTCTTCGGGCCA	CSAAVQPSTYNEQFF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	4	5	2	1	12	26	35	39	36	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAVQPSTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTTCTGTGCCAGCAGCGTGGGGACAGGGGGCTGAGTAGCGGGAGGATCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDDJ	2	72	4.039905286664946E-4		64	TCRBV21			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	1	3	4	4	4	31	45	35	49		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-01	TCRBV21	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGTTGTAAGGCAGGGGGCCAGATACGCAGTATTTTGGCCCA	CSARGL*GRGPDTQYF	Stop	VDJ	2	73	4.09601508231307E-4		48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	0	4	12	0	26	37	-1	49	57		TCRBV20-01,TCRBV20-or09_02												CSARGL*GRGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCTAGAGCCCCGGGACAGGGGTATCAGCCCCAGCATTTTGGTGAT	CNARAPGQGYQPQHF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	2	5	4	1	26	39	53	43	54		TCRBV20-01,TCRBV20-or09_02												CNARAPGQGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACCCCGCCGGGACAGGGAGTAATGAGCAGTTCTTCGGGCCA	CSAHPAGTGSNEQFF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	7	9	3	26	35	53	44	56		TCRBV20-01,TCRBV20-or09_02												CSAHPAGTGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATTCTGGGGGGTATAGCCCTGGGGCCAACGTCCTGACTTTCGGGGCC	XASSQDSGGYSPGANVLTF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	9	1	2	4	7	22	39	49	43	56	TCRBV01,TCRBV04													XASSQDSGGYSPGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCCCTGGACAGGGAAATTCACCCCTCCACTTTGGGAAC	CASSPGQGNSPLHF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	7	3	1	19	31	42	34	43	TCRBV05,TCRBV07													CASSPGQGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGGGGTAGGGGGAATCGGAAACACCATATATTTTGGAGAG	CASSLGVGGIGNTIYF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	5	1	4	4	4	19	35	45	39	49	TCRBV05,TCRBV11													CASSLGVGGIGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGTATAGACTCTATGGCTACACCTTCGGTTCG	CSARDPYRLYGYTF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	2	10	4	8	0	26	40	-1	48	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPYRLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAAGACAGGGGGCGCGCAATGAGCAGTTCTTCGGGCCA	CSAPRQGARNEQFF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	6	4	3	26	35	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSAPRQGARNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCCTAGCGGGAGGGACTACGAGCAGTACTTCGGGCCG	CASSPSGRDYEQYF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	0	3	2	1	24	35	49	37	50	TCRBV24,TCRBV27													CASSPSGRDYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGAGACAGGGGGCGAGAAGCTTTCTTTGGACAA	CASSGDRGREAFF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	8	2	2	24	37	49	39	51		TCRBV24-01,TCRBV24-or09_02												CASSGDRGREAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCATGGGATTAGGGACAGATACGCAGTATTTTGGCCCA	CASSPMGLGTDTQYF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	8	3	5	6	18	30	39	35	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPMGLGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTTACAGGCTTCAATGAGCAGTTCTTCGGGCCA	CASSFTGFNEQFF	In	VDJ	2	75	4.208234673609319E-4	5.150568279366824E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	4	6	1	3	42	56	62	57	65	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSFTGFNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGCAAGGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDLARGTNTGELFF	In	VDJ	2	77	4.320454264905567E-4	5.287916766816605E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	1	0	3	1	24	42	51	45	52		TCRBV24-01,TCRBV24-or09_02												CATSDLARGTNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGGTTAGCGGAATACAATGAGCAGTTCTTCGGGCCA	CASSLGLAEYNEQFF	In	VDJ	2	77	4.320454264905567E-4	5.287916766816605E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	5	4	3	2	19	35	44	38	46	TCRBV07,TCRBV11					01,02								CASSLGLAEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTGGGGCCCATAAGTGAGCAGTTCTTCGGGCCA	CASSQGVGPISEQFF	In	VDJ	2	79	4.432673856201816E-4	5.425265254266387E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	9	4	7	26	42	51	46	58		TCRBV03-01,TCRBV03-02												CASSQGVGPISEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGTTGGGGGACGAGAGACCCAGTACTTCGGGCCA	CSAKVGGRETQYF	In	VDJ	2	80	4.48878365184994E-4	5.493939497991278E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	0	7	4	7	1	26	36	48	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKVGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGTACCCTGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSATVPWGGTDTQYF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	1	1	9	0	26	36	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSATVPWGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTCCTTGTGGGCATTGGCTACACCTTCGGTTCG	CSASVLVGIGYTF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	7	9	2	26	37	50	46	52		TCRBV20-01,TCRBV20-or09_02												CSASVLVGIGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTATTCGCGGGGTGGGACACAGATACGCAGTATTTTGGCCCA	CASSLFAGWDTDTQYF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	3	2	3	5	19	34	43	37	48	TCRBV07,TCRBV11													CASSLFAGWDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCCCTCTAGCGGACTCCTACGAGCAGTACTTCGGGCCG	CASSPLADSYEQYF	In	VDJ	2	83	4.657113038794313E-4	5.699962229165951E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	5	0	4	1	26	37	48	41	49	TCRBV07,TCRBV12					01,02								CASSPLADSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTAGGTTTAGGAGTTATGAGCAGTTCTTCGGGCCA	CSASPRFRSYEQFF	In	VDJ	2	83	4.657113038794313E-4	5.699962229165951E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	8	2	11	26	37	43	39	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPRFRSYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCGTGACAGGGTACACTGAAGCTTTCTTTGGACAA	CASSAVTGYTEAFF	In	VDJ	2	85	4.769332630090561E-4	5.837310716615734E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	3	4	1	23	36	47	40	48	TCRBV09,TCRBV21													CASSAVTGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATTATGCTTCCCATTTCAGGCTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	87	4.88155222138681E-4		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	5	16	3	26	38	58	54	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTACCCAGGGGACCCCTCACAGATACGCAGTATTTTGGCCCA	CASSLPRGPLTDTQYF	In	VDJ	2	87	4.88155222138681E-4	5.974659204065515E-4	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	2	3	6	19	33	42	36	48		TCRBV05-06,TCRBV05-07												CASSLPRGPLTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATTCCCCCCCGGATGGAATGAGCAGTTCTTCGGGCCA	CASSQEFPPGWNEQFF	In	VDJ	3	90	5.049881608331183E-4	6.180681935240188E-4	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	1	8	7	10	3	26	43	56	53	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEFPPGWNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGATGGTCCCAAAAGAGATCAGCCCCAGCATTTTGGTGAT	CASSLDGPKRDQPQHF	In	VDJ	3	91	5.105991403979306E-4	6.249356178965079E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	2	5	12	0	26	42	-1	54	57		TCRBV12-03,TCRBV12-04												CASSLDGPKRDQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGGTCGACAGGGGAAGCAGTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CSAVVDRGSSLAKNIQYF	In	VDJ	3	91	5.105991403979306E-4	6.249356178965079E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	2	0	6	9	26	35	49	41	58		TCRBV20-01,TCRBV20-or09_02												CSAVVDRGSSLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATCCAAGATACGCAGTATTTTGGCCCA	CSARDIQDTQYF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	6	5	0	4	26	-1	42	40	46		TCRBV20-01,TCRBV20-or09_02												CSARDIQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTCAACCGGGACACTACACAGATACGCAGTATTTTGGCCCA	CASQPGHYTDTQYF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	6	2	6	3	23	31	43	37	46	TCRBV02,TCRBV09													CASQPGHYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGACTAGGATCCTACGAGCAGTACTTCGGGCCG	CSARDRLGSYEQYF	In	VDJ	3	94	5.27432079092368E-4	6.455378910139752E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	8	1	2	2	26	40	48	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRLGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCCGCGCGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASRSARNTGELFF	In	VDJ	3	95	5.330430586571803E-4	6.524053153864643E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	6	2	4	3	26	37	44	41	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRSARNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCCCTTGGAGGCGGTTTCCTACGAGCAGTACTTCGGGCCG	CASSPLEAVSYEQYF	In	VDJ	3	95	5.330430586571803E-4	6.524053153864643E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	1	5	5	22	34	44	39	49	TCRBV02,TCRBV12													CASSPLEAVSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATGAGGAGGGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	95	5.330430586571803E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	0	0	3	2	18	33	42	36	44	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSISNTGELFF	In	VDJ	3	97	5.442650177868052E-4	6.661401641314426E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	9	0	1	1	26	38	41	39	42		TCRBV12-03,TCRBV12-04				01,02								CASSISNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCCAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CSASASGGADTQYF	In	VDJ	3	97	5.442650177868052E-4	6.661401641314426E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	4	4	0	26	37	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSASASGGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGATTCGCCCGGGACAGGGGGCGGTACAATGAGCAGTTCTTCGGGCCA	CASRFARDRGRYNEQFF	In	VDJ	3	97	5.442650177868052E-4	6.661401641314426E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	4	8	2	18	29	49	37	51	TCRBV07,TCRBV11													CASRFARDRGRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGGACTAGCGGGGGGGCCGAAGATACGCAGTATTTTGGCCCA	XASSRTSGGAEDTQYF	In	VDJ	3	97	5.442650177868052E-4	6.661401641314426E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	5	1	4	22	34	50	35	54	TCRBV01,TCRBV07,TCRBV17													XASSRTSGGAEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGGGTACGAAATGAACACTGAAGCTTTCTTTGGACAA	CASSQAGYEMNTEAFF	In	VDJ	3	98	5.498759973516177E-4	6.730075885039316E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	0	0	7	26	-1	47	42	54		TCRBV03-01,TCRBV03-02												CASSQAGYEMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGGACAGTTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	99	5.5548697691643E-4		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	3	0	3	26	-1	50	43	53		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSRTGNYGYTF	In	VDJ	3	99	5.5548697691643E-4	6.798750128764207E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	3	2	2	0	24	35	-1	37	45		TCRBV24-01,TCRBV24-or09_02												CASSRTGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCACAGGGGAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHRGGAKNIQYF	In	VDJ	3	100	5.610979564812425E-4	6.867424372489098E-4	45							TCRBJ02	TCRBJ02-04	01	5	3	2	1	1	4	36	48	56	49	60	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRGGAKNIQYF+X+TCRBJ02-04			TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACACCGTCGTTCAGGTCCCGCCTGAGACCCAGTACTTCGGGCCA	CASSHTVVQVPPETQYF	In	VDJ	3	100	5.610979564812425E-4	6.867424372489098E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	5	10	8	26	40	54	50	62		TCRBV03-01,TCRBV03-02												CASSHTVVQVPPETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCTGGACGGTGGAAGAAACACCATATATTTTGGAGAG	CASSLDGGRNTIYF	In	VDJ	3	100	5.610979564812425E-4	6.867424372489098E-4	42	TCRBV12						TCRBJ01	TCRBJ01-03	01	6	1	7	5	3	7	22	33	40	36	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGGRNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCAGTGAGCCCCGGACTAGCGGGAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAISEPRTSGRGTGELFF	In	VDJ	3	102	5.723199156108674E-4	7.00477285993888E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	0	4	5	1	24	38	58	43	59		TCRBV24-01,TCRBV24-or09_02												CAISEPRTSGRGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCATCTGGATATTCGGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	3	102	5.723199156108674E-4		40				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	2	6	11	0	41	51	-1	62	66	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												X+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTTATGGCGCCGGGGAATGAGCAGTTCTTCGGGCCA	CASSQVMAPGNEQFF	In	VDJ	3	104	5.835418747404922E-4	7.142121347388662E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	7	9	0	23	39	-1	48	53	TCRBV01,TCRBV04													CASSQVMAPGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGGGGGCGCGAAATGAGCAGTTCTTCGGGCCA	CASSSGGARNEQFF	In	VDJ	3	106	5.94763833870117E-4	7.279469834838444E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	7	2	5	24	36	46	38	51		TCRBV24-01,TCRBV24-or09_02												CASSSGGARNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGAGACAGGGGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSQETGGSYNEQFF	In	VDJ	3	106	5.94763833870117E-4	7.279469834838444E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	1	3	2	3	20	35	46	37	49	TCRBV01,TCRBV23													CASSQETGGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGACTTTTTGGCACAGGGGACTATGGCTACACCTTCGGTTCG	CASRLFGTGDYGYTF	In	VDJ	3	107	6.003748134349294E-4	7.348144078563335E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	2	3	14	0	24	31	-1	45	52		TCRBV24-01,TCRBV24-or09_02												CASRLFGTGDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCCCCAATGAGCAGTTCTTCGGGCCA	CASSQTPNEQFF	In	VDJ	3	110	6.172077521293668E-4	7.554166809738008E-4	36	TCRBV03						TCRBJ02	TCRBJ02-01	01	2	3	7	6	0	3	26	-1	43	41	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTPNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAACTTAACGGGACTTCGGGCAGTACTTCGGGCCG	CASSST*RDFGQYF	Stop	VDJ	3	110	6.172077521293668E-4		42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	9	10	4	24	36	52	46	56		TCRBV24-01,TCRBV24-or09_02				01,02								CASSST*RDFGQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGCTCGGACTCGTGCGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSELGLVRNNEKLFF	In	VDJ	3	112	6.284297112589916E-4	7.69151529718779E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	4	7	9	23	34	46	41	55	TCRBV02,TCRBV09					01,02								CASSELGLVRNNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGYAGCCTCGGGGAACTAGCTAGCAATGAGCAGTTCTTCGGGCCA	XASSLGELASNEQFF	In	VDJ	3	114	6.396516703886165E-4	7.828863784637572E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	3	7	6	17	3	22	25	48	42	51	TCRBV04,TCRBV17					01,02								XASSLGELASNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGGTGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVGGGSNQPQHF	In	VDJ	3	115	6.452626499534288E-4	7.897538028362463E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	0	6	2	1	0	4	23	-1	43	39	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGGGSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGACTAGCGGGACAAGAGCAGTACTTCGGGCCG	CSASGLAGQEQYF	In	VDJ	3	116	6.508736295182413E-4	7.966212272087354E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	1	3	7	1	3	26	37	50	38	53		TCRBV20-01,TCRBV20-or09_02												CSASGLAGQEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCACTCTCGAGGAGCGGGAGATCCTACGAGCAGTACTTCGGGCCG	CASSSLSRSGRSYEQYF	In	VDJ	3	116	6.508736295182413E-4	7.966212272087354E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	1	12	1	24	36	56	48	57		TCRBV24-01,TCRBV24-or09_02												CASSSLSRSGRSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAGGGGCGTTTGAAGCTTTCTTTGGACAA	CASSLSGAFEAFF	In	VDJ	3	116	6.508736295182413E-4	7.966212272087354E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	7	4	4	24	36	46	40	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGAFEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCTTCCGGACTGCACAGATACGCAGTATTTTGGCCCA	CASSPLPDCTDTQYF	In	VDJ	3	118	6.620955886478662E-4	8.103560759537135E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	1	8	0	26	38	-1	46	51		TCRBV12-03,TCRBV12-04				01,02								CASSPLPDCTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TTTCTGTGCCAGCAGCGTAGGGTCAACGATACGAGGGACTAGCGGGAGATTGGAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	3	122	6.845395069071159E-4		64	TCRBV21			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	18	7	4	16	48	34	55		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-01	TCRBV21	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGGGGACAGGGCCCTATTCACCCCTCCACTTTGGGAAC	CASSGGTGPYSPLHF	In	VDJ	3	123	6.901504864719282E-4	8.44693197816159E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	3	8	3	4	24	36	48	39	52	TCRBV09,TCRBV21													CASSGGTGPYSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGAGGGGCGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSLEGRTGNYGYTF	In	VDJ	4	125	7.013724456015531E-4	8.584280465611373E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	2	5	0	26	43	-1	48	56		TCRBV03-01,TCRBV03-02												CASSLEGRTGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGACTAGCGGGGGTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	125	7.013724456015531E-4		40	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	6	1	1	26	34	49	35	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTACTTTAGCTATGGCTACACCTTCGGTTCG	CASSLSYFSYGYTF	In	VDJ	4	125	7.013724456015531E-4	8.584280465611373E-4	42				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	3	10	4	7	4	24	36	46	43	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSYFSYGYTF+X+TCRBJ01-02		TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGAGTCTTGGGGGACTAGCGGGACAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARESWGTSGTSSYNEQFF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	60	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	3	0	7	4	15	29	49	36	53		TCRBV20-01,TCRBV20-or09_02												CSARESWGTSGTSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGGGGGACCGCTCAACTGAAGCTTTCTTTGGACAA	CASSVGDRSTEAFF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	5	4	6	24	36	45	40	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGDRSTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGCAAGGGGTAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPQGVSNQPQHF	In	VDJ	4	127	7.125944047311779E-4	8.721628953061155E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	1	4	2	23	36	45	40	47	TCRBV01,TCRBV04													CASSPQGVSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCAGCCGGACACACCTTGGAAGGGGGCAGTACTTCGGGCCG	CASSPSRTHLGRGQYF	In	VDJ	4	128	7.182053842959904E-4	8.790303196786045E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	9	7	14	18	30	42	37	56	TCRBV07,TCRBV11													CASSPSRTHLGRGQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCCGGTTGGGCTAGCAGAGACCCAGTACTTCGGGCCA	CSASPPVGLAETQYF	In	VDJ	4	130	7.294273434256153E-4	8.927651684235827E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	7	4	13	0	26	37	-1	50	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPPVGLAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGCCCGGGGCCGCACAAGAGACCCAGTACTTCGGGCCA	CSASRPGAAQETQYF	In	VDJ	4	130	7.294273434256153E-4	8.927651684235827E-4	45	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	7	0	2	7	4	26	37	49	44	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRPGAAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCAGGGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASRPGGGEKLFF	In	VDJ	4	132	7.406493025552401E-4	9.065000171685609E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	7	2	2	26	37	47	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGGGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAACCTTTGACAGGGAGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	132	7.406493025552401E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	3	6	8	3	24	40	55	48	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGACCACAGTCTCGCCGGGCAGTATTTTGGCCCA	CSARDHSLAGQYF	In	VDJ	4	133	7.462602821200525E-4	9.1336744154105E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	0	7	11	2	14	26	34	41	36	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDHSLAGQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGGGAAGAAGAGACCCAGTACTTCGGGCCA	CASSPGEEETQYF	In	VDJ	4	134	7.51871261684865E-4	9.202348659135391E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	3	3	2	3	26	38	45	40	48		TCRBV12-03,TCRBV12-04												CASSPGEEETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGACAGGGGAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	134	7.51871261684865E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	2	4	1	2	24	33	44	34	46		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCCGGGACAGGACGGTCCATGAGCAGTTCTTCGGGCCA	CSARTRDRTVHEQFF	In	VDJ	4	135	7.574822412496773E-4	9.271022902860282E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	4	8	4	7	26	38	50	42	57		TCRBV20-01,TCRBV20-or09_02												CSARTRDRTVHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCTCCGGGACATTGTACAATGAGCAGTTCTTCGGGCCA	CSTSGTLYNEQFF	In	VDJ	4	136	7.630932208144898E-4	9.339697146585174E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	6	4	6	3	26	32	44	38	47		TCRBV20-01,TCRBV20-or09_02												CSTSGTLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCACTAGCGGGAGGGCCCTATGAGCAGTTCTTCGGGCCA	CATSDSLAGGPYEQFF	In	VDJ	4	136	7.630932208144898E-4	9.339697146585174E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	0	8	1	4	24	40	54	41	58		TCRBV24-01,TCRBV24-or09_02												CATSDSLAGGPYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGACCCAGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASRPRGPYNEQFF	In	VDJ	4	141	7.911481186385519E-4	9.683068365209628E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	2	3	0	23	34	-1	37	45	TCRBV02,TCRBV09													CASRPRGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGATCGGTGGGGGAGACCCAGTACTTCGGGCCA	CSARGSVGETQYF	In	VDJ	4	144	8.079810573329892E-4	9.889091096384301E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	6	2	5	7	0	26	39	-1	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGSVGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGAGGAAGGGACTAGCGGGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CARGRD*RGPNTGELFF	Stop	VDJ	4	144	8.079810573329892E-4		51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	9	0	3	0	5	2	18	26	44	31	46	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CARGRD*RGPNTGELFF+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGGACTAGTCTTCTCCTACGAGCAGTACTTCGGGCCG	CASSPGLVFSYEQYF	In	VDJ	4	145	8.135920368978016E-4	9.957765340109191E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	8	0	3	4	26	37	48	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPGLVFSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCGGGGACTAGCGGAGCGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	145	8.135920368978016E-4		58				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	5	0	3	6	18	35	49	38	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								X+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTAGAGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFRESSYEQYF	In	VDJ	4	148	8.304249755922389E-4	0.0010163788071283866	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	8	0	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04				01,02								CASSFRESSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTTAAGGGTGCGGCTAATGAAAAACTGTTTTTTGGCAGT	CSARGLKGAANEKLFF	In	VDJ	4	149	8.360359551570513E-4	0.0010232462315008756	48	TCRBV20						TCRBJ01	TCRBJ01-04	01	1	5	3	3	6	5	26	39	49	45	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGLKGAANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCCAGCACATTCTATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTFYSSYNEQFF	In	VDJ	4	149	8.360359551570513E-4	0.0010232462315008756	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	9	0	4	3	18	28	35	32	38	TCRBV07,TCRBV11					01,02								CASTFYSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCCGAGGGAAGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLSEGRGTGELFF	In	VDJ	4	155	8.697018325459258E-4	0.0010644507777358102	48	unresolved						TCRBJ02	TCRBJ02-02	01	6	5	2	5	12	1	24	36	53	48	54	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSEGRGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTACTGGGACTAGCGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSLAVLGLAGKETQYF	In	VDJ	4	155	8.697018325459258E-4	0.0010644507777358102	54				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	0	3	3	6	1	18	35	54	41	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAVLGLAGKETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCACAGCTGGACAGGCGAATCCTACGAGCAGTACTTCGGGCCG	CASSHSWTGESYEQYF	In	VDJ	5	160	8.97756730369988E-4	0.0010987878995982556	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	1	5	4	23	37	49	42	53	TCRBV01,TCRBV23													CASSHSWTGESYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATGGTGGACACACCTGGAACACTGAAGCTTTCTTTGGACAA	XASSQDGGHTWNTEAFF	In	VDJ	5	166	9.314226077588626E-4	0.0011399924458331903	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	1	4	6	23	40	49	44	55	TCRBV01,TCRBV04													XASSQDGGHTWNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTGGTDTQYF	In	VDJ	5	167	9.370335873236749E-4	0.0011468598702056793	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	2	1	0	0	18	-1	-1	34	43	TCRBV07,TCRBV11													CASSLGTGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTTGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSLGWNNEKLFF	In	VDJ	5	170	9.538665260181123E-4	0.0011674621433231467	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	3	0	9	4	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWNNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTCCGACAGACTTAACAATGAGCAGTTCTTCGGGCCA	CASSSSDRLNNEQFF	In	VDJ	5	171	9.594775055829246E-4	0.0011743295676956357	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	5	5	5	5	26	39	49	44	54		TCRBV12-03,TCRBV12-04												CASSSSDRLNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACTCCTTGGGGGCCCTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTPWGPSSNQPQHF	In	VDJ	5	177	9.931433829717992E-4	0.0012155341139305704	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	6	0	0	7	4	26	38	51	45	55		TCRBV03-01,TCRBV03-02												CASSTPWGPSSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTAAGCCCCGAGGGGGCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	177	9.931433829717992E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	0	5	9	2	24	36	52	45	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAGGGTTATAACTCGCGGGAGCAGTACTTCGGGCCG	XASSQGYNSREQYF	In	VDJ	5	191	0.0010716970968791732	0.0013116780551454177	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	5	7	12	0	22	36	-1	48	52	TCRBV04,TCRBV07,TCRBV17					01,02								XASSQGYNSREQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGGTGACCCGGGGCGAGGCGGCTACACCTTCGGTTCG	CASSQGDPGRGGYTF	In	VDJ	5	192	0.0010773080764439856	0.001318545479517907	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	7	0	8	11	5	18	30	46	41	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDPGRGGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGGGACTTCCAATCCAGGCATTCAGTACTTCGGCGCC	CASSLWGTSNPGIQYF	In	VDJ	6	203	0.0011390288516569223	0.001394087147615287	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	0	10	9	6	11	24	36	48	42	59		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLWGTSNPGIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCGGGGGCGAACTCCTACGAGCAGTACTTCGGGCCG	CATSPGANSYEQYF	In	VDJ	6	205	0.001150250810786547	0.001407821996360265	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	6	0	0	3	3	24	35	44	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSPGANSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGACAGAAGGCGAGCAGTACTTCGGGCCG	CATSDSTEGEQYF	In	VDJ	6	205	0.001150250810786547	0.001407821996360265	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	6	1	4	24	40	46	41	50		TCRBV24-01,TCRBV24-or09_02												CATSDSTEGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGGACTAGCGGGAGGTCCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	6	210	0.0011783057086106091		55	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	0	1	0	2	5	26	34	51	36	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTCTCTGTATCAGGGGGCGTTAACCGGGGAGCTGTTTTTTGGAGAA	CASSFSLYQGALTGELFF	In	VDJ	6	210	0.0011783057086106091	0.0014421591182227106	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	5	12	4	24	36	56	48	60		TCRBV24-01,TCRBV24-or09_02												CASSFSLYQGALTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTTTGGGACTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLGLAGTDTQYF	In	VDJ	6	213	0.0011951386473050465	0.0014627613913401779	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	5	1	3	0	18	32	-1	35	46	TCRBV07,TCRBV11					01,02								CASSFLGLAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCGGACAGGGGGAGTAGGGGAGCAGTACTTCGGGCCG	CSAIRTGGVGEQYF	In	VDJ	7	233	0.001307358238601295	0.0016001098787899598	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	1	7	3	7	26	36	49	39	56		TCRBV20-01,TCRBV20-or09_02												CSAIRTGGVGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGCCCAATTTCGAGAACACTGAAGCTTTCTTTGGACAA	CASRPNFENTEAFF	In	VDJ	7	237	0.0013298021568605447	0.0016275795762799162	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	6	2	8	1	10	0	26	37	-1	47	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPNFENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGAACCCGACAGTAGCCTAAACTATGGCTACACCTTCGGTTCG	CASSEPDSSLNYGYTF	In	VDJ	7	245	0.001374689993379044	0.001682518971259829	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	5	2	5	7	23	36	46	41	53	TCRBV09,TCRBV12													CASSEPDSSLNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCCACGGCGGGGGCTCAGGAAGCTTTCTTTGGACAA	CASSSTAGAQEAFF	In	VDJ	7	248	0.0013915229320734814	0.0017031212443772963	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	2	8	7	5	26	37	51	44	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSTAGAQEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCCGGACGTCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGRLSGANVLTF	In	VDJ	7	255	0.0014307997890271684	0.00175119321498472	48	TCRBV24						TCRBJ02	TCRBJ02-06	01	7	1	7	0	4	4	24	35	43	39	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGRLSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGTAGGCTACAATGAGCAGTTCTTCGGGCCA	CSATVGYNEQFF	In	VDJ	7	258	0.0014476327277216055	0.0017717954881021872	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	4	5	3	0	4	26	-1	39	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATVGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTGAGGGGCGCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSVRGARNNEQFF	In	VDJ	7	258	0.0014476327277216055	0.0017717954881021872	45	unresolved						TCRBJ02	TCRBJ02-01	01	4	5	2	5	2	8	23	36	43	38	51	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVRGARNNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCACTGAATCAGCCCCAGCATTTTGGTGAT	CASSLSLNQPQHF	In	VDJ	7	260	0.0014588546868512305	0.0017855303368471654	39				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	10	4	5	1	24	36	44	41	45	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSLNQPQHF+X+TCRBJ01-05		TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACTTCCACCTGGGTCGCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	7	265	0.0014869095846752926		50	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	9	2	11	4	24	38	52	49	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGACCCCCTCTGGGTAGCGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSDPLWVAGGTDTQYF	In	VDJ	8	268	0.00150374252336973	0.0018404697318270783	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	1	13	0	24	36	-1	49	58	TCRBV09,TCRBV21													CASSDPLWVAGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCACCTGGGACTAGCGACCATGGTAGATACGCAGTATTTTGGCCCA	CSARHLGLATMVDTQYF	In	VDJ	8	271	0.0015205754620641672	0.0018610720049445455	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	5	8	8	26	35	53	43	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARHLGLATMVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGACAGATAGGGAACACTGAAGCTTTCTTTGGACAA	CASSGQIGNTEAFF	In	VDJ	8	281	0.0015766852577122914	0.0019297462486694366	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	1	0	5	26	-1	44	38	49		TCRBV03-01,TCRBV03-02												CASSGQIGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAAATGGGTAGCAGCGCTGAAGCTTTCTTTGGACAA	CATKMGSSAEAFF	In	VDJ	8	284	0.0015935181964067287	0.0019503485217869038	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	5	7	6	7	4	24	34	45	41	49		TCRBV24-01,TCRBV24-or09_02				01,02								CATKMGSSAEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACTTTAGGGGGGTGAGGCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	8	286	0.0016047401555363534		44	TCRBV24						TCRBJ02	TCRBJ02-07	01	11	5	1	3	7	8	24	31	44	38	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQDKGNTEAFF	In	VDJ	8	287	0.001610351135101166	0.001970950794904371	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	5	3	1	2	0	26	43	-1	45	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDKGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTCTCGGCGGGGGTTGGGACGAGCAGTACTTCGGGCCG	CASSPLGGGWDEQYF	In	VDJ	8	295	0.0016552389716196654	0.002025890189884284	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	2	5	8	5	26	37	52	45	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPLGGGWDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAAAAGTTTATTCCAGACTAGCGGGAGGTCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	8	301	0.0016889048490085399		61	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	1	4	16	3	20	32	61	48	64		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTATGACACCTTTGAATGAGCAGTTCTTCGGGCCA	CATMTPLNEQFF	In	VDJ	9	302	0.0016945158285733522	0.0020739621604917075	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	2	6	7	3	6	24	32	39	35	45		TCRBV24-01,TCRBV24-or09_02												CATMTPLNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACCTACCAGGGTACCTAACCGAGCAGTACTTCGGGCCG	CASSHLPGYLTEQYF	In	VDJ	9	308	0.001728181705962227	0.002115166706726642	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	5	8	23	37	47	42	55	TCRBV01,TCRBV04													CASSHLPGYLTEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCAGGGCGGGGGAGGCCAGTACTTCGGGCCA	CASSLAQGGGGQYF	In	VDJ	9	314	0.0017618475833511013	0.002156371252961577	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	2	10	5	3	18	35	47	40	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAQGGGGQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGAGCGGGACATTCACAGATACGCAGTATTTTGGCCCA	CASSQRSGTFTDTQYF	In	VDJ	9	323	0.0018123463994344133	0.0022181780723139785	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	3	2	3	4	26	41	51	44	55		TCRBV03-01,TCRBV03-02												CASSQRSGTFTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGCGGGCAGAGCTAAAAGCAGTACTTCGGGCCG		Out	VDJ	9	326	0.0018291793381288504		35	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	7	4	8	2	10	24	31	38	33	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGCGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CSASSVNTGELFF	In	VDJ	9	336	0.0018852891337769748	0.002307454589156337	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	6	2	0	2	26	-1	42	37	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSVNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCTCGGACAGGGGAGGTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	10	344	0.0019301769702954742		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	2	4	2	5	19	28	39	30	44	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTGGCGCCTCCGACAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	11	379	0.002126561255063909		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	6	5	11	0	24	35	-1	46	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTACAGGATTCACCGGGGAGCTGTTTTTTGGAGAA	CSARPTGFTGELFF	In	VDJ	12	422	0.0023678333763508435	0.0028980530851903993	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	4	4	3	3	26	38	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARPTGFTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCCAGAGGGTAGCGGGAGAAGTTCGGCCAAAAACATTCAGTACTTCGGCGCC	CASSPEGSGRSSAKNIQYF	In	VDJ	13	444	0.0024912749267767165	0.0030491364213851594	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	5	2	1	3	7	23	40	52	43	59	TCRBV01,TCRBV23													CASSPEGSGRSSAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGAGGCTGGGCTAAAAAACATTCAGTACTTCGGCGCC	CSASEAGLKNIQYF	In	VDJ	13	464	0.002603494518072965	0.0031864849088349416	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	10	1	4	2	8	26	35	42	37	50		TCRBV20-01,TCRBV20-or09_02												CSASEAGLKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGGAGCTGGGCTAGCGGCATCCAAGAGACCCAGTACTTCGGGCCA	CASGSWASGIQETQYF	In	VDJ	13	465	0.002609105497637778	0.0031933523332074304	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	4	5	1	10	3	26	35	52	45	55		TCRBV03-01,TCRBV03-02				01,02								CASGSWASGIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGCGAAAGCAATGAGCAGTTCTTCGGGCCA	CASSLSESNEQFF	In	VDJ	13	477	0.0026764372524155267	0.0032757614256772997	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	6	0	4	26	-1	45	41	49		TCRBV12-03,TCRBV12-04				01,02								CASSLSESNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGTCCAACAGGGTATTCCCTACGAGCAGTACTTCGGGCCG	CASSLSVQQGIPYEQYF	In	VDJ	14	510	0.002861599578054337	0.00350238642996944	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	2	11	5	24	36	53	47	58	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSVQQGIPYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCACGGAGAATGTCCGATACGCAGTATTTTGGCCCA	CASSQARRMSDTQYF	In	VDJ	15	537	0.0030130960263042724	0.0036878068880266458	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	2	6	3	7	23	39	46	42	53	TCRBV01,TCRBV04													CASSQARRMSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACTTTAACAGGGGGCGCATCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	16	555	0.003114093658470896		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	0	4	6	5	24	35	50	41	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTACTAGTTTTTCGGCAGATACGCAGTATTTTGGCCCA	CASSPTSFSADTQYF	In	VDJ	21	744	0.004174568796220444	0.005109363733131889	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	8	4	3	8	24	36	44	39	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPTSFSADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGATCGGGAGGGATGAGCAGTTCTTCGGGCCA	CASSLIGRDEQFF	In	VDJ	22	794	0.004455117774461065	0.005452734951756344	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	0	8	3	0	26	40	-1	43	51		TCRBV12-03,TCRBV12-04												CASSLIGRDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGGGAGGCTAGCTGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSGRLAGYNEQFF	In	VDJ	22	796	0.0044663397335906905	0.005466469800501322	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	3	2	8	24	36	45	38	53		TCRBV24-01,TCRBV24-or09_02												CASSSGRLAGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCCGAGGGGCAGGGGATTTGCAGATACGCAGTATTTTGGCCCA	CSAIPRGRGFADTQYF	In	VDJ	27	951	0.0053360415661366165	0.006530920578237132	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	4	10	5	26	36	52	46	57		TCRBV20-01,TCRBV20-or09_02												CSAIPRGRGFADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTACGGGCCTTCGTACAGAGACCCAGTACTTCGGGCCA	CASSFTGLRTETQYF	In	VDJ	28	989	0.005549258789599488	0.006791882704391718	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	8	0	4	3	8	26	40	47	43	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTGLRTETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGACAGGGGACTCTACGAGCAGTACTTCGGGCCG	CASSQGDRGLYEQYF	In	VDJ	29	1027	0.00576247601306236	0.0070528448305463036	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	3	0	3	23	-1	49	39	52	TCRBV01,TCRBV04													CASSQGDRGLYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAAATGCAGCGACGTACAATGAGCAGTTCTTCGGGCCA	CASSENAATYNEQFF	In	VDJ	36	1279	0.007176442863395091	0.008783435772413556	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	4	5	3	23	38	47	43	50	TCRBV02,TCRBV12					01,02								CASSENAATYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCCGATCTTCCGCCCGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	42	1494	0.008382803469829763		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	2	4	15	0	18	30	-1	45	48	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGATTCCAGGACAGCATCTACGAGCAGTACTTCGGGCCG	CASGFQDSIYEQYF	In	VDJ	45	1614	0.009056121017607255	0.011084022937197404	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	5	3	10	3	24	31	47	41	50		TCRBV24-01,TCRBV24-or09_02												CASGFQDSIYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTACAGGCTTCAATGAGCAGTTCTTCGGGCCA	CASSFTGFNEQFF	In	VDJ	48	1702	0.009549887219310747	0.011688356281976444	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	6	3	3	24	36	44	39	47		TCRBV24-01,TCRBV24-or09_02												CASSFTGFNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATCTGGATATTCGGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	49	1722	0.009662106810606997		40	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	10	2	6	14	0	24	31	-1	45	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATTAGCGGGGGGGACCCTAAGGAGACCCAGTACTTCGGGCCA	CSARDISGGDPKETQYF	In	VDJ	50	1765	0.00990337893189393	0.012121004017443258	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	3	8	26	40	54	43	62		TCRBV20-01,TCRBV20-or09_02												CSARDISGGDPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCCCCAGGAGGGGCGATGAGCAGTTCTTCGGGCCA	CATSDPPRRGDEQFF	In	VDJ	70	2481	0.013920840300299626	0.017038079868145452	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	8	7	3	24	39	52	46	55		TCRBV24-01,TCRBV24-or09_02												CATSDPPRRGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAGGCGGCTACGAGCAGTACTTCGGGCCG	CASSVEGGYEQYF	In	VDJ	77	2725	0.015289919314113857	0.018713731415032794	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	3	3	0	23	39	-1	42	46	TCRBV09,TCRBV21					01,02								CASSVEGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCACAGGGGGCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSPQGAGGELFF	In	VDJ	91	3217	0.018050521260001572	0.02209250420629743	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	7	2	3	18	30	41	32	44	TCRBV07,TCRBV11													CASSPQGAGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	114	4038	0.022657135482712573		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	1	1	1	26	43	47	44	48		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAAGACCTACTCTGAACACTGAAGCTTTCTTTGGACAA	CASSQRPTLNTEAFF	In	VDJ	129	4573	0.02565900954988722	0.03140473165539265	45	unresolved						TCRBJ01	TCRBJ01-01	01	2	2	7	0	1	6	20	35	39	36	45	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRPTLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGCCGGGAGTGACCTACGAGCAGTACTTCGGGCCG	CARSLPGVTYEQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	42	TCRBV05	TCRBV05-03		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	2	1	3	18	33	40	34	43			01,02											CARSLPGVTYEQYF+TCRBV05-03+TCRBJ02-07	TCRBV05-03	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGGTTAAGGGTAAAGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	122	6.845395069071159E-4		46	TCRBV05	TCRBV05-03					TCRBJ01	TCRBJ01-04	01	0	5	3	5	3	5	18	34	41	37	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-03+TCRBJ01-04	TCRBV05-03		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGCCGGGAGAACGATAAAAGCTTTCTTTGGACAA	CASSAGRTIKAFF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	9	2	8	18	30	38	32	46														CASSAGRTIKAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTATTCCAGGGCTACGAGCAGTACTTCGGGCCG	CASSLFQGYEQYF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	3	0	18	33	-1	36	41														CASSLFQGYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAACCATCTAGGGGGGAATGAGCAGTTCTTCGGGCCA	CASNHLGGNEQFF	In	VDJ	5	165	9.258116281940501E-4	0.001133125021460701	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	7	5	1	7	7	1	18	28	41	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNHLGGNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGAAGGGCTACGAGCAGTACTTCGGGCCG	CASSLGKGYEQYF	In	VDJ	5	171	9.594775055829246E-4	0.0011743295676956357	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-07	01	1	5	3	3	3	0	18	34	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGKGYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCGGGCATGGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CAGHGTNTGELFF	In	VDJ	12	414	0.002322945539832344	0.0028431136902104864	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	8	0	0	0	6	18	-1	28	24	34														CAGHGTNTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGGGGAGCCTCTACGAGCAGTACTTCGGGCCG	CASSPGGSLYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	3	2	5	18	30	39	32	44														CASSPGGSLYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGAAGGGAGTGGGGACGCAGATACGCAGTATTTTGGCCCA	CASSEGSGDADTQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	7	4	10	1	18	30	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGSGDADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCTCCCCAGACTAGCGGGTACACAGATACGCAGTATTTTGGCCCA	CASSLPPQTSGYTDTQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	4	2	8	2	18	33	51	41	53						01,02								CASSLPPQTSGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAACAGCTTAACGCTCAGCGGCCTCAAAAACATTCAGTACTTCGGCGCC	CANSLTLSGLKNIQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	6	5	3	6	3	18	33	44	39	47						01,02								CANSLTLSGLKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGACGTAGCGGGGGGGATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRRSGGDSYNEQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	1	8	2	18	30	49	38	51														CASSPRRSGGDSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGCCCAAATTCCCCTGAACACTGAAGCTTTCTTTGGACAA	CASSAQIPLNTEAFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	6	0	3	8	18	30	35	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAQIPLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGGGGGACTAGCGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSGGLAGTGELFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	4	5	2	1	18	30	44	32	45						01,02								CASSGGLAGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCATGGGGTGGACAGATACGCAGTATTTTGGCCCA	CASSIMGWTDTQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	2	3	5	3	18	30	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIMGWTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCTCAGGGGAACAAAGCAACTTACGAGCAGTACTTCGGGCCG	CASSPPQGNKATYEQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	4	6	12	18	30	42	36	54														CASSPPQGNKATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGAGCGACACCTCGGGGACCCAGTACTTCGGGCCA	CASSLSDTSGTQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	6	2	6	7	7	7	18	29	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSDTSGTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGACAGGRGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSDRXSSYEQYF	In	VDJ	1	14	7.855371390737395E-5	9.614394121484737E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	0	2	2	18	31	42	33	44														CASSSDRXSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGATGGACTAGCGGCCCCTACGAGCAGTACTTCGGGCCG	CASGWTSGPYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	1	5	2	4	2	18	27	41	31	43						01,02								CASGWTSGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGGAAGGACTAGCGGGGATAAATGAGCAGTTCTTCGGGCCA	CASSMEGLAGINEQFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	6	3	18	30	48	36	51														CASSMEGLAGINEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGCTGGGGACAGGGACCGAGTATGGCTACACCTTCGGTTCG	CASSPQLGTGTEYGYTF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	5	9	6	18	30	48	39	54														CASSPQLGTGTEYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTAGCGGTTTCGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRSGFGSYEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	5	0	2	6	18	30	38	32	44						01,02								CASSRSGFGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTAGCGGGGGGGCGGCGTACGAGCAGTTCTTCGGGCCA	CASSLVSGGAAYEQFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	5	0	10	1	8	18	34	46	35	54														CASSLVSGGAAYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGGATGGCCACCCCTAACTATGGCTACACCTTCGGTTCG	CASRMATPNYGYTF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	0	3	5	18	29	35	32	40														CASRMATPNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATTTGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSSFGTYNEQFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	0	8	2	5	0	18	31	-1	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSFGTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACCGGGAGCGTGTACGAGCAGTACTTCGGGCCG	CASSLTGSVYEQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	4	3	4	18	32	41	35	45														CASSLTGSVYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAAGTTCAGGGTTCGGAACCTACAAGCAGTACTTCGGGCCG	CASSLSSGFGTYKQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	8	7	13	18	30	42	37	55														CASSLSSGFGTYKQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCTCGGGGGGTGATTCACCCCTCCACTTTGGGAAC	CASSLGSGGDSPLHF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	1	8	1	8	3	2	18	34	44	37	46														CASSLGSGGDSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCGAATAGCGTCGCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSNSVASTGELFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	5	6	4	5	7	18	27	37	32	44						01,02								CASSNSVASTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSFRVAGTDTQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	5	1	5	0	18	32	-1	37	43						01,02								CASSFRVAGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTGGTAGCGGGAGGGATCGGGGAGCTGTTTTTTGGAGAA	CASSQVVAGGIGELFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	0	7	7	2	18	30	48	37	50														CASSQVVAGGIGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACATCAGCGGGGGGATGTACAATGAGCAGTTCTTCGGGCCA	CASSYISGGMYNEQFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	1	4	5	3	18	31	45	36	48														CASSYISGGMYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACGACAAGGTGGGGCCGCTAACTATGGCTACACCTTCGGTTCG	CASSSRQGGAANYGYTF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	7	0	0	11	2	18	31	47	42	49														CASSSRQGGAANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCGGGAGTAGTACGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	1.1783057086106093E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	0	2	5	1	6	18	31	46	32	52														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGCACAGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLDAQVNTEAFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	0	3	0	18	35	-1	38	43														CASSLDAQVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGGCAATACAATGAGCAGTTCTTCGGGCCA	CASSLDGQYNEQFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	4	1	2	18	35	40	36	42														CASSLDGQYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGACAGGGGGCCGGGATGGCTATACCTTCGGTTCG	CASSGTGGRDGYTF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	14	0	12	18	-1	42	30	54														CASSGTGGRDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCGTCAGGGACCTACGAGCAGTACTTCGGGCCG	CASSPSSGTYEQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	2	7	1	18	30	42	37	43														CASSPSSGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGACAGGGCGTTGACCGGGGAGCTGTTTTTTGGAGAA	CASSLDDRALTGELFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	3	5	1	5	18	35	43	36	48														CASSLDDRALTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAACGGGCAATGAGCAGTTCTTCGGGCCA	CASSLGLTGNEQFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	9	6	0	5	18	-1	39	34	44						01,02								CASSLGLTGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCACCTCACAGGGGGCAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSTSQGAGSTDTQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	0	5	4	18	30	44	35	48														CASSTSQGAGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCCCTGTCACAGGGGACAAATGAGCAGTTCTTCGGGCCA	CASSLSLSQGTNEQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	2	7	9	3	18	32	48	41	51														CASSLSLSQGTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGTAGCGGGGTTAGCGCAGATACGCAGTATTTTGGCCCA	CASSPGSGVSADTQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	3	4	5	6	18	30	43	35	49														CASSPGSGVSADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGCCGGGACAGGGCCGGAAAAACTGTTTTTTGGCAGT	CASSSAGTGPEKLFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	8	5	3	18	31	45	36	48														CASSSAGTGPEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGTAGGGGGCTTGAATCAGCCCCAGCATTTTGGTGAT	CASSLEVGGLNQPQHF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	4	3	3	18	35	45	38	48														CASSLEVGGLNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGTTGGGTGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGWVASTDTQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	1	0	0	10	18	-1	38	34	48														CASSLGGWVASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGCGGTCACTTACAATGAGCAGTTCTTCGGGCCA	CASSLVAVTYNEQFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	5	4	0	5	18	-1	40	34	45						01,02								CASSLVAVTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCAGGGATAAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRDKGSYEQYF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	3	0	2	7	18	27	34	29	41														CASSRDKGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATAGGAGCTACCACAGATACGCAGTATTTTGGCCCA	CASSLIGATTDTQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	2	2	4	4	18	32	40	36	44														CASSLIGATTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAACTAGCGGGAGGGCGGGATACGCAGTATTTTGGCCCA	CASSLELAGGRDTQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	0	6	3	3	18	32	48	35	51														CASSLELAGGRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCGGGAGTTTGGAGATACGCAGTATTTTGGCCCA	CASSSREFGDTQYF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	8	2	5	2	5	18	31	39	33	44														CASSSREFGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCATATCCTCAGTGAACACTGAAGCTTTCTTTGGACAA	CASSISSVNTEAFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	5	0	7	0	18	30	-1	37	40														CASSISSVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTCCGGGGAGGGGGCAGGGAGCAGTTCTTCGGGCCA	CASSQVRGGGREQFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	5	0	10	11	3	18	30	48	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVRGGGREQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGGGACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASTGTSGGYEQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	3	2	0	18	28	-1	30	44														CASTGTSGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGGCGGGACCGGGAGACCCAGTACTTCGGGCCA	CASSLGGRDRETQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	6	0	5	0	8	18	-1	40	34	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGRDRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCATGACAGGGTCGGTGAGAGAGACCCAGTACTTCGGGCCA	CASSSMTGSVRETQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	3	4	4	8	18	31	42	35	50														CASSSMTGSVRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTCGTCTAGCGGAGGGATACAATGAGCAGTTCTTCGGGCCA	CASSLGRLAEGYNEQFF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	4	7	5	18	32	46	39	51						01,02								CASSLGRLAEGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTACAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLGTGNQPQHF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	3	4	2	0	18	34	-1	36	42														CASSLGTGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGTTGCCGGTAGGTGACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	1.795513460739976E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	2	5	4	7	11	3	18	33	47	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGCAGGGGGCATGGAATGAGCAGTTCTTCGGGCCA	CASSFGQGAWNEQFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	7	4	4	18	32	44	36	48														CASSFGQGAWNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTCCGTCCCGGGAGAGCAGAGACCCAGTACTTCGGGCCA	CASSLFRPGRAETQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	2	4	8	3	18	33	47	41	50														CASSLFRPGRAETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGGGACACGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGGDTGSYEQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	0	0	8	18	-1	39	32	47														CASSLGGDTGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAGAGACAGCCTTATACAATGAGCAGTTCTTCGGGCCA	CASSVETALYNEQFF	In	VDJ	1	36	2.019952643332473E-4	2.4722727740960753E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	5	4	0	5	18	-1	40	35	45														CASSVETALYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCTTCGGGTACAATRAGCAGTTCTTCGGGCCA	CASSLPFGYNXQFF	In	VDJ	1	37	2.0760624389805973E-4	2.5409470178209664E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	4	11	5	7	18	33	42	38	49						01,02								CASSLPFGYNXQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGCAGTGACGGAGACGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSSSDGDGKTYGYTF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	2	4	9	10	18	30	43	39	53														CASSSSDGDGKTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGTCAGCAGCGAACTACCCGGGGCGAAGGGCTACACCTTCGGTTCG	CVSSELPGAKGYTF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	7	0	8	9	4	18	30	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSSELPGAKGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGACCCCCCCCGGACAGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	41	2.3005016215730943E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	5	1	11	0	18	31	-1	42	48														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGAACCGGACAGACTGAAAAACTGTTTTTTGGCAGT	CASSPRTGQTEKLFF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	7	9	2	18	30	45	39	47														CASSPRTGQTEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTTCCGGGACAGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	2.3566114172212185E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	4	1	7	1	18	32	47	39	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTATCCCACTAGCGGGATTCAAGAACCAAGAGACCCAGTACTTCGGGCCA	CASSFIPLAGFKNQETQYF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	3	3	0	6	7	18	32	48	38	55														CASSFIPLAGFKNQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTACCTTATACTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	45	2.524940804165591E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	4	9	0	1	7	18	28	32	29	39						01,02								X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGACAGGGACGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	48	2.693270191109964E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	3	3	4	18	31	41	34	45														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTTGGGACAGGAGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	48	2.693270191109964E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	2	4	3	18	31	43	35	46														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGACGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGRTNTGELFF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	1	7	0	3	3	18	30	37	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGACCGGGACCGTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSWTGTVGTGELFF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	0	7	4	5	6	18	31	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWTGTVGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGACAGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRDRSGANVLTF	In	VDJ	1	52	2.917709373702461E-4	3.571060673694331E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	1	1	1	18	30	38	31	39														CASSRDRSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGACCATCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGPSSTDTQYF	In	VDJ	2	54	3.0299289649987095E-4	3.7084091611441127E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	7	0	2	5	18	30	37	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPSSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCTCCGAAGCCTACGAGCAGTACTTCGGGCCG	CASSLVSEAYEQYF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	2	8	2	5	2	18	34	41	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSEAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATCACAGGGAAGGCCGCGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	56	3.142148556294958E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	6	4	9	18	30	40	34	49														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCGTGGGGGACTAGCGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSPPWGTSGSGELFF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	4	6	9	1	18	30	51	39	52						01,02								CASSPPWGTSGSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCGACAGGGCAACTACGAGCAGTACTTCGGGCCG	CASSPRQGNYEQYF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	3	4	3	18	30	41	34	44														CASSPRQGNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGCCTCCGACAGGGGAGTAATGGCTACACCTTCGGTTCG	CASSPRLRQGSNGYTF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	6	10	4	18	30	48	40	52														CASSPRLRQGSNGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGACTAGCGGAGACAGATACGCAGTATTTTGGCCCA	CASSRGLAETDTQYF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	5	3	2	2	18	30	43	32	45						01,02								CASSRGLAETDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLLGSGANVLTF	In	VDJ	2	58	3.2543681475912065E-4	3.983106136043677E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	2	6	2	1	2	0	18	33	-1	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGACAGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSLRTGLTDTQYF	In	VDJ	2	59	3.310477943239331E-4	4.0517803797685676E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	3	2	1	2	18	33	42	34	44														CASSLRTGLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTTGTGGGACAGGTACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	63	3.534917125831828E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	4	2	5	3	18	34	47	39	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCAAGCCCGACCATGGGATGAGCAGTTCTTCGGGCCA	CASSSQARPWDEQFF	In	VDJ	2	67	3.759356308424325E-4	4.6011743295676957E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	0	9	8	15	0	18	31	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQARPWDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGATTTTAGCACTGAAGCTTTCTTTGGACAA	CASSSGDFSTEAFF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	4	0	7	18	-1	37	31	44														CASSSGDFSTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCCCCGGGTTCACAACCGGGGAGCTGTTTTTTGGAGAA	CASSLSPGFTTGELFF	In	VDJ	2	68	3.815466104072449E-4	4.669848573292587E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	5	5	6	18	33	42	38	48						01,02								CASSLSPGFTTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAACCCCCTCGAGGTGGGAGGGCGGTAGCTATGGCTACACCTTCGGTTCG	CASS*TPSRWEGGSYGYTF	Stop	VDJ	2	69	3.871575899720573E-4		57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	4	15	6	18	31	53	46	59														CASS*TPSRWEGGSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCATTCGGGTACAGCTTTGGAGGAGCGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	70	3.9276856953686975E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	1	3	18	4	18	28	51	46	55														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGAACACCCAAGAGACCCAGTACTTCGGGCCA	CASSLMNTQETQYF	In	VDJ	2	70	3.9276856953686975E-4	4.8071970607423684E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	6	1	4	1	18	33	40	37	41														CASSLMNTQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGGTGCAGGGATCCTACGAGCAGTACTTCGGGCCG	CASSPGVQGSYEQYF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	1	1	8	18	30	37	31	45														CASSPGVQGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTAGGCGGGGGAGGAGATACGCAGTATTTTGGCCCA	CASSLLGGGGDTQYF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	2	5	4	3	18	33	44	37	47														CASSLLGGGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGTCTAGCCGGGACGAGCAGTACTTCGGGCCG	CASSLWSSRDEQYF	In	VDJ	2	79	4.432673856201816E-4	5.425265254266387E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	7	5	5	4	18	32	42	37	46						01,02								CASSLWSSRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAGGGACTAGCGGGAGGGCCAGCCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	83	4.657113038794313E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	0	5	2	7	18	31	49	33	56														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCCGGGACTAACTTACAATGAGCAGTTCTTCGGGCCA	CASSLGPGLTYNEQFF	In	VDJ	2	83	4.657113038794313E-4	5.699962229165951E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	9	4	4	3	18	34	45	38	48						01,02								CASSLGPGLTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCTCAGCGGGTGGAGTCGGGCGGCTGAAGCTTTCTTTGGACAA	CASSYLSGWSRAAEAFF	In	VDJ	2	84	4.713222834442437E-4	5.768636472890843E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	4	6	5	13	18	31	42	36	55						01,02								CASSYLSGWSRAAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCGGGGTTCGGGGGTCCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGRGSGVPGANVLTF	In	VDJ	2	85	4.769332630090561E-4	5.837310716615734E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	1	8	2	2	9	3	18	34	49	43	52														CASSLGRGSGVPGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGTGTAGCGAGCAGCGGTACACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	89	4.993771812683058E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	2	7	12	18	30	42	37	54						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCCCCATACCAGGACAAACATACGCAGTATTTTGGCCCA		Out	VDJ	3	92	5.162101199627431E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	6	7	10	3	18	27	42	37	45														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGCGAATGGCAGCCCCAGCATTTTGGTGAT	CASSLGGEWQPQHF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	7	0	7	0	6	18	-1	39	34	45														CASSLGGEWQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAAGCAGGGGCCCATCAGCCCCAGCATTTTGGTGAT	CASSLKAGAHQPQHF	In	VDJ	3	98	5.498759973516177E-4	6.730075885039316E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	5	5	3	18	32	43	37	46														CASSLKAGAHQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTGGGGGGTCGGTTACGAGCAGTACTTCGGGCCG	CASSLDWGVGYEQYF	In	VDJ	3	117	6.564846090830537E-4	8.034886515812245E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	1	4	2	5	18	35	43	37	48														CASSLDWGVGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGACTAGCGGAATACAATGAGCAGTTCTTCGGGCCA	CASSLGLAEYNEQFF	In	VDJ	3	119	6.677065682126785E-4	8.172235003262026E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	4	2	2	18	30	43	32	45						01,02								CASSLGLAEYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTCAAGCTGTTGGGGCCGGCGCTGGGAGTGAAGGGGCCCAGTACTTCGGGCCA		Out	VDJ	3	120	6.73317547777491E-4		59	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	6	5	2	9	32	0	18	29	-1	61	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCCGACGCAGAGCCTTTACGAGCAGTACTTCGGGCCG	CASSLGPTQSLYEQYF	In	VDJ	3	124	6.957614660367407E-4	8.515606221886482E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	2	7	4	4	10	18	34	41	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPTQSLYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGTCCGGGGCAGGCCGCGAGCAGTACTTCGGGCCG	CASSLVSGAGREQYF	In	VDJ	5	160	8.97756730369988E-4	0.0010987878995982556	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	7	0	6	7	6	18	32	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSGAGREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCGGGACAGGGGTTGGCTACACCTTCGGTTCG	CASSLSGTGVGYTF	In	VDJ	5	163	9.145896690644252E-4	0.001119390172715723	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	7	3	1	18	33	46	36	47														CASSLSGTGVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCTCTTTTACAGGACACTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	5	165	9.258116281940501E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	1	12	2	18	30	47	42	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCCAATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPNPYNEQFF	In	VDJ	5	177	9.931433829717992E-4	0.0012155341139305704	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	4	6	2	5	3	18	30	37	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPNPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGGGTCGGGCACTGAAGCTTTCTTTGGACAA	CASSLTGSGTEAFF	In	VDJ	5	193	0.001082919056008798	0.001325412903890396	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	4	1	5	18	33	39	34	44														CASSLTGSGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGGCGGGCGGGAGACCCAGTACTTCGGGCCA	CASSSGGGRETQYF	In	VDJ	6	202	0.0011334178720921097	0.0013872197232427978	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	5	0	6	18	-1	39	31	45														CASSSGGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCACGGCTGGCCCCATGAGCAGTTCTTCGGGCCA	CASSPHGWPHEQFF	In	VDJ	6	203	0.0011390288516569223	0.001394087147615287	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	9	0	8	6	7	18	30	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHGWPHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGACTAGCGGCAAGAGACCCAGTACTTCGGGCCA	CASSRD*RQETQYF	Stop	VDJ	6	204	0.0011446398312217347		42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	2	1	0	18	30	-1	31	42						01,02								CASSRD*RQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGAGGGGCAGAAACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPREGQKPGANVLTF	In	VDJ	6	204	0.0011446398312217347	0.001400954571987776	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	8	0	2	3	8	18	30	41	33	49														CASSPREGQKPGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGCTGGGGGACCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSWLGDPTGELFF	In	VDJ	6	211	0.0011839166881754217	0.0014490265425951996	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	4	0	7	4	6	2	18	31	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWLGDPTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCTTAGGACAGGGGGCGGATGGCTACACCTTCGGTTCG	CASSRLGQGADGYTF	In	VDJ	6	213	0.0011951386473050465	0.0014627613913401779	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	0	6	6	2	18	30	47	36	49														CASSRLGQGADGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGACGAATACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQGRILAKNIQYF	In	VDJ	6	217	0.0012175825655642962	0.0014902310888301343	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	5	1	7	0	3	7	18	30	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRILAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTTGGCGGGAGCAGGCAGATACGCAGTATTTTGGCCCA	CASSLIWREQADTQYF	In	VDJ	6	218	0.0012231935451291085	0.0014970985132026233	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	4	5	4	18	33	45	38	49														CASSLIWREQADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACAGGGGGCCGGGACGAGCAGTACTTCGGGCCG	CASSPTGGRDEQYF	In	VDJ	6	221	0.0012400264838235459	0.0015177007863200907	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	5	2	4	18	30	42	32	46														CASSPTGGRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACAGTTCTAACTATGGCTACACCTTCGGTTCG	CASSLDSSNYGYTF	In	VDJ	9	327	0.001834790317693663	0.002245647769803935	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	0	0	2	18	-1	38	32	40														CASSLDSSNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGACCGCGTAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGDRVGSNQPQHF	In	VDJ	13	448	0.0025137188450359664	0.003076606118875116	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	1	2	7	0	2	8	18	34	39	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDRVGSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGATCTAGCGGGAGAGCGGCGAATGAGCAGTTCTTCGGGCCA	CASSQGSSGRAANEQFF	In	VDJ	13	470	0.00263716039546184	0.003227689455069876	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	7	7	7	18	30	47	37	54														CASSQGSSGRAANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGTCACGGACAGGGTCGATCGAGCAGTACTTCGGGCCG	CASSSSRTGSIEQYF	In	VDJ	18	624	0.003501251248442953	0.004285272808433197	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	6	6	5	18	31	45	37	50														CASSSSRTGSIEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGTGGGGGCTTACGAGATACGCAGTATTTTGGCCCA	CASSLVGGGLRDTQYF	In	VDJ	20	712	0.003995017450146446	0.0048896061532122375	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	6	0	5	5	5	18	34	45	39	50														CASSLVGGGLRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGCGGACTCCTACGAGCAGTACTTCGGGCCG	CASSLQADSYEQYF	In	VDJ	23	801	0.004494394631414753	0.005500806922363767	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	4	4	0	0	4	18	-1	37	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQADSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCCCCCTAGCGGCGGAAACATTCAGTACTTCGGCGCC	CASSPPPSGGNIQYF	In	VDJ	55	1967	0.01103679680398604	0.013508223740686056	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	4	5	6	7	3	18	30	44	37	47						01,02								CASSPPPSGGNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCTGGGGGACACCATTTTGAACACTGAAGCTTTCTTTGGACAA	CASSTLGDTILNTEAFF	In	VDJ	77	2733	0.015334807150632358	0.018768670810012704	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	7	6	18	30	43	37	49														CASSTLGDTILNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCACCGGCCTCACACGACTAGCAGGGTTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATGLTRLAGLSSYNEQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	57	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	2	7	0	14	9	24	29	50	43	59						01,02								CATGLTRLAGLSSYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGCCAGAGCGGGGGAAACAATGAGCAGTTCTTCGGGCCA	CASGQSGGNNEQFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	6	2	5	10	2	26	31	49	41	51														CASGQSGGNNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACCTACCGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASGPTGQGTDTQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	4	1	7	0	26	37	-1	44	51														CASGPTGQGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTAGATTCGGGACGGAACAAGAGACCCAGTACTTCGGGCCA	CASRFGTEQETQYF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	8	0	7	2	6	4	26	35	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFGTEQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTACCTGTTCTCTGGAAACACCATATATTTTGGAGAG	CASYLFSGNTIYF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	12	4	5	0	0	9	26	-1	34	31	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASYLFSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCACAACAGGGCTGGCAGATACGCAGTATTTTGGCCCA	CASGTTGLADTQYF	In	VDJ	5	173	9.706994647125495E-4	0.001188064416440614	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	4	4	4	26	37	47	41	51														CASGTTGLADTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTCGTCAGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	7	239	0.0013410241159901696		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	4	4	0	26	40	-1	44	49														X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTACATGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASTTWGGTDTQYF	In	VDJ	16	578	0.0032431461884615815	0.003969371287298699	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	9	0	3	11	1	26	31	49	42	50														CASTTWGGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCTTAGGGACCAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGLALGTSSSYNEQFF	In	VDJ	17	611	0.0034283085141003917	0.004195996291590839	54	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	1	0	7	0	5	6	26	42	52	47	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLALGTSSSYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCTGGGGGTCAACCCCGGACTGTTTTTTGGCAGT	CASLGVNPGLFF	In	VDJ	18	647	0.003630303778433639	0.004443223569000446	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	12	6	1	13	6	10	26	31	42	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLGVNPGLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGACCACCTGGGAGGAAACACCATATATTTTGGAGAG	CASSQDHLGGNTIYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	2	0	8	4	8	0	20	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDHLGGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGACCGGCAGTCCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDRQSPSTDTQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	51	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	0	0	12	20	-1	38	35	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRQSPSTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATACATCGGACTATGGCTACACCTTCGGTTCG	CASSQDTSDYGYTF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	3	6	3	3	4	20	35	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDTSDYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGTTCTGGAGGCCCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	20	1.122195912962485E-4		50	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	10	1	0	5	3	20	35	45	40	48														X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGCCAGGGGCCCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	1.122195912962485E-4		41	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	4	2	3	20	34	42	36	45														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCGAAACAGGGGGACTCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	1.2344155042587335E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	1	3	5	3	20	31	44	36	47														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACTTGACAGCGACGTTGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	1.4027448912031063E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	5	3	3	9	20	30	38	33	47														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTCGGGACTTCGGAGACCCAGTACTTCGGGCCA	CASSFGTSETQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	10	5	4	3	20	31	41	35	44						01,02								CASSFGTSETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGCCCATCAATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	2.24439182592497E-4		44	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	0	4	6	1	3	4	20	37	42	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGCGGCAGGAGCAAAATTTGAAGCTTTCTTTGGACAA		Out	VDJ	1	43	2.4127212128693428E-4		47	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	0	4	4	7	4	9	20	37	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTATCGAGACGCACGCAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	48	2.693270191109964E-4		55	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-06	01	5	2	7	5	5	15	20	32	40	37	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCTCCAGTATGCCACAAGAAAAACTGTTTTTTGGCAGT	CASSLSSMPQEKLFF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	6	8	13	1	20	33	49	46	50														CASSLSSMPQEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGGGACAAGGCCTACGAGCAGTACTTCGGGCCG	CASSWDKAYEQYF	In	VDJ	2	59	3.310477943239331E-4	4.0517803797685676E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	2	2	3	20	31	39	33	42														CASSWDKAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGGGACAGAAGAATGAACATGAACACTGAAGCTTTCTTTGGACAA	CASSRDRRMNMNTEAFF	In	VDJ	2	60	3.366587738887455E-4	4.1204546234934586E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	0	11	20	-1	40	33	51														CASSRDRRMNMNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTCTCCACCCGGGGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	66	3.7032465127762005E-4		46	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	3	5	8	1	20	37	50	45	51														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACTCCGCGACAGGGGAATCCTACGAGCAGTACTTCGGGCCG	CASSHSATGESYEQYF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	1	9	2	20	31	48	40	50														CASSHSATGESYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGCGTCAGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQASGSTGELFF	In	VDJ	4	130	7.294273434256153E-4	8.927651684235827E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	2	4	3	4	4	2	20	35	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQASGSTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCATTCCGGGACAGGGTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPHSGTGFSNQPQHF	In	VDJ	5	161	9.033677099348004E-4	0.0011056553239707449	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	0	8	2	20	33	50	41	52														CASSPHSGTGFSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCCATCTTTTAATATGGCTACACCTTCGGTTCG	CASSQPIF*YGYTF	Stop	VDJ	5	193	0.001082919056008798		42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	4	6	5	2	8	20	35	39	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPIF*YGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCCAGGGACAGGGGTTTCCCTACGAGCAGTACTTCGGGCCG	CASSRQGQGFPYEQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	2	6	4	23	34	50	40	54														CASSRQGQGFPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGTGGGGGGCCCCAATGAGCAGTTCTTCGGGCCA	CASSDSVGGPNEQFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	6	0	6	4	2	23	40	50	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSVGGPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTGCGGGGGGGCATACCGGGGAGCTGTTTTTTGGAGAA	CASSYGAGGHTGELFF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	0	5	3	3	23	38	50	41	53														CASSYGAGGHTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAAGCGCTCCCGGTACGCAGTATTTTGGCCCA	CASSLSAPGTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	6	8	2	7	23	36	42	38	49						01,02								CASSLSAPGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCATAGGACTAGCGGGAGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASIIGLAGGPSTDTQYF	In	VDJ	1	10	5.610979564812425E-5	6.867424372489098E-5	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	1	0	0	5	3	23	33	53	38	56														CASIIGLAGGPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCGACAGTCGAACACTGAAGCTTTCTTTGGACAA	CASRRQSNTEAFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	2	2	23	34	41	36	43														CASRRQSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGTGGCGGGAGATGATGAGCAGTTCTTCGGGCCA	CASSPVAGDDEQFF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	8	6	3	23	35	48	41	51														CASSPVAGDDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACAGGGAAGCAGCCCCAGCATTTTGGTGAT	CASSETGKQPQHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	7	2	3	23	35	44	37	47														CASSETGKQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAATAGGAGGGGATCAGCCCCAGCATTTTGGTGAT	CASSVIGGDQPQHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	0	5	6	1	23	35	47	41	48														CASSVIGGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCACCGGGACAAATGACGAGCAGTACTTCGGGCCG	CAISTGTNDEQYF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	5	4	4	23	34	44	38	48														CAISTGTNDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCCAGACATCTGTGTACTTGTGTGCCAACAGTTACTCCGTCCGGGACAGTCGAGGGAGGTTTAATTCACCCCTCCACTTTGGGAAC	CANSYSVRDSRGRFNSPLHF	In	VDJ	1	11	6.172077521293668E-5	7.554166809738007E-5	60	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	6	5	12	21	38	50	43	62														CANSYSVRDSRGRFNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATACACGGGATTAATGAAAAACTGTTTTTTGGCAGT	CASSIHGINEKLFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	8	3	4	5	1	23	35	45	40	46														CASSIHGINEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTACTAGCGGCGCCTACGAGCAGTACTTCGGGCCG	CASSRTSGAYEQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	2	3	2	23	35	46	38	48						01,02								CASSRTSGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGCGGGGGGGCAAATGAGCAGTTCTTCGGGCCA	CASSDSSGGANEQFF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	0	7	1	2	23	40	51	41	53														CASSDSSGGANEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAAGGACCTCGCCCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	6.73317547777491E-5		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	9	1	7	2	3	7	23	31	38	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAACAGGGCTCGAGTGGCTACACCTTCGGTTCG	CASSQQGSSGYTF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	7	2	6	23	35	43	37	49														CASSQQGSSGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACTAGCGGGAGCACAAAGCAGTTCTTCGGGCCA	CASSYTSGSTKQFF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	2	11	0	5	23	-1	49	38	54														CASSYTSGSTKQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGAGGGTACGCAGTATTTTGGCCCA	CASSYSEGTQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	8	0	0	23	-1	-1	40	46														CASSYSEGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGAGCGGGGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLGAGGTYEQYF	In	VDJ	1	13	7.294273434256153E-5	8.927651684235828E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	0	2	4	1	23	36	50	40	51														CASSLGAGGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCGGGGCCTTAGGGCAGCGACCTACGAGCAGTACTTCGGGCCG	CATRGLRAATYEQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	10	7	0	2	3	13	23	30	38	33	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRGLRAATYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGCGGGGGGGCCCGATACGCAGTATTTTGGCCCA	CASSYSAGGPDTQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	6	1	3	23	40	50	41	53														CASSYSAGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTTTAAGCGGGTGGAACACAGATACGCAGTATTTTGGCCCA	CASSYSLSGWNTDTQYF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	4	2	4	5	23	40	50	44	55						01,02								CASSYSLSGWNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAACCCACAGGGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSSTHRDAGELFF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	6	6	3	23	36	48	42	51														CASSSTHRDAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGTGATGGACGCAGAACCGGGGAGCTGTTTTTTGGAGAA	CASRGDGRRTGELFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	1	7	5	7	5	23	34	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGDGRRTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGAGGACAGCAGATACGCAGTATTTTGGCCCA	CASSRRTADTQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	4	4	0	23	35	-1	39	45														CASSRRTADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCTCCGGGACTGGGAATTAACTATGGCTACACCTTCGGTTCG	CASSAPPGLGINYGYTF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	1	8	6	23	35	49	43	55						01,02								CASSAPPGLGINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGGGGACTCTACTGAAGCTTTCTTTGGACAA	CASSYAGDSTEAFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	0	10	5	4	2	23	38	48	42	50						01,02								CASSYAGDSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCGGGGCGTCGAATCAGCCCCAGCATTTTGGTGAT	CAISVGASNQPQHF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	7	0	4	3	4	23	35	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISVGASNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCACATATGGGAAGCAGTTCACCCCTCCACTTTGGGAAC	CATSHMGSSSPLHF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	10	0	8	9	10	5	23	30	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSHMGSSSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCAAGGGCACCTCACAGATACGCAGTATTTTGGCCCA	CASSDQGHLTDTQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	5	3	2	5	5	23	35	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDQGHLTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGATAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGDSSGANVLTF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	0	8	0	1	3	23	35	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGTTTCGGGTCTAACTATGGCTACACCTTCGGTTCG	CASSVGFGSNYGYTF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	0	8	1	23	35	47	43	48						01,02								CASSVGFGSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATTGGTATGCAAGCTTTCTTTGGACAA	CASSYSIGMQAFF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	10	9	4	5	23	40	46	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSIGMQAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCCTCTTCACCCCTCCACTTTGGGAAC	CASSYPSSPLHF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	4	10	9	3	1	23	37	42	40	43						01,02								CASSYPSSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGCCGCGGGACTCTTTTACGAGCAGTACTTCGGGCCG	CASSYAAGLFYEQYF	In	VDJ	1	17	9.538665260181123E-5	1.1674621433231467E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	4	6	4	23	37	49	43	53						01,02								CASSYAAGLFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAGGGTAGCAACTCACCCCTCCACTTTGGGAAC	CASRQGSNSPLHF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	10	0	7	23	-1	40	34	47														CASRQGSNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACAGGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGQENTGELFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	2	0	2	23	-1	42	35	44														CASSGQENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGACCGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGDRANTGELFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	0	7	0	1	4	23	35	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDRANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCTGCGGGGGACTGGGACAGATACGCAGTATTTTGGCCCA	CASSYLRGTGTDTQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	3	3	6	23	37	47	40	53														CASSYLRGTGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCCGGTTCACCCCTCCACTTTGGGAAC	CASSSPGSPLHF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	8	5	9	4	0	23	36	-1	40	43						01,02								CASSSPGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGGTTATATGACCGGGGAGCTGTTTTTTGGAGAA	CASGGYMTGELFF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	8	6	1	5	0	7	23	-1	37	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGGYMTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCTAGCGGGAGGGTCAGAGACCCAGTACTTCGGGCCA	CASSPLAGGSETQYF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	0	4	3	2	23	35	50	38	52														CASSPLAGGSETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGATCCCGGGACAGGGTGAAGCTTTCTTTGGACAA	CASSAIPGQGEAFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	7	8	0	23	35	-1	43	52														CASSAIPGQGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTACCCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSSYPAGELFF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	9	6	1	5	23	36	40	37	45						01,02								CASSSYPAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAAGACCGTAGGCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	20	1.122195912962485E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	10	2	7	0	1	8	23	30	34	31	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAATGCAGGGAGGGAAGCTTTCTTTGGACAA	CASRNAGREAFF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	8	7	0	23	34	-1	41	47														CASRNAGREAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTCACACAGGGGTTGAGAATCAGCCCCAGCATTTTGGTGAT	CASSPHTGVENQPQHF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	4	7	5	23	34	48	41	53														CASSPHTGVENQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGACGGACGTGACTGGCTACACCTTCGGTTCG	CASSVGTDVTGYTF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	7	7	3	9	23	35	43	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGTDVTGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCACCAAGAGACCCAGTACTTCGGGCCA	CASSYHQETQYF	In	VJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	0	0	0	0	1	23	-1	38	-1	39														CASSYHQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGAGACCAATCAGCCCCAGCATTTTGGTGAT	CASSYGETNQPQHF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	2	3	1	2	23	38	44	39	46														CASSYGETNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAACCTAGCGGGAGGGCCGCTATCGGGCCA	CASSKPSGRAAI	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02			5	4	0	20	4	6	23	35	51	39	57								TCRBJ02-01,TCRBJ02-05						CASSKPSGRAAI+TCRBV06-08+TCRBJ02-X	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATATAACGGGGGGTTCCCGCTATAATTCACCCCTCCACTTTGGGAAC	CASSDITGGSRYNSPLHF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	8	1	3	7	6	23	35	49	42	55														CASSDITGGSRYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTATCGACGGACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASIDGRANTEAFF	In	VDJ	1	21	1.1783057086106093E-4	1.4421591182227106E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	9	1	7	1	7	4	23	31	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIDGRANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTTCTCATACGGACAGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	1.1783057086106093E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	1	5	0	9	1	23	31	46	40	47														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAATCTACGGCCAGGGGGCCTTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	22	1.2344155042587335E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	0	3	12	3	23	30	50	42	53														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGAACCCGGGACAGTCGGGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.2344155042587335E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	8	9	4	23	35	51	44	55														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGCCTGGCGTAGGTGAAAAACTGTTTTTTGGCAGT	CASSAPGVGEKLFF	In	VDJ	1	22	1.2344155042587335E-4	1.5108333619476014E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	5	4	7	11	0	23	35	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPGVGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTCAGGGGGCCTAGAACTATGGCTACACCTTCGGTTCG	CASIQGA*NYGYTF	Stop	VDJ	1	22	1.2344155042587335E-4		42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	0	2	2	4	23	33	43	35	47														CASIQGA*NYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTAAGGCGGCAGGGGGCGCCCCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	23	1.2905252999068578E-4		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	3	9	7	23	34	51	43	58														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCTAATCGACAGGGGGCCAGGATTGACTATGGCTACACCTTCGGTTCG	CASSPPNRQGARIDYGYTF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	0	3	10	8	23	35	55	45	63														CASSPPNRQGARIDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACGGGGTGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSYTGWGQETQYF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	6	1	2	7	0	23	38	-1	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTGWGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCCGGACAGGGGGAGGAATGAGCAGTTCTTTGGGCCA	CASSYSPDRGRNEQFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02			0	1	1	22	3	18	23	40	53	43	71								TCRBJ02-01,TCRBJ02-05						CASSYSPDRGRNEQFF+TCRBV06-08+TCRBJ02-X	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTAAATCAGCCCCAGCATTTTGGTGAT	CASSYLNQPQHF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	5	9	4	0	0	23	-1	-1	39	41						01,02								CASSYLNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGGGAAGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSPGEGVNTEAFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	0	2	6	23	34	42	36	48														CASSPGEGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACAGGGGGGAAACTATGGCTACACCTTCGGTTCG	CASRGQGGNYGYTF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	2	0	2	23	-1	45	34	47														CASRGQGGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGAACCCCGGGACAGCATAGGCTACACCTTCGGTTCG	CASSGEPRDSIGYTF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	8	10	4	23	35	52	45	56														CASSGEPRDSIGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGTGCTAGACAGGGAAGGCTACAATGAGCAGTTCTTCGGGCCA	CAVLDREGYNEQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	2	3	3	6	4	23	29	42	35	46														CAVLDREGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGTACAATGAGCAGTTCTTCGGGCCA	CASSYSGQYNEQFF	In	VDJ	1	25	1.4027448912031063E-4	1.7168560931222744E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	4	0	0	23	-1	-1	40	47														CASSYSGQYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTCTAACCCGGGACAGAAGACCTAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASTSNPGQKT*NTGELFF	Stop	VDJ	1	26	1.4588546868512305E-4		57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	5	2	10	9	23	33	50	43	59														CASTSNPGQKT*NTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCACCCCTCCACAGGCCGCTATGGCTACACCTTCGGTTCG	CATHPSTGRYGYTF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	3	4	4	11	3	23	30	46	41	49														CATHPSTGRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAGGATAGCGGGCTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKDSGLNTGELFF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	4	2	5	3	23	35	47	40	50						01,02								CASSKDSGLNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATCAGGGGCGACGTTCAGCCCCAGCATTTTGGTGAT	CASSYIRGDVQPQHF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	6	2	6	23	38	46	40	52														CASSYIRGDVQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCAGGGAGGGCGCTATGGCTACACCTTCGGTTCG	CASSFQGGRYGYTF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	4	4	2	23	36	47	40	49														CASSFQGGRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTACAGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	1.5149644824993548E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	2	0	3	0	23	32	-1	35	42														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCGCGCAGGGAGTCCGGGAGATGGCCATCAGCCCCAGCATTTTGGTGAT	CASSYSRAGSPGDGHQPQHF	In	VDJ	1	27	1.5149644824993548E-4	1.8542045805720563E-4	60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	8	2	5	14	6	21	38	58	52	64														CASSYSRAGSPGDGHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGACAGGGGGCGATTACGCAGTATTTTGGCCCA	CASSGQGAITQYF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	0	8	1	3	23	34	46	35	49														CASSGQGAITQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCCGGACAGGGTTGGAAGATACGCAGTATTTTGGCCCA	CASSSRTGLEDTQYF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	5	4	5	23	35	47	39	52														CASSSRTGLEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGGATCCCTAGGGGTGAGCAGTTCTTCGGGCCA	CASSYSRIPRGEQFF	In	VDJ	1	28	1.571074278147479E-4	1.9228788242969474E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	9	10	0	23	40	-1	50	55														CASSYSRIPRGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCGATCAGGGAAAAGACTTTCGGGGGGCTACACCTTCGGTTCG	CASTRSGKRLSGGYTF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	4	3	8	6	15	23	33	44	39	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRSGKRLSGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTCCCCCGAGCAGTACTTCGGGCCG	CASSYSSPEQYF	In	VJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	0	0	6	0	6	23	-1	40	-1	46														CASSYSSPEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGTGGACAGGGAGCTACGAGCAGTACTTCGGGCCG	CASSSWTGSYEQYF	In	VDJ	1	29	1.6271840737956033E-4	1.9915530680218385E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	3	3	2	23	36	47	39	49														CASSSWTGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGATGACAGACCCTACGAGCAGTACTTCGGGCCG	CASSRDDRPYEQYF	In	VDJ	1	30	1.6832938694437275E-4	2.0602273117467293E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	2	5	2	7	2	23	34	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDDRPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATGACAGGGTACTACGAGCAGTACTTCGGGCCG	CASSYSMTGYYEQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	3	3	2	23	40	50	43	52														CASSYSMTGYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGGCCTATCCTACGAGCAGTACTTCGGGCCG	CASSYSGGLSYEQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	8	0	1	0	6	23	-1	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGGLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCAAGCCGGGACCCAGTACTTCGGGCCA	CASSYQAGTQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	6	7	7	3	3	23	37	43	40	46						01,02								CASSYQAGTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTAGCGTTGAAGCTTTCTTTGGACAA	CASSYRSVEAFF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	6	7	2	1	23	38	45	40	46						01,02								CASSYRSVEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAAGGAGGCATCAATCAGCCCCAGCATTTTGGTGAT	CASSYSKGGINQPQHF	In	VDJ	1	32	1.795513460739976E-4	2.1975757991965112E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	1	3	4	3	23	40	49	44	52														CASSYSKGGINQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCTTAAACCAAACAAAGGCACCTACGAGCAGTACTTCGGGCCG	CASSPLKPNKGTYEQYF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	3	6	2	14	6	23	34	51	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLKPNKGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGGGACAGGCCGAAGCTTTCTTTGGACAA	CASRTGQAEAFF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	8	3	2	23	34	45	37	47														CASRTGQAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCTCTACAGGGTTGGCCTACTATGGCTACACCTTCGGTTCG	CASSASTGLAYYGYTF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	3	6	7	23	35	47	41	54														CASSASTGLAYYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAGGGGGTCTATGGCTACACCTTCGGTTCG	CASSKGVYGYTF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	1	4	1	1	23	35	42	36	43														CASSKGVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGACCCCACTAGCGGGGAACCTACAATGAGCAGTTCTTCGGGCCA	CASSYRPH*RGTYNEQFF	Stop	VDJ	1	34	1.9077330520362245E-4		54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	3	2	7	2	23	38	55	45	57														CASSYRPH*RGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTACCATCAGGTCACAGGGAGGAGAGACCCAGTACTTCGGGCCA	CTIRSQGGETQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	3	3	4	3	3	23	34	43	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTIRSQGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACGGAAATTCACCCCTCCACTTTGGGAAC	CASSRDGNSPLHF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	5	0	7	7	1	3	23	35	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGGACAGCTCTACGAGCAGTACTTCGGGCCG	CASSFGQLYEQYF	In	VDJ	1	35	1.9638428476843488E-4	2.4035985303711842E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	3	2	2	23	36	44	38	46														CASSFGQLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGGCAGGGGGCCTTCACCCCTCCACTTTGGGAAC	CASSLGRGPSPLHF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	0	9	4	1	23	36	48	40	49														CASSLGRGPSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGTCCGGGACAGTCGAGGGGGGTTTAATTCACCCCTCCACTTTGGGAAC	CASSYSVRDSRGGFNSPLHF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	60	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	6	5	12	21	38	50	43	62														CASSYSVRDSRGGFNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTTTGACAGGGATCCGAACACTGAAGCTTTCTTTGGACAA	CAISFDRDPNTEAFF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	2	4	23	36	45	38	49														CAISFDRDPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCGGACAGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRPGQTSGANVLTF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	5	0	4	2	23	34	44	38	46														CASRPGQTSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTACTAGGTCGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	41	2.3005016215730943E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	8	4	3	5	23	35	43	38	48						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGAGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDSEGSGANVLTF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	10	0	0	0	0	23	-1	-1	40	46														CASSDSEGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGCAGGGTGATTCACCCCTCCACTTTGGGAAC	CASSYRQGDSPLHF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	3	8	3	2	23	38	46	41	48														CASSYRQGDSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCCAATCCCTAATGAAAAACTGTTTTTTGGCAGT	CASSYTPIPNEKLFF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	3	7	3	0	8	23	-1	40	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTPIPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGATCAGCCCCAGCATTTTGGTGAT	CASSYGTDQPQHF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	5	5	0	0	23	-1	-1	38	45														CASSYGTDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCTGGGCCCACCGGGGAGCAGTACTTCGGGCCG	CASSPPGPTGEQYF	In	VDJ	1	43	2.4127212128693428E-4	2.9529924801703124E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	8	0	7	6	8	23	35	45	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGPTGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCGCGGGGCCTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	2.468831008517467E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	2	3	4	23	37	46	40	50														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAACCGACAGATCTCTGGAAACACCATATATTTTGGAGAG	CASRNRQISGNTIYF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	5	0	5	2	23	34	44	39	46														CASRNRQISGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATGGGTAGCGGGGGGGCCCGGTACAAGTTCTTCGGGCCA	CASSYMGSGGARYKFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	14	5	9	23	38	54	43	63														CASSYMGSGGARYKFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACAGGGGGGAGTCACTGAAGCTTTCTTTGGACAA	CASSLQGGVTEAFF	In	VDJ	1	45	2.524940804165591E-4	3.090340967620094E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	4	1	4	23	36	45	37	49														CASSLQGGVTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTTCAGGGGGGGAGCAGTACTTCGGGCCG	CASSPSGGEQYF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	7	4	1	23	35	46	39	47														CASSPSGGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGACTAGCGGGAGGGCTGGGTGAGCAGTTCTTCGGGCCA	CASSAGLAGGLGEQFF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	0	9	2	5	23	35	53	37	58														CASSAGLAGGLGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGGTTCGACAGGCCCTAAGCTACGAGCAGTACTTCGGGCCG	CASSYPVRQALSYEQYF	In	VDJ	1	46	2.5810505998137155E-4	3.159015211344985E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	4	3	7	7	23	38	51	45	58														CASSYPVRQALSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCTAGCGGGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSSSGGSYEQYF	In	VDJ	1	47	2.63716039546184E-4	3.227689455069876E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	1	2	0	23	34	-1	36	47														CASSSSGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGGGACTGTAGGGTAACTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	48	2.693270191109964E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	0	10	2	2	11	23	33	41	35	52						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGACCCAGGGACTTCTCACCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSDDPGTSHLAKNIQYF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	0	10	0	9	8	23	35	50	44	58						01,02								CASSDDPGTSHLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTCAGCTCTGAACACTGAAGCTTTCTTTGGACAA	CASSVSALNTEAFF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	4	5	0	4	3	23	35	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSALNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGCGGGAGGCAGGAATGAGCAGTTCTTCGGGCCA	CASSLAGGRNEQFF	In	VDJ	1	50	2.8054897824062125E-4	3.433712186244549E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	1	7	1	4	23	34	46	35	50														CASSLAGGRNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATCAGGGGCGAGGATCCACTGAAGCTTTCTTTGGACAA	CASSYDQGRGSTEAFF	In	VDJ	1	50	2.8054897824062125E-4	3.433712186244549E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	4	3	8	23	38	47	41	55														CASSYDQGRGSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGCTGTCTCCCAATGAAAAACTGTTTTTTGGCAGT	CASSYGLSPNEKLFF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	8	0	5	1	8	23	37	42	38	50														CASSYGLSPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAAGACCGAGTACTCTATGGCTACACCTTCGGTTCG	CASSYEDRVLYGYTF	In	VDJ	2	54	3.0299289649987095E-4	3.7084091611441127E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	2	7	4	3	8	23	38	44	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEDRVLYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGACTAATGTGGGATACGCAGTATTTTGGCCCA	CASSGGLMWDTQYF	In	VDJ	2	55	3.086038760646834E-4	3.777083404869004E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	6	2	6	23	35	44	37	50						01,02								CASSGGLMWDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCAGGGGGTCGTAGAAACACCATATATTTTGGAGAG	CASSSPGGRRNTIYF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	1	5	3	5	23	36	46	39	51														CASSSPGGRRNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGACAGGCCTTCTATGGCTACACCTTCGGTTCG	CASSSGQAFYGYTF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	4	1	4	23	36	45	37	49														CASSSGQAFYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDNTGELFF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	2	7	2	0	0	23	-1	-1	35	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCAAACCTCCGGGACAGGGTCCGGCTACACCTTCGGTTCG	CASSYQTSGTGSGYTF	In	VDJ	2	57	3.198258351943082E-4	3.914431892318786E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	8	10	3	23	37	56	47	59														CASSYQTSGTGSGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGTAAAAATGGACAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	58	3.2543681475912065E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	0	10	0	23	34	-1	44	52														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCGAGACCCAGTACTTCGGGCCA	CASSYSTETQYF	In	VDJ	2	60	3.366587738887455E-4	4.1204546234934586E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	2	7	5	0	1	23	-1	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCACAGCGAAGATTCACCCCTCCACTTTGGGAAC	CASSYHSEDSPLHF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	3	3	5	8	2	5	23	37	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYHSEDSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAACTAGCGGCGAAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	62	3.4788073301837035E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	5	3	3	5	23	38	49	41	54						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTGACAGTTACCAAGAGACCCAGTACTTCGGGCCA	CASSADSYQETQYF	In	VDJ	2	63	3.534917125831828E-4	4.326477354668132E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	5	0	3	2	23	35	43	38	45														CASSADSYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGAAGCTATGGGACAGCTTACTACGAGCAGTACTTCGGGCCG	CASSRSYGTAYYEQYF	In	VDJ	2	66	3.7032465127762005E-4	4.5325000858428046E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	9	4	23	35	51	44	55														CASSRSYGTAYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTTCTTATAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	69	3.871575899720573E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	10	5	23	35	48	45	53														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGTGCAGACCCAGTACTTCGGGCCA	CASSYSGVQTQYF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	6	1	6	0	3	23	-1	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGVQTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCAAGGGAGCAGTCTGTTCTTCGGGCCA	CASSYPQGSSLFF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	2	15	6	6	23	38	49	44	55														CASSYPQGSSLFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGACCGGGGCCTAATCAGCCCCAGCATTTTGGTGAT	CAIRPGPNQPQHF	In	VDJ	2	72	4.039905286664946E-4	4.944545548192151E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	7	0	4	3	2	23	34	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRPGPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCAAGTGGGCTGAAGCTTTCTTTGGACAA	CASSYGKWAEAFF	In	VDJ	2	77	4.320454264905567E-4	5.287916766816605E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	9	6	7	0	23	38	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGKWAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTAATTACAGGGAGGAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	78	4.3765640605536915E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	3	3	3	7	6	23	34	47	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCCGACAGCTCTTGAACACTGAAGCTTTCTTTGGACAA	CASRPRQLLNTEAFF	In	VDJ	2	80	4.48878365184994E-4	5.493939497991278E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	0	5	4	23	34	44	39	48														CASRPRQLLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGGGGACAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CAIRGDRAYNEQFF	In	VDJ	2	80	4.48878365184994E-4	5.493939497991278E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	2	2	0	23	34	-1	36	45														CAIRGDRAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGACACTCGACAGGCACTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTGHSTGTYSNQPQHF	In	VDJ	2	81	4.544893447498064E-4	5.562613741716169E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	4	0	10	6	23	33	49	43	55														CASTGHSTGTYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGGGAGGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGTGEVSNQPQHF	In	VDJ	2	81	4.544893447498064E-4	5.562613741716169E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	2	1	0	5	23	-1	48	38	53														CASSYGTGEVSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCGGATGTGAACACTGAAGCTTTCTTTGGACAA	CASTPDVNTEAFF	In	VDJ	2	82	4.6010032431461885E-4	5.63128798544106E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	1	8	0	4	2	23	33	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPDVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGAGGCGGGGAAGCAGATACGCAGTATTTTGGCCCA	CASSSGGGEADTQYF	In	VDJ	2	84	4.713222834442437E-4	5.768636472890843E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	4	6	3	23	36	48	42	51														CASSSGGGEADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCTTGCGGGGGGGCGGTCCTACGAGCAGTACTTCGGGCCG	CASRLAGGRSYEQYF	In	VDJ	2	85	4.769332630090561E-4	5.837310716615734E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	0	1	4	3	23	34	47	38	50														CASRLAGGRSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGATGCCGGGACTAGCGGTTTAGGAATGAGCAGTTCTTCGGGCCA	CASRRCRD*RFRNEQFF	Stop	VDJ	3	89	4.993771812683058E-4		51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	7	8	6	23	34	53	42	59						01,02								CASRRCRD*RFRNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCCCGAGGAGGACTACAAGAGACCCAGTACTTCGGGCCA	CASRARGGLQETQYF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	9	2	10	0	23	34	-1	44	50						01,02								CASRARGGLQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAGACGAGGGGATGTATGAAAAACTGTTTTTTGGCAGT	CASSYLDEGMYEKLFF	In	VDJ	3	93	5.218210995275555E-4	6.386704666414861E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	5	2	6	7	4	23	38	50	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLDEGMYEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGAGAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	93	5.218210995275555E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	2	0	1	2	23	37	42	38	44														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGCCCCCATACTAGCGGGGGGGCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	93	5.218210995275555E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	4	10	2	23	34	57	44	59														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACTTCGGGACTAGCGGGGGTGGGTCCTACGAGCAGTACTTCGGGCCG	CAISDFGTSGGGSYEQYF	In	VDJ	3	96	5.386540382219928E-4	6.592727397589534E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	1	2	4	23	39	55	41	59														CAISDFGTSGGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCACCTTCAACTATGGCTACACCTTCGGTTCG	CASSSTFNYGYTF	In	VDJ	3	98	5.498759973516177E-4	6.730075885039316E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	4	3	7	2	2	4	23	36	40	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTFNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACAGGGAAGGCAGATACGCAGTATTTTGGCCCA	CASRTGKADTQYF	In	VDJ	3	101	5.667089360460549E-4	6.936098616213989E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	4	0	4	23	-1	41	34	45														CASRTGKADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCTAGAGGAGCAGTTCTTCGGGCCA	CASSYGLEEQFF	In	VDJ	3	102	5.723199156108674E-4	7.00477285993888E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	8	0	10	0	5	23	-1	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGLEEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGATGAGATCACCCCTCCACTTTGGGAAC	CASSYSGQMRSPLHF	In	VDJ	3	104	5.835418747404922E-4	7.142121347388662E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	10	0	6	23	-1	47	40	53														CASSYSGQMRSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGAGTCCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGSPGTGELFF	In	VDJ	3	110	6.172077521293668E-4	7.554166809738008E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	4	0	6	23	-1	40	34	46														CASSGSPGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGGACAGGGAATGAAAACTGTTTTTTGGCAGT		Out	VDJ	3	112	6.284297112589916E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	10	1	4	23	36	46	37	50														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTTACTCCCCGGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASIYSPGRNTEAFF	In	VDJ	3	119	6.677065682126785E-4	8.172235003262026E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	3	1	2	2	23	40	47	42	49						01,02								CASIYSPGRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACCGGGGAGCCCACAGATACGCAGTATTTTGGCCCA	CASTTGEPTDTQYF	In	VDJ	3	123	6.901504864719282E-4	8.44693197816159E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	8	3	2	4	4	23	33	42	37	46						01,02								CASTTGEPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCTTAAACCAAACAGGGGCACCTACGAGCAGTACTTCGGGCCG	CASSPLKPNRGTYEQYF	In	VDJ	3	123	6.901504864719282E-4	8.44693197816159E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	2	14	2	23	34	55	48	57														CASSPLKPNRGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTCGGGATCATGAACACTGAAGCTTTCTTTGGACAA	CASRVGIMNTEAFF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	3	0	3	3	23	34	42	37	45														CASRVGIMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGGACAGGGAGACGCCAACGTCCTGACTTTCGGGGCC	CASSYLGQGDANVLTF	In	VDJ	4	126	7.069834251663656E-4	8.652954709336264E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	0	3	7	2	4	23	38	49	40	53														CASSYLGQGDANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGAAGCGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKKRENTGELFF	In	VDJ	4	131	7.350383229904276E-4	8.996325927960718E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	6	3	1	3	0	23	33	-1	36	43														CASKKRENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACAGGGGCCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSTGAHTGELFF	In	VDJ	4	132	7.406493025552401E-4	9.065000171685609E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	3	1	3	23	34	42	35	45														CASSTGAHTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTACCTGGGCGAACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	4	139	7.79926159508927E-4		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	8	0	0	4	4	23	39	47	43	51														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAACAGGACTTTCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRTGLSSSYNEQFF	In	VDJ	4	156	8.753128121107383E-4	0.0010713182021082992	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	3	4	0	3	9	23	35	43	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTGLSSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGAAGCGGAAAAACTGTTTTTTGGCAGT	CASSYAEAEKLFF	In	VDJ	4	156	8.753128121107383E-4	0.0010713182021082992	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	6	6	8	5	0	23	38	-1	43	47						01,02								CASSYAEAEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAACAGGGGTGGCCCTGAAGCTTTCTTTGGACAA	CASRNRGGPEAFF	In	VDJ	5	162	9.089786894996129E-4	0.0011125227483432339	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	6	2	5	23	34	43	36	48														CASRNRGGPEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGACGCCGGGGAGCTACACCTTCGGTTCG	CASSYSTGTPGSYTF	In	VDJ	5	163	9.145896690644252E-4	0.001119390172715723	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	9	0	10	23	-1	47	40	57														CASSYSTGTPGSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCCCCGGGGCTTAGACATTTCTGAAGCTTTCTTTGGACAA	CASSPRGLDISEAFF	In	VDJ	5	186	0.001043642199055111	0.0012773409332829722	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	7	0	6	7	10	23	32	44	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGLDISEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAATCCCCTACGAGCAGTACTTCGGGCCG	CASSVIPYEQYF	In	VDJ	5	194	0.0010885300355736103	0.0013322803282628851	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	9	2	1	4	23	35	38	36	42						01,02								CASSVIPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTAAACCCGGGGGACAGGGGGTTATTGAGCAGTTCTTCGGGCCA	CAIKPGGQGVIEQFF	In	VDJ	6	204	0.0011446398312217347	0.001400954571987776	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	1	9	10	4	23	30	51	40	55														CAIKPGGQGVIEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGAGAGAGGGGAAGCGCAGGCGCCGAATTCACAGATACGCAGTATTTTGGCCCA	CAIGERGSAGAEFTDTQYF	In	VDJ	7	241	0.0013522460751197944	0.0016550492737698727	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	10	5	2	2	8	18	23	30	43	38	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIGERGSAGAEFTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGACCGAAAAACTGTTTTTTGGCAGT	CASSYVTEKLFF	In	VDJ	7	256	0.0014364107685919808	0.001758060639357209	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	2	7	8	2	1	23	38	43	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVTEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTATTGGTTACGGTAATACGCAGTATTTTGGCCCA	CASSFIGYGNTQYF	In	VDJ	10	345	0.0019357879498602866	0.0023692614085087387	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	5	7	10	2	23	36	49	46	51						01,02								CASSFIGYGNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGCGGGGGCTTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	13	474	0.0026596043137210893		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	2	2	5	23	35	44	37	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGACAGGGATCGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASATGIGTNEKLFF	In	VDJ	18	638	0.0035798049623503273	0.004381416749648044	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	2	3	2	2	6	23	32	41	34	47														CASATGIGTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTGGACTAGCGGGAGTCTAGATACGCAGTATTTTGGCCCA		Out	VDJ	20	711	0.0039894064705816345		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	1	2	5	3	3	23	38	54	41	57														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATGAGGGGGTATGAGACCCAGTACTTCGGGCCA	CASRMRGYETQYF	In	VDJ	20	722	0.004051127245794571	0.004958280396937129	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	4	3	23	34	44	38	47														CASRMRGYETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACGGGACCCCCAGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSDGTPRGAKNIQYF	In	VDJ	1	12	6.73317547777491E-5	8.240909246986918E-5	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	2	0	11	0	24	36	-1	47	53													Vb 18	CASSDGTPRGAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGAGGCTCAGCCCCAGCATTTTGGTGAT	CASSPGEAQPQHF	In	VDJ	1	15	8.416469347218638E-5	1.0301136558733647E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	1	6	2	1	24	38	46	40	47													Vb 18	CASSPGEAQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCTACGGGGGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSTGGPNTGELFF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	1	0	4	2	24	39	50	43	52													Vb 18	CASSPSTGGPNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGTTTGGTGGCGAGGAATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCATACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSPPILAGGETQYF	In	VDJ	1	16	8.97756730369988E-5	1.0987878995982556E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	1	4	3	0	33	50	-1	53	65													Vb 18	CASSPPILAGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGTTTGGTGGCGAGGAGATTCGGCAGCTATTTCTGTGCCAGCTCACCACCCATACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSPPILAGGETQYF	In	VDJ	1	18	1.0099763216662365E-4	1.2361363870480376E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	1	4	3	0	33	50	-1	53	65													Vb 18	CASSPPILAGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGACAGGTTAGAGTCACCCCTCCACTTTGGGAAC	CASSPTDRLESPLHF	In	VDJ	1	19	1.0660861173143608E-4	1.3048106307729287E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	4	10	2	6	24	39	48	41	54													Vb 18	CASSPTDRLESPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAACTCACCACGATTGAGCGGGGGCCCCGGATGGGAGCAGTACTTCGGGCCG	CANSPRLSGGPGWEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	2	7	5	10	24	40	53	45	63													Vb 18	CANSPRLSGGPGWEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAGCCGGGACAGGTAACTACGAGCAGTACTTCGGGCCG	CASSPAGTGNYEQYF	In	VDJ	1	20	1.122195912962485E-4	1.3734848744978195E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	4	3	3	3	24	39	50	42	53													Vb 18	CASSPAGTGNYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATTAGTAGACGGGGGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSPISRRGTTGELFF	In	VDJ	1	23	1.2905252999068578E-4	1.5795076056724925E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	2	4	9	2	24	39	54	48	56													Vb 18	CASSPISRRGTTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
TATTTCTGTGCCAGCTCACCCCCGGAAGCGACTAGCGGGATCCCCATCCTATACAATGAGCAGTTCTTCGGGCCA	CASSPPEATSGIPILYNEQFF	In	VDJ	1	24	1.346635095554982E-4	1.6481818493973836E-4	63	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	2	3	4	9	11	6	20	40	29	51													Vb 18	CASSPPEATSGIPILYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAGGGACAGGCAAACTACCTACGAGCAGTACTTCGGGCCG	CASSRDRQTTYEQYF	In	VDJ	1	26	1.4588546868512305E-4	1.7855303368471655E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	2	7	24	35	45	37	52													Vb 18	CASSRDRQTTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCTTACGGTTACCAAGAGACCCAGTACTTCGGGCCA	CASSPSYGYQETQYF	In	VDJ	1	31	1.7394036650918518E-4	2.1289015554716204E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	5	0	5	2	24	39	47	44	49						01,02							Vb 18	CASSPSYGYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGATACCGGACAGTCTCTACTATGGCTACACCTTCGGTTCG	CASSPIPDSLYYGYTF	In	VDJ	1	33	1.8516232563881003E-4	2.2662500429214023E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	3	6	5	24	38	50	44	55													Vb 18	CASSPIPDSLYYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGACAGGGTGATTCTAGCGAGCAGTACTTCGGGCCG	CASSPPGQGDSSEQYF	In	VDJ	1	34	1.9077330520362245E-4	2.3349242866462934E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	6	0	9	24	-1	50	41	59													Vb 18	CASSPPGQGDSSEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCACCGGCGGGGGCAAGAGCTTTCTTTGGACAA	CASSPPAGARAFF	In	VDJ	1	38	2.1321722346287215E-4	2.6096212615458575E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	2	10	1	4	24	41	49	42	53													Vb 18	CASSPPAGARAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTAAAAGGCCCCGGGACCCAGTACTTCGGGCCA	CASSPVKGPGTQYF	In	VDJ	1	39	2.1882820302768458E-4	2.678295505270748E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	5	4	7	5	6	24	39	47	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPVKGPGTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCTCCGACATTCCAAGAGACCCAGTACTTCGGGCCA	CASSPPPTFQETQYF	In	VDJ	1	40	2.24439182592497E-4	2.746969748995639E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	6	1	6	2	24	38	48	44	50													Vb 18	CASSPPPTFQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCACGGGGGGAGGGCCTGAAGCTTTCTTTGGACAA	CASSPLTGGGPEAFF	In	VDJ	1	41	2.3005016215730943E-4	2.81564399272053E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	1	6	3	5	24	40	50	43	55						01,02							Vb 18	CASSPLTGGGPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACAGCAGCTAACTATGGCTACACCTTCGGTTCG	CASSTAANYGYTF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	5	0	0	3	24	-1	40	36	43													Vb 18	CASSTAANYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCCGGACTAGCGGGGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPPSGLAGGSSYEQYF	In	VDJ	1	42	2.3566114172212185E-4	2.884318236445421E-4	57	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	1	0	0	4	2	24	41	60	45	62													Vb 18	CASSPPSGLAGGSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGGGACCCCGCGAGGTCGAAAAACTGTTTTTTGGCAGT	CASSEGPREVEKLFF	In	VDJ	1	48	2.693270191109964E-4	3.296363698794767E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	5	0	7	8	2	11	24	36	43	38	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSEGPREVEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGACCAGGGAGGAGAAAGGACCTTCGGTTCG	CASSDQGGERTF	In	VDJ	1	49	2.749379986758088E-4	3.365037942519658E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	14	6	7	24	35	47	41	54													Vb 18	CASSDQGGERTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGAGTTGACGGGGAGCTGTTTTTTGGAGAA	CASSPRVDGELFF	In	VDJ	1	51	2.861599578054337E-4	3.50238642996944E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	2	7	0	6	24	-1	41	38	47													Vb 18	CASSPRVDGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGTCTCGGGGGAAAAACTGTTTTTTGGCAGT	CASSPVSGEKLFF	In	VDJ	1	53	2.973819169350585E-4	3.639734917419222E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	8	5	0	24	38	-1	43	48													Vb 18	CASSPVSGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGTTCCGGCAGGCTCTCATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGRLSSGANVLTF	In	VDJ	2	56	3.142148556294958E-4	3.845757648593895E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	4	4	1	6	6	24	32	42	38	48													Vb 18	CASSGRLSSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGCTAGCAGGGGCACGCAGTATTTTGGCCCA	CASSPPASRGTQYF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	9	6	1	24	41	53	47	54													Vb 18	CASSPPASRGTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGGGGGGCCGTTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPEGGRYSGANVLTF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	2	5	1	0	1	7	24	39	46	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPEGGRYSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGACTGAGCCATCCTACGAGCAGTACTTCGGGCCG	CASSETEPSYEQYF	In	VDJ	2	61	3.422697534535579E-4	4.1891288672183497E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	1	2	6	24	36	42	38	48						01,02							Vb 18	CASSETEPSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGCGACTCCTCCGTGGGGAGACCCAGTACTTCGGGCCA	CASSPRRLLRGETQYF	In	VDJ	2	62	3.4788073301837035E-4	4.257803110943241E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	2	10	5	4	10	24	39	47	43	57						01,02							Vb 18	CASSPRRLLRGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCCAAAACGGGGGACAACGAGCAGTACTTCGGGCCG	CASSPKTGDNEQYF	In	VDJ	2	65	3.647136717128076E-4	4.4638258421179135E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	6	0	6	5	11	0	24	35	-1	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPKTGDNEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCGGGACAGGGAAAGAGCAGTACTTCGGGCCG	CASSTGTGKEQYF	In	VDJ	2	69	3.871575899720573E-4	4.7385228170174773E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	7	3	3	24	36	48	39	51													Vb 18	CASSTGTGKEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGCCAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGPGAYNEQFF	In	VDJ	2	71	3.983795491016822E-4	4.8758713044672595E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	2	5	0	24	38	-1	43	49													Vb 18	CASSPGPGAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAACCCGCAGGGGAGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSPNPQGRSGELFF	In	VDJ	2	74	4.1521248779611945E-4	5.081894035641933E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	2	4	2	6	6	4	24	39	51	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPNPQGRSGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTACAGGGACGTAACGAGCGAGCAGTACTTCGGGCCG	CASSPYRDVTSEQYF	In	VDJ	2	76	4.264344469257443E-4	5.219242523091715E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	6	2	10	24	38	46	40	56													Vb 18	CASSPYRDVTSEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGGACGGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	80	4.48878365184994E-4		47	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	3	1	7	0	3	3	24	38	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTACAGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPLQSTGELFF	In	VDJ	2	80	4.48878365184994E-4	5.493939497991278E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	5	4	3	2	24	38	45	41	47													Vb 18	CASSPLQSTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCAAGGGGGAGGGAGAGCGAGCAGTACTTCGGGCCG	CASSPSRGRESEQYF	In	VDJ	2	86	4.8254424257386855E-4	5.905984960340625E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	0	6	7	4	24	38	52	45	56													Vb 18	CASSPSRGRESEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGTTCGGGCGGATGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGFGRMVSYNEQFF	In	VDJ	3	91	5.105991403979306E-4	6.249356178965079E-4	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	8	0	0	7	7	24	38	49	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGFGRMVSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCGGACTAGCGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	95	5.330430586571803E-4		52	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	0	2	2	24	37	52	39	54													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTGGCACGAATACTGAAGCTTTCTTTGGACAA	CASSLGTNTEAFF	In	VDJ	3	98	5.498759973516177E-4	6.730075885039316E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	5	2	6	24	37	42	39	48													Vb 18	CASSLGTNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGCCGGGGGGCGCGAGGACTGAAGCTTTCTTTGGACAA	CASSPPGGARTEAFF	In	VDJ	3	99	5.5548697691643E-4	6.798750128764207E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	5	5	7	24	35	47	40	54													Vb 18	CASSPPGGARTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPRGNTGELFF	In	VDJ	3	103	5.779308951756797E-4	7.073447103663771E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	1	0	0	24	-1	-1	41	47													Vb 18	CASSPPRGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGACAGGGGGGACCCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSGQGGPGNQPQHF	In	VDJ	3	103	5.779308951756797E-4	7.073447103663771E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	1	2	3	6	24	36	49	39	55													Vb 18	CASSSGQGGPGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAAGACGACAGCAGAAGCTTTCTTTGGACAA	CASSPKTTAEAFF	In	VDJ	3	119	6.677065682126785E-4	8.172235003262026E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	8	6	2	24	38	49	44	51													Vb 18	CASSPKTTAEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGCCGGGACAGGGGCTGACTGAAGCTTTCTTTGGACAA	CASSRPGQGLTEAFF	In	VDJ	4	130	7.294273434256153E-4	8.927651684235827E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	5	4	3	24	37	51	41	54													Vb 18	CASSRPGQGLTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGCAGGGAAACGAAAAACTGTTTTTTGGCAGT	CASSLQGNEKLFF	In	VDJ	4	138	7.743151799441147E-4	9.477045634034955E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	8	3	4	24	36	44	39	48													Vb 18	CASSLQGNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGCGTGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPRGNTGELFF	In	VDJ	5	181	0.0010155873012310489	0.0012430038114205268	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	6	1	0	3	24	-1	44	41	47						01,02							Vb 18	CASSPPRGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCGCCGAAGAGGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASSPAEEGTYNEQFF	In	VDJ	7	253	0.0014195778298975435	0.0017374583662397418	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	4	13	0	24	35	-1	48	54						01,02							Vb 18	CASSPAEEGTYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACCGGACTATGGCTACACCTTCGGTTCG	CASSRPDYGYTF	In	VDJ	9	308	0.001728181705962227	0.002115166706726642	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	0	0	10	3	0	0	24	-1	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRPDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGGGAGGGAGTTAAGACCCAGTACTTCGGGCCA		Out	VDJ	18	633	0.003551750064526265		44	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	0	6	3	5	24	39	49	42	54													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCATACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSPPILAGGETQYF	In	VDJ	120	4277	0.02399815959870274	0.02937197404113587	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	1	4	3	0	24	41	-1	44	56													Vb 18	CASSPPILAGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8674A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5385	4399	868	116	0	1693	1412	249	32	0	178222	145615	28758	3849	0	0.172498837	8.65857887	0.167190179	8.9321909				61582	0.0774133205	0.0372832455	0.030462008	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:22	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 924,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 435,treatment:nact,type of chemo:carbo/taxol	0.8168987706776233	MSKCC- Snyder- P01-01		4767.0	
